METHOD AND SYSTEM OF ANALYSIS OF A SAMPLE FOR AN ANALYTE

专利摘要:
optical imaging system and methods using it. The present invention relates to methods and systems for analyzing a sample for an analyte. methods under certain modalities include illuminating a sample with a slit-shaped beam of light, detecting the light transmitted by the sample, determining the absorbance of transmitted light at one or more wavelengths, and calculating the analyte concentration based on the absorbance to analyze the sample for the analyte. systems for practicing the present methods are also described.
公开号:BR112016010721B1
申请号:R112016010721-7
申请日:2014-11-10
公开日:2021-06-01
发明作者:Scott Bornheimer；Edward Goldberg
申请人:Becton, Dickinson And Company；
IPC主号:

专利说明:

CROSS REFERENCE TO RELATED ORDERS
[001] This application claims priority to United States Provisional Patent Application Serial No. 61/903,804, filed November 13, 2013, and United States Provisional Patent Application Serial No. 61/949,833 filed on March 7, 2014, the disclosures of such applications being incorporated herein by reference. INTRODUCTION
[002] The characterization of analytes in biological fluids has become an integral part of medical diagnoses and assessments of a patient's health and well-being. In particular, the detection of analytes in physiological fluids, eg blood or blood products, is of increasing importance, where results can play a prominent role in a patient's treatment protocol in a variety of disease conditions. In response to this growing importance of analyte detection, a variety of protocols and analyte detection devices for laboratory, clinical and private use have been developed.
[003] For example, patients who have abnormal hemoglobin levels often suffer from various conditions, including anemia, sickle cell anemia, blood loss, nutritional deficiency, bone marrow problems and disorders, including polycythemia rubra vera, dehydration, lung disease, certain tumors, and drug abuse including drug abuse erythropoietin. The specific treatment of these conditions often depends on the duration and level of the hemoglobin abnormality. Therefore, being able to quickly and accurately determine a patient's blood hemoglobin concentration will substantially assist in the diagnosis and management of conditions in a patient that arise due to abnormal hemoglobin levels. SUMMARY
[001] Aspects of this description include methods for analyzing a sample for an analyte. Methods according to certain embodiments include illuminating a sample in a sample chamber with a light source through a slit projection module, detecting the light transmitted by the sample, and calculating the absorbance of the detected light at one or more lengths. waveform for analyzing the sample for the analyte. A slit projection module having a slit that narrows a beam of light from the light source coupled to a focusing lens to focus the slit light, a microcartridge device having a sample chamber for analyzing the samples and imaging systems containing a light source, a slit projection module, an objective lens for focusing light transmitted through the sample, and a detector for detecting one or more wavelengths of transmitted light suitable for practicing the methods covered are also described.
[002] As summarized above, aspects of the present invention include a method of analyzing a sample for an analyte, where the method includes the steps of illuminating a sample in a sample chamber with a light source through a module of slit projection, detection of the light transmitted by the sample and calculation of the absorbance of the light detected at one or more wavelengths for the analysis of the sample to the analyte.
[003] In some embodiments, the sample is illuminated with one or more broad-spectrum light sources. The sample can be illuminated with light using one or more visible or near-infrared light sources, in certain cases with wavelengths ranging from 500 nm to 850 nm. For example, the sample can be illuminated with two broad-spectrum light sources where the sample is illuminated with the first broad-spectrum light source having a wavelength range from 500 nm to 700 nm and a second light source of broad spectrum having a wavelength range from 700 nm to 850 nm. In certain embodiments, the one or more broad spectrum light sources have an irradiation profile with emission peaks at about 450 nm, 550 nm and 830 nm.
[004] In embodiments, the sample is illuminated with the broad spectrum light source through a slit projection module having a slit that narrows a light beam coupled to a focusing lens to focus the reduced light from the light source . The slit projection module, when illuminated, projects a beam of light in the form of a slit into the sample chamber. In some embodiments, the sample chamber is illuminated by moving the sample chamber along the slit beam. In other embodiments, the sample chamber is illuminated by moving the slit-shaped projection module along the length of the sample chamber.
[005] In some examples, the slit-projection module narrows the light beam in such a way that the length of the slit-shaped beam projection is less than the width of the sample chamber. In other cases, the slit-projection module narrows the light beam such that the length of the slit-shaped beam projection is greater than the width of the sample chamber. In still other cases, the slit-projection module narrows the light beam such that the projection length of the slit-shaped beam is substantially the same as the width of the sample chamber. In these embodiments, the slit-projection module narrows the light beam such that the slit-shaped beam projection has a length of from about 2.5 mm to about 3.5 mm, such as about 3 mm. . In some embodiments, the slit projection module is configured to project a beam of light in the form of a slit with a width of about 25 µm to about 75 µM, such as, for example, about 50 µm.
[006] In some modalities, the sample is illuminated by displacing the microfluidic chamber containing the sample along the slit-shaped beam projection along 75% or more of the microfluidic chamber length. In certain cases, the sample is illuminated by shifting the length of the sample chamber along the slit beam projection. In some cases, the method includes moving the length of the microfluidic chamber along the slit beam projection in discrete increments, such as, for example, in increments of 1 mm or more, such as 2 mm or larger increments and including 5 mm or larger increments. In other cases, the methods also include continuous displacement of the length of the sample chamber along the slit beam projection. In some embodiments, light absorbance is measured continuously as the length of the sample chamber moves along the slit.
[007] In other embodiments, the sample is illuminated by displacing the slit-projection module sufficiently to shift the slit-shaped beam projection along 75% or more of the length of the microfluidic chamber. In certain examples, the sample is illuminated by displacing the slit projection module sufficiently to shift the slit beam projection along the length of the sample chamber. In some examples, the method includes shifting the slit projection module sufficiently to shift the slit beam projection along the length of the sample chamber in discrete increments, such as, for example, in increments of 1mm or more, such as 2mm or larger increments and including 5mm or larger increments. In other examples, methods include displacing the slit projection module in a manner sufficient to continuously shift the slit beam projection along the length of the sample chamber. In some embodiments, light absorbance is measured continuously.
[008] In some embodiments, detecting the light transmitted by the sample includes spatially separating wavelengths from the transmitted light. In certain instances, spatially separating transmitted light wavelengths includes the use of a diffraction grating. In certain embodiments, detecting light transmitted by the sample includes projecting an undiffrated image of the slit onto the detector, such as for use in detector calibration.
[009] In embodiments, the methods include calculating the absorbance of light detected at one or more wavelengths for analyzing the sample for the analyte. For example, the absorbance of detected light can be calculated at two different wavelengths. In certain examples, to analyze the sample for the analyte the absorbance of transmitted light is calculated at a wavelength between 500 nm and 600 nm, such as at 548 nm. In other examples, to analyze the sample for the analyte the absorbance of transmitted light is calculated at a wavelength between 600 nm and 700 nm, such as 650 nm and such as 675 nm. In still other examples, to analyze the sample for the analyte a first absorbance of the transmitted light is calculated at a wavelength between 500 nm and 600 nm and a second absorbance is calculated at a wavelength between 600 nm and 700 nm, such as how to calculate the absorbance of transmitted light at 548 nm and at 675 nm. In yet another example, to test the sample for the analyte a first absorbance of transmitted light is calculated at a wavelength between 500 nm and 600 nm and a second absorbance is calculated at a wavelength between 600 nm and 700 nm, such as how to calculate the absorbance of transmitted light at 548 nm and at 650 nm.
[0010] Aspects of the present invention also include systems for practicing the subject methods. Systems, in accordance with certain embodiments, include a light source to illuminate a sample chamber and a slit projection module that contains a slit that narrows the light beam from the light source and a focusing lens to focus the reduced light. through the slit to provide a slit-shaped beam projection into the sample chamber. The systems also include an objective lens to focus light transmitted through the sample and a detector to detect one or more wavelengths of light transmitted through the sample.
[0011] In some embodiments, the systems include one or more broad-spectrum light sources. Broad-spectrum light sources, in certain cases, include one or more visible or near-infrared light sources, such as with wavelengths ranging from 500 nm to 850 nm. For example, the first broad-spectrum light source may have emission wavelengths ranging from 500 nm to 700 nm and the second broad-spectrum light source having emission wavelengths ranging from 700 nm to 850 nm. In certain embodiments, the one or more broad spectrum light sources have an irradiation profile with emission peaks at about 450 nm, 550 nm and 830 nm.
[0012] The systems also include a slit projection module having a slit that narrows a beam of light from the light source and a focusing lens that focuses the reduced beam of light to provide a projection of a light beam in the form of a crack. The slit-projection module can be configured such that the length of the slit-shaped beam projection is orthogonal to the width of the sample chamber. The width of the beam of light projected in the form of slit can vary, such as ranging from 75 µm to 125 µm, including 100 µm. The length of the beam of light projected in the form of a slit can also vary, ranging from 2 mm to 3 mm, such as 2.5 mm. The slit projection module can be configured to project a beam of light in the form of a slit that is wider than the width of the sample chamber. Alternatively, the slit projection module can be configured to project a beam of light in the form of a slit that is equal to the width of the sample chamber. Likewise, the slit-projection module can be configured to project a slit-shaped beam of light that is smaller than the width of the sample chamber.
[0013] In some examples, the slit projection module also includes an optical adjustment protocol. By "optical adjustment" is meant that the slit-shaped beam of light can be altered as desired, such as increasing or decreasing the dimensions or improving the optical resolution of the slit-shaped beam. In some examples, optical adjustment is a magnification protocol configured to increase the slit width, such as by 5% or more, such as by 10% or more, such as by 25% or more, such as by 50% or more and including increasing the slit beam width by 75% or more. In other examples, optical adjustment is a reduction protocol configured to decrease the slit width, such as by 5% or more, such as by 10% or more, such as by 25% or more, such as by 50% or more and including decreasing the slit beam width by 75% or more. In certain embodiments, optical adjustment is an enhanced resolution protocol configured to improve the resolution of the slit beam, such as 5% or more, such as 10% or more, such as 25% or more, such as. as by 50% or more and including increasing the resolution of the slit beam by 75% or more. The slit beam can be adjusted with any suitable optical adjustment protocol, including but not limited to lenses, mirrors, holes, slits and combinations thereof. In certain embodiments, the slit projection module includes a focusing lens coupled to the slit to focus light reduced by the slit. Focusing lenses, for example, can be a reduction lens, such as having a magnification factor of about 0.5 to 0.75. For example, the reduction lens may be an achromatic doublet reduction lens having a magnification factor of about 0.6.
[0014] Systems according to some embodiments include an objective lens to focus the light transmitted through the sample chamber. In some examples, the objective lens is a magnifying lens, such as having a magnification factor of 1.5 to 2.5. For example, the objective lens can be a dual achromatic magnification lens having a magnification factor of about 1.7.
[0015] As described above, the collected light transmitted through the sample can be spatially separated into distinct wavelengths for detection. In some embodiments, the systems include a diffraction grating for separating light into separate wavelengths. In other embodiments, the systems can include a plurality of filters for separating light into distinct wavelengths for detection. In still other embodiments, the systems can include a combination of one or more diffraction gratings and a plurality of filters.
[0016] The systems also include a detector to detect transmitted light from the sample. In some embodiments, the detector is a charge-coupled device. The detector, in certain examples, is configured to detect light transmitted by the sample at wavelengths ranging from 400 nm to 900 nm. For example, the detector can be configured to detect a spectrum of transmitted light from 500 nm to 800 nm.
[0017] In embodiments of the present description, the systems are configured to provide a spatial separation resolution between 5 nm or less, such as 4 nm or less, such as 3 nm or less, such as 2 nm or less and including 1 nm or less. As such, in some system modalities including the slit projection module, objective lens, diffraction grating and a detector to detect transmitted light are configured to provide a spatial separation resolution between 5 nm or less, such as 4 nm or less, such as 3 nm or less, such as 2 nm or less and including 1 nm or less. In other embodiments, systems including the slit projection module, objective lens, filter wheel and a detector detecting transmitted light are configured to provide a spatial resolution of about 5 nm or less, such as 4 nm or less, such as such as 3 nm or less, such as 2 nm or less and including 1 nm or less.
[0018] Aspects of the present description also include a slit projection module for testing a sample in accordance with the present methods. The slit projection module, in some embodiments, includes a slit that narrows a beam of light from the light source and a focusing lens that focuses the narrow beam of light to provide a beam of light in the form of a slit. The slit projection module can be configured such that the slit length is orthogonal to the sample chamber width. In certain examples, the slit projection module is configured to project a beam of light in the form of a slit illuminating the sample chamber. The width of the beam of light projected in the form of a slit can vary, such as ranging from 75 µm to 125 µm, including 100 µm. The length of the beam of light projected in the form of a slit can also vary, ranging from 2 mm to 3 mm, such as 2.5 mm. The slit projection module can be configured to project a beam of light in the form of a slit that is wider than the width of the sample chamber. Alternatively, the slit projection module can be configured to project a beam of light in the form of a slit that is equal to the width of the sample chamber. Likewise, the slit-projection module can be configured to project a slit-shaped beam of light that is smaller than the width of the sample chamber. In certain embodiments, the slit projection module includes a focusing lens coupled to the slit to focus light reduced by the slit. The focusing lens, in certain embodiments, is a reduction lens, such as having a magnification factor of about 0.5 to 0.75. For example, the reduction lens may be an achromatic doublet reduction lens having a magnification factor of about 0.6.
[0019] The methods also include calculating the absorbance of light detected at one or more wavelengths to analyze the sample for the analyte. For example, the absorbance of detected light can be calculated at two different wavelengths. In certain examples, to analyze the sample for the analyte the absorbance of transmitted light is calculated at a wavelength between 500 nm and 600 nm, such as at 548 nm. In other examples, to analyze the sample for the analyte the absorbance of transmitted light is calculated at a wavelength between 600 nm and 700 nm, such as at 675 nm. In still other examples, to analyze the sample for the analyte a first absorbance of the transmitted light is calculated at a wavelength between 500 nm and 600 nm and a second absorbance is calculated at a wavelength between 600 nm and 700 nm, such as how to calculate the absorbance of transmitted light at 548 nm and 675 nm, including the calculation of absorbance of transmitted light at 548 nm and 650 nm.
[0020] Aspects of the present description also include a microfluidic device configured to perform an assay of a liquid sample, where the device includes an attached sample application site, and inlet, a capillary channel sample and a mixing chamber reagent for contacting a sample with one or more reagents. The microfluidic device, in certain embodiments, also includes a blank reference window configured to provide a blank assay during absorbance measurement. BRIEF DESCRIPTION OF THE FIGURES
[0021] The invention can be better understood from the following detailed description when read in conjunction with the accompanying drawings. Included in the drawings are the following figures:
[0022] Figure 1 illustrates an example of illumination of a sample chamber with a slit-shaped beam provided by a slit projection module according to certain embodiments.
[0023] Figures 2a and 2b illustrate an example of configurations of absorbance systems with a slit projection module for illuminating a sample chamber with a slit-shaped beam according to certain embodiments. Figure 2a represents a side view of absorbance systems with a slit projection module. Figure 2b represents a top view of absorption systems with a slit projection module.
[0024] Figure 3 illustrates an example of a configuration of absorbance systems with a slit projection module coupled to a fluorescence detection system according to certain modalities.
[0025] Figure 4 represents an example of a system of interest according to certain modalities.
[0026] Figure 5 illustrates an example of a microfluidic cartridge having a microfluidic sample chamber and a slit reference window for providing blank transmittance according to certain embodiments.
[0027] Figure 6 shows an example of a kit with a microfluidic cartridge according to certain modalities.
[0028] Figure 7 shows an example of a set of different types of kits supplied together within a box according to certain arrangements.
[0029] Figure 8 shows a scheme for determining hemoglobin concentration according to certain modalities.
[0030] Figures 9a-c illustrate examples of absorbance spectra of hemoglobin acquired by illuminating a sample chamber through a slit projection module according to certain embodiments. Figure 9a represents an absorption spectrum of hemoglobin at a concentration of 25 g/dL in whole blood. Figure 9b represents an absorption spectrum of hemoglobin at a concentration of 7 g/dL in whole blood. Figure 9c represents a graph of hemoglobin concentration and absorption at 569 nm.
[0031] Figure 10 illustrates a comparison between the measurement of hemoglobin in whole blood with methods according to certain modalities and a hematology analyzer. DETAILED DESCRIPTION
[0032] Before the present invention is described in greater detail, it is to be understood that this invention is not limited to the particular embodiments described, and as such may vary. It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments only, and is not intended to be limiting, as the scope of the present invention will be limited only by the appended claims.
[0033] When a range of values is provided, it is understood that each intermediate value, to the tenth of a unit of the lower limit unless the context clearly dictates otherwise, between the upper and lower limit of that range and any other indicated value or intermediate in the specified range is encompassed within the scope of the invention. The upper and lower limits of these smaller ranges may independently be included in the smaller ranges and are also encompassed within the scope of the invention, subject to any specifically excluded limit in the indicated range. When the indicated range includes one or both of the limits, the ranges excluding either or both of these included limits are also included in the invention.
Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. While any methods and materials similar or equivalent to those described herein may also be used in the practice or testing of the present invention, representative illustrative methods and materials are now described.
[0035] All publications and patents cited in this specification are hereby incorporated by reference as if each individual publication or patent were specifically and individually indicated to be incorporated by reference and are hereby incorporated by reference to disclose and describe the methods and/or materials in link with which publications are cited. Citation of any publication is for its description prior to the filing date and should not be construed as an admission that the present invention has no right to predate such publication by virtue of a prior invention. In addition, the publication dates provided may differ from the actual publication dates which may need to be independently confirmed.
It should be noted that, as used herein and in the appended claims, the singular forms "a", "an", and "the" include the plural references unless the context clearly dictates otherwise. It is further noted that claims may be worded to exclude any optional elements. As such, this statement is intended to serve as an antecedent basis for the use of such exclusive terminology as "exclusively", "only" and the like in connection with the recitation of claim elements, or the use of a "negative" limitation.
[0037] As will be apparent to those skilled in the art upon reading this description, each of the individual embodiments described and illustrated herein has components and features that can be easily separated from or combined with the features of any of the other various embodiments without becoming depart from the scope or essence of the present invention. Any enumerated method can be performed in the order of the enumerated events or in any other order that is logically possible.
[0038] As summarized above, the present description provides methods for analyzing a sample for one or more analytes. In further describing embodiments of the present description, methods for analyzing a sample for an analyte are first described in greater detail. Next, systems suitable for practicing the present methods for analyzing the sample for the analyte are described. Computer controlled microcartridges, systems and kits are also provided. METHODS OF ANALYSIS OF A SAMPLE FOR AN ANALYTE
[0039] As summarized above, aspects of the present description include methods for analyzing a sample for one or more analytes. The term "assay" is used herein in its conventional sense to refer to evaluating qualitatively or quantitatively by measuring the presence or amount of a species of the target analyte. In certain embodiments, the methods include analyzing a hemoglobin sample.
[0040] A variety of different samples can be analyzed according to the methods of the invention, for example, as described herein. In some cases, the sample is a biological sample. The term "biological sample" is used in its conventional sense to refer to an entire organism, plants, fungi or a subset of animal tissues, cells or parts of components that may in certain cases be found in blood, mucus, lymph fluid, synovial fluid, cerebrospinal fluid, saliva, bronchoalveolar lavage, amniotic fluid, amniotic cord blood, urine, vaginal fluid, and semen. As such, a "biological sample" refers to the native organism or a subset of its tissues, as well as a homogenate, lysate or prepared extract from the organism or a subset of its tissues, including, but not limited to, for example , plasma, serum, spinal fluid, lymph fluid, sections of skin, respiratory tract, gastrointestinal, cardiovascular, and genitourinary, tears, saliva, milk, blood cells, tumors, organs. Biological samples can be any tissue type from organisms, including normal and diseased tissue (eg, cancerous, malignant, necrotic, etc.). In certain embodiments, the biological sample is a liquid sample, such as blood or its derivative, e.g., plasma, tears, urine, semen, etc., where in some cases the sample is a blood sample, including whole blood, such as such as blood obtained from venipuncture or fingerstick (where the blood may or may not be combined with any reagents prior to testing, such as preservatives, anticoagulants, etc.).
[0041] In certain embodiments the source of the sample is a "mammal", where this term is used broadly to describe organisms that are found within the class Mammalia, including the order carnivore (eg dogs and cats), Rodentia (by example, mice, guinea pigs, and rats), and primates (eg, humans, chimpanzees, and monkeys). In some cases, the subjects are human beings. The methods can be applied to samples obtained from human subjects of both sexes and at any stage of development (ie, neonates, infant, juvenile, adolescent, adult), where in certain modalities the human subject is a young, adolescent or adult. Although the present invention can be applied to samples from a human subject, it is to be understood that the methods can also be performed on samples from other animal subjects (i.e., on "non-human subjects"), such as, but not limited to, birds, mice, rats, dogs, cats, cattle and horses.
[0042] In modalities, the amount of sample analyzed in the methods in question may vary, for example, ranging from 0.01 μL to 1000 μL, such as from 0.05 μL to 900 μL, such as from 0.1 μL to 800 μL, such as from 0.5 μL to 700 μL, such as from 1 μL to 600 μL, such as from 2.5 μL to 500 μL, such as from 5 μl to 400 μl, such as from 7.5 μL to 300 μL and including from 10 μL to 200 μL of sample.
[0043] In some embodiments, the biological sample is a specimen that has been preloaded into a container (eg, blender cup, micro vortex tube, sonicator container, etc.) and stored for a predetermined period of time prior to biological sample to be analyzed. For example, the biological sample can be pre-loaded into a microfluidic cartridge, as described in more detail below, for a period of time before the biological sample is analyzed in accordance with the present methods. The amount of time the biological sample is stored following pre-loading into the container prior to analysis of the biological sample may vary, such as 0.1 hours or more, such as 0.5 hours or more, such as 1 hour or more, such as 2 hours or more, such as 4 hours or more, such as 8 hours or more, such as 16 hours or more, such as 24 hours or more, such as 48 hours or more, such as 72 hours or more , such as 96 hours or more, such as 120 hours or more, such as 144 hours or more, such as 168 hours or more and including pre-loading the biological sample into the container, 240 hours or more prior to analysis of the biological sample or it may vary, such as from 0.1 hours to 240 hours before the analysis of the biological sample, such as from 0.5 hours to 216 hours, such as from 1 hour to 192 hours and including from 5 hours to 168 hours before the analysis of the biological sample. For example, the biological sample can be pre-loaded into a container (eg, microfluidic cartridge) configured for use with a system (as described below) to analyze the sample in a remote location (eg, at home, using a kit for use at home or in a doctor's office) and sent to a laboratory for analysis according to the present methods. By "remote location" is meant a location other than the location where the sample is contained and preloaded within the container. For example, a remote location can be another location (eg office, laboratory, etc.) in the same city, another location in a different city, another location in a different state, another location in a different country, etc., with respect to the location of the processing device, for example, as described in more detail below. In some cases, two locations are spaced apart from each other if they are separated from each other by a distance of 10 m or more, such as 50 m or more, including 100 m or more, eg 500 m or more, 1000 m or more, 10,000 m or more, etc.
[0044] In the practice of methods according to certain modalities, a sample in a sample chamber is illuminated with a light source through a slit projection module, detecting the light transmitted by the sample and calculating the absorbance of the light detected in one or more wavelengths to analyze the sample for the analyte. Depending on the target analyte, the sample can be illuminated with one or more light sources. In some embodiments, the sample is illuminated with one or more broadband light sources. The term "broadband" is used herein in its conventional sense to refer to a light source that emits light with a wide range of wavelengths, such as, for example, spanning 50 nm or more, such as 100 nm or more, such as 150 nm or more, such as 200 nm or more, such as 250 nm or more, such as 300 nm or more, such as 350 nm or more, such as 400 nm or more and including covering 500 nm or more . For example, a suitable broadband light source emits light having wavelengths from 400 nm to 700 nm. Another example of a suitable broadband light source includes a light source that emits light having wavelengths from 500 nm to 700 nm. Any suitable broadband light source protocol can be employed, such as a halogen lamp, deuterium arc lamp, xenon arc lamp, stabilized fiber coupled broadband light source, a continuous spectrum wideband LED , superluminescent emitting diode, semiconductor light emitting diode, wide-spectrum LED white light source, an integrated multi-LED white light source, among other broadband light sources or any combination thereof.
[0045] In other embodiments, the sample is illuminated with one or more narrowband light sources that emit a particular wavelength or narrow range of wavelengths. The term "narrowband" is used herein in its conventional sense to refer to a light source that emits light that has a narrow range of wavelengths, such as for example, 50 nm or less, such as 40 nm or less. , such as 30 nm or less, such as 25 nm or less, such as 20 nm or less, such as 15 nm or less, such as 10 nm or less, such as 5 nm or less, such as 2 nm or less and including light sources that emit a specific wavelength of light (ie, monochromatic light). Any suitable narrowband light source protocol can be employed, such as a narrow wavelength LED, laser diode or a wideband light source coupled to one or more bandpass filters, optical diffraction gratings, monochromators , or any combination thereof.
[0046] Depending on the analyte to be analyzed as well as interferents present in the biological sample, the biological sample can be illuminated using one or more light sources, such as two or more light sources, such as three or more light sources, such as as four or more light sources, such as five or more light sources and including ten or more light sources. Any combinations of light sources can be used as desired. For example, when two light sources are employed, a first light source can be a wideband white light source (eg white wideband LED) and the second light source can be a wideband light source near-infrared wideband (eg near-IR wideband LED). In other examples, where two light sources are employed, a first light source may be a wideband white light source (e.g., wideband white light LED) and the second light source may be a white light source. narrow-spectrum light (for example, a narrow-band or near-IR visible light LED). In still other examples, the light source is a plurality of narrowband light sources each emitting specific wavelengths, such as an array of two or more LEDs, such as an array of three or more LEDs, such as an array of five or more LEDs, including an array of ten or more LEDs.
[0047] When using more than one light source, the sample can be illuminated with the light sources simultaneously or sequentially, or a combination thereof. For example, where the sample is illuminated with two light sources, the methods in question may include simultaneously illuminating the sample with both light sources. In other modalities, the sample can be sequentially illuminated by two light sources. When the sample is sequentially illuminated with two or more light sources, the time each light source illuminates it can independently be 0.001 seconds or more, such as 0.01 seconds or more, such as 0.1 seconds or more, such as one second or more, such as 5 seconds or more, such as 10 seconds or more, such as 30 seconds or more, and including 60 seconds or more. In modalities where the sample is sequentially illuminated by two or more light sources, the time the sample is illuminated by each light source can be the same or different.
[0048] The period of time between illumination by each light source may also vary, as desired, being independently separated by a delay of 1 second or more, such as 5 seconds or more, such as for 10 seconds or more, such as such as for 15 seconds or more, such as for 30 seconds or more and including for 60 seconds or more. In modalities where the sample is sequentially illuminated by more than two light sources (i.e., three or more), the delay between illumination by each light source can be the same or different.
[0049] Depending on the analysis protocol, the illumination of the sample can be continuous or at discrete intervals. For example, in some modalities, the sample can be illuminated continuously throughout the entire time the sample is being analyzed. When the light includes two or more light sources, the sample can be continuously illuminated by all light sources simultaneously. In other cases, the sample is illuminated continuously with each light source sequentially. In other embodiments, the sample may be illuminated at regular intervals, such as illuminating the sample every 0.001 microseconds, every 0.01 microseconds, every 0.1 microseconds, every microsecond, every 10 microseconds, every 100 microseconds and including every 1000 microseconds . The sample may be illuminated with the light source one or more times in any given measurement period, such as 2 or more times, such as 3 or more times, including 5 or more times in each measurement period.
[0050] As described in more detail below, the light source to illuminate the sample may emit a spectrum having light wavelengths ranging from 400 nm to 900 nm, such as from 450 nm to 850 nm, such as from 500 nm to 800 nm, such as from 550 nm to 750 nm and including 600 nm to 700 nm. In some embodiments, the sample is illuminated with a single wideband light source emitting light with wavelengths from 400 nm to 900 nm. In other embodiments, the sample is illuminated with light having wavelengths from 400 nm to 900 nm, using a plurality of light sources. For example, the sample can be illuminated by a plurality of narrowband light sources each independently emitting light having wavelengths in the range of 400 nm to 900 nm.
[0051] In certain embodiments, the sample is illuminated with two broadband light sources emitting light with wavelengths from 400 nm to 900 nm. For example, light sources can be a white light LED emitting light with wavelengths ranging from 400 nm to 700 nm and a near infrared LED emitting light with wavelengths ranging from 700 nm to 900 nm. Depending on the type of light source, as described above, the irradiation profile of each light source can vary, having any number of emission peaks. In certain cases, the sample is illuminated with a white LED light emitting light with wavelengths ranging from 400 nm to 700 nm and with emission peaks at around 450 nm and 550 nm and a near infrared LED emitting light with lengths waves ranging from 700 nm to 900 nm and an emission peak at about 830 nm.
[0052] In other embodiments, the sample is illuminated with a plurality of narrowband lamps or LEDs each independently emitting specific wavelengths of light in the range of 400 nm to 900 nm. In one example, the narrowband light source is one or more monochromatic LEDs emitting light in the range of 500 nm to 700 nm, such as at 504 nm, 506 nm, 514 nm, 532 nm, 543 nm, 548 nm, 550 nm, 561 nm, 568 nm, 579 nm, 580 nm, 585 nm, 586 nm or any combination thereof. In another example, the narrowband light source is one or more narrowband lamps emitting light in the range of 500 nm to 700 nm, such as a narrowband cadmium lamp, cesium lamp, helium lamp, mercury lamp , mercury cadmium lamp, potassium lamp, sodium lamp, neon lamp, zinc lamp or any combination thereof.
[0053] In embodiments of the present invention, the sample is illuminated with an illuminating light slit. Illuminating light slit, for example, as described in more detail below, can be produced using any suitable protocol. In some embodiments, the illuminating light slit is produced using a slit projection module, which includes a slit that may or may not be optically coupled to one or more additional components, for example, one or more lenses. For example, in some cases, the illuminating light slit is produced from one or more light sources through a slit projection module having a slit that narrows a beam of light coupled to a focusing lens to focus the reduced beam. of light from the light source. The slit projection module reduces the light beam and produces a light beam in the form of a slit projected onto the sample chamber. During sample evaluation, the sample chamber, slit-projection module or both the sample chamber and slit-projection module can be moved (if desired) to shift the slit-shaped light beam along the sample chamber.
[0054] As described above, the slit projection module is configured to provide a slit-shaped beam with a length and width, wherein the length and width of the illuminating slit can vary. The slit projection module includes a slit having an aperture configured to narrow the beam of light from the one or more light sources and a focusing lens coupled to the slit to focus light passing through the aperture in the slit. The slit opening can be of any suitable shape, including but not limited to an oval, rectangle or other polygon shape. In certain embodiments, the slit opening is rectangular. Depending on the desired dimensions of the slit beam provided by the light source as described above, the dimensions of the opening slit may vary, having a size ranging from 01 mm to 10 mm, such as from 1.25 mm to 9.5 mm, such as between 1.5 mm and 9 mm, such as between 2 mm and 8 mm, such as 2.5 mm to 7 mm, such as 3 mm to 6 mm and including 3.5 mm to 5 mm. The width of the slit opening can range from 1 µm to 250 µm, such as 2 µm to 225 µm, such as 5 µm to 200 µm, such as 10 µm to 150 µm, and including from 15 µm to 125 µm , for example a slit having an opening width of 100 µm.
[0055] The beam of light reduced by the slit can, if desired, be focused using a focusing lens coupled to the slit. In some embodiments, the reduced light beam is focused through a reduction lens having a magnification factor ranging from 0.1 to 0.95, such as a magnification factor of 0.2 to 0.9, such as a magnification factor of 0.3 to 0.85, such as a magnification factor of 0.35-0.8, such as a magnification factor of 0.5 to 0.75 and including reduced light beam focusing by means of a reduction lens having a magnification factor of 0.55 to 0.7, for example a magnification factor of 0.6. For example, the reduced light beam is, in certain cases, focused through a double achromatic reduction lens having a magnification factor of about 0.6.
[0056] As described in greater detail below, the slit projection module can be configured to provide a slit-shaped beam having a varying length and width. In some embodiments, the slit projection module is configured to provide a slit-shaped beam with a length ranging from 1 mm to 5 mm, such as 1.5 mm to 4.5 mm, such as 2 mm to 4mm, such as 2.5mm to 3.5mm and including a slit-shaped beam with a 3mm c. In these embodiments, the slit projection module is configured to provide a slit-shaped beam with a width ranging from 10 μm to 100 μm, such as 15 μm to 95 μm, such as 20 μm to 90 μm, such as as from 25 μm to 85 μm, such as from 30 μm to 80 μm, such as from 35 μm to 75 μm, such as from 40 μm to 70 μm, such as from 45 μm to 65 μm, and including 50 µm to 60 µm.
[0057] In some embodiments, the slit-projection module is configured to provide a slit-shaped beam of light wherein the length of the slit-shaped beam is orthogonal to the length of a sample chamber being analyzed. In other words, the length of the slit beam is positioned across the width of the sample chamber being analyzed. Depending on the size of the sample chamber (as described in more detail below) and projection of the slit beam, the slit beam may illuminate 50% or more of the sample chamber width, such as or more 55% , such as 60% or more, such as 65% or more, such as 70% or more, such as 75% or more, such as 80% or more, such as 85% or more, such as 90% or more, such as 95% or more, such as 97% or more and including illuminating 99% or more of the sample chamber width. In certain cases, the slit-shaped beam projection has a length that is substantially the same as the width of the sample chamber. In other embodiments, the slit projection module is configured to provide slit-shaped beam projection that has a length that is greater than the width of the sample chamber. For example, the slit-shaped light beam may have a length that is 1% or more than the width of the sample chamber, such as 2% or more, such as 5% or more, such as 10% or more , such as 15% or more, such as 20% or more, and which includes a length that is 25% more than the width of the sample chamber. In still other embodiments, the slit projection module is configured to provide a slit-shaped beam projection that has a length that is less than the width of the sample chamber. For example, the slit-shaped light beam can have a length that is 1% or more or less than the width of the sample chamber, such as a length that is 2% or more or less than the width of the sample chamber. sample, such as a length that is 5% or more or less than the width of the sample chamber, such as a length that is 10% or more or less than the width of the sample chamber, such as a length that is 15 % or more or less than the width of the sample chamber, such as a length that is 20% or more or less than the width of the sample chamber and including a length that is 25% or more or less than the width of the chamber of sample.
[0058] During sample evaluation, the sample chamber, the slit projection module or both the sample chamber and the slit projection module can be moved (if desired) to shift the slit-shaped light beam along the sample chamber. The term "moving" refers to the displacement between the slit projection module and the sample chamber such that the slit-shaped light beam projected onto the sample chamber changes position with time along the sample chamber. sample during sample analysis. In some embodiments, the sample chamber is moved while the slit-projection module is held in a stationary position in order to laterally shift the slit-shaped light beam across the sample chamber during evaluation. In other embodiments, the slit-projection module is moved and the sample chamber is held in a stationary position in order to laterally shift the slit-shaped light beam across the sample chamber during evaluation. In still other embodiments, both the slit projection module and the sample are moved so as to laterally shift the slit-shaped light beam across the sample chamber during evaluation.
[0059] In embodiments, the sample chamber or the slit projection module can be moved so that the slit-shaped light beam is displaced laterally with respect to the sample chamber in any direction, where in some cases the length of the slit-shaped beam remains orthogonal to the length of the sample chamber. In some cases, the sample chamber or slit projection module is moved such that the slit-shaped light beam is moved from a distal end to a proximal end of the sample chamber. In other cases, the sample chamber or slit-projection module is moved such that the slit-shaped light beam is moved from a proximal end to a distal end of the sample chamber. The sample chamber or slit projection module can be configured to move such that the slit-shaped light beam is moved along all or a portion of the length of the sample chamber to evaluate the sample. In some embodiments, the slit-shaped beam of light is moved along 50% or more of the sample chamber, such as 55% or more, such as 60% or more, such as 65% or more, such as 70 % or more, such as 75% or more, such as 80% or more, such as 85% or more, such as 90% or more, such as 95% or more, such as 97% or more and including over 99% or more of the length of the sample chamber. In certain cases, the slit-shaped beam is displaced along substantially the entire length of the sample chamber.
[0060] In certain embodiments, the sample chamber or slit projection module is moved so that the slit-shaped light beam is moved in a back-and-forth motion relative to the sample chamber, such as moving a slit. distal end to a proximal end of the sample chamber and back from the proximal end to the distal end of the sample chamber. In other cases, the sample chamber or slit-projection module is moved so that the slit-shaped light beam is displaced relative to the sample chamber from the proximal end to the distal end of the sample and slit chamber. from the distal end to the proximal end of the sample chamber. The sample chamber or slit projection module is moved so that the slit-shaped light beam is, in certain cases, moved in a back-and-forth motion along only a portion of the sample chamber. For example, the sample chamber or slit projection module is moved so that the slit-shaped beam can be moved in a back-and-forth motion along 99% or less of the sample chamber, such as 95 % or less, such as 90% or less, such as 85% or less, such as 80% or less, such as 75% or less, such as 70% or less, such as 65% or more, including moving the camera The specimen or slit projection module is moved so that the slit-shaped beam is moved in a back-and-forth motion along 50% or less of the length of the specimen chamber.
[0061] Whenever the slit-shaped light beam is moved in a back-and-forth motion, the movement of the sample chamber or slit projection module may be repeated one or more times during a given evaluation period, such as 2 or more times, such as 5 or more times, such as 10 or more times, such as 15 or more times and including 25 or more times during each evaluation period.
[0062] The amplitude of displacement of the slit-shaped light beam along the sample chamber during evaluation may vary. By "range of displacement" or "total displacement" is meant the sum total of distance traveled by the slit-shaped light beam along the sample chamber. In one example, where the slit-shaped light beam is moved from a proximal end to a distal end of a 60 mm sample chamber, the total displacement of the slit-shaped light beam is 60 mm. In another example, where the slit-shaped beam is moved from a distal end to a proximal end of a 60 mm sample chamber, the total displacement of the slit-shaped light beam is 60 mm. In yet another example, where the slit-shaped beam is moved back and forth from the proximal end to a distal end and back from the distal end to the proximal end of a 60mm sample chamber, the total displacement is 120 mm. In yet another example, where the slit-shaped beam is moved in a back-and-forth motion (eg, from the proximal end to the distal end and back from the distal end to the proximal end) along 50% of a chamber of 60 mm samples, the total displacement is 60 mm. In yet another example, where the slit-shaped beam is moved in a back-and-forth motion (eg, from the distal end to the proximal end and back from the proximal end to the distal end) along 50% of a chamber of 60 mm sample and repeated five times, the total displacement is 300 mm.
[0063] In embodiments of the present description, the total displacement varies, ranging from 0.1 mm to 1000 mm, such as from 0.2 mm to 950 mm, such as from 0.3 mm to 900 mm, such as 0 0.4mm to 850mm such as 0.5mm to 800mm such as 0.6mm to 750mm such as 0.7mm to 700mm such as 0.8mm to 650mm , such as from 0.9mm to 600mm, such as from 1mm to 550mm, such as from 1.25mm to 500mm, such as from 1.5mm to 450mm, such as from 1.75mm to 400mm, such as from 2mm and 300mm, such as from 2.5mm to 250mm, and including from 3mm to 200mm.
[0064] The slit-shaped light beam can be moved through the sample chamber at a rate that varies, such as at a rate of 0.001 mm/second or more, such as at a rate of 0.005 mm/second or more, such as at a rate of 0.01 mm/second or more, such as at a rate of 0.05 mm/second or more, such as at a rate of 0.1 mm/second or more, such as a rate of 0.5 mm/second or more, such as a rate of 1 mm/second or more, such as a rate of 1.5 mm/second or more, such as a rate of 2 mm/second or more, such as at a rate of 2.5 mm/second or more, such as at a rate of 3 mm/second, such as at a rate of 5 mm/second or more, such as at a rate of 10 mm /second or more, such as at a rate of 20 mm/second or more, such as at a rate of 30 mm/second or more, such as at a rate of 40 mm/second or more and including shifting the beam in shape across the sample chamber at a rate of 60 mm/second or more. Whenever the slit beam is moved across the sample chamber in a back and forth motion, the ratio can be 1 cycle of back and forth per minute or more, such as 2 cycles per minute or more, such as 3 cycles per minute or more, such as 4 cycles per minute or more, such as 5 cycles per minute or more, such as 10 cycles per minute or more, such as 15 cycles per minute or more, such as 20 cycles per minute or more, such as 30 cycles per minute or more, such as 45 cycles per minute or more, and including 60 cycles of back and forth per minute or more.
[0065] The movement of the sample chamber or slit projection module to move slit-shaped beam along the sample chamber can be continuous or in discrete increments. In some embodiments, the sample chamber or slit-projection module is moved so that the slit-shaped light beam is moved across the sample chamber continuously throughout the entire time the sample is being analyzed. , such as at a rate of 0.001 mm/second or more, such as a rate of 0.005 mm/second or more, such as a rate of 0.01 mm/second or more, such as a rate of 0 .05 mm/second or more, such as at a rate of 0.1 mm/second or more, such as at a rate of 0.5 mm/second or more, such as at a rate of 1 mm/second or more , such as at a rate of 1.5 mm/second or more, such as at a rate of 2 mm/second or more, such as at a rate of 2.5 mm/second or more, such as at a rate of 3 mm/second, such as at a rate of 5 mm/second or more, such as at a rate of 10 mm/second or more, such as at a rate of 20 mm/second or more, such as at a rate of 30 mm/second or more, such as at a rate of 40 mm /second or more and including moving the sample chamber or slit-projection module so that the slit-shaped light beam is continuously displaced relative to the sample chamber at a rate of 60 mm/second or more.
[0066] In other embodiments, the sample chamber or slit projection module is moved such that the slit-shaped beam is shifted relative to the sample chamber in discrete increments. In these modalities, the slit-shaped light beam is, in some cases, shifted relative to the sample chamber in regular increments, such as in 0.01 mm increments, 0.05 mm increments, 0.1 increments mm, 0.2 mm increments, 0.3 mm increments, 0.5 mm increments, 0.75 mm increments, 1 mm increments, 2.5 mm increments, 5 mm increments, 7 increments 5mm, 10mm increments, 15mm increments, 20mm increments, or some other increment. In other cases, the slit-shaped light beam is displaced relative to the sample chamber at random intervals ranging in increments from 0.01 mm to 20 mm, such as 0.1 mm to 17.5 mm, such as in increments from 0.5 mm to 15 mm, including random increments ranging in increments from 1 mm to 10 mm.
[0067] As described above, in some embodiments the sample chamber is sequentially illuminated with a plurality of light sources. When the sample chamber is sequentially illuminated with more than one light source, each light source independently provides a slit-shaped beam of light that is displaced relative to the sample chamber. The movement of each slit-shaped light beam relative to the sample chamber provided by the plurality of light sources may be the same or different as described above. For example, when the sample chamber is sequentially illuminated by two light sources (eg a wideband white light LED and a near IR LED), a first slit-shaped beam produced by the first light source ( eg wideband white light LED) sequentially evaluates the sample chamber with a second slit-shaped beam produced by the second light source (eg near-IR LED). In other words, in these embodiments, at least two slit-shaped beams are provided to evaluate the sample chamber. For example, in some embodiments a first light source providing a slit-shaped first beam may be moved across the sample chamber in a back-and-forth motion, while a second light source providing a slit-shaped second beam. it can be moved along the sample chamber in only one direction. In other embodiments, a first light source providing a slit-shaped first beam may be moved along the sample chamber in a back-and-forth motion in a plurality of cycles, while the second light source providing a second beam. slit shape can be moved in a back-and-forth motion in a single cycle.
[0068] Figure 1 represents the displacement of a slit-shaped light beam with respect to a sample chamber. The slit-shaped beam (101) provided by a slit-projection module is oriented across the width of the sample chamber (102) and the sample chamber is moved laterally (103) along the slit-shaped light beam to illuminate all or part of the sample chamber. As desired, the sample chamber or slit projection module can be moved so that the slit-shaped beam can be moved relative to the sample chamber one or more times or in a back-and-forth motion.
[0069] In some embodiments, light transmitted through the sample chamber is collected and passed through one or more objective lens. In certain cases, light transmitted through the sample chamber is collected and passed through a magnifying glass with a nominal magnification ranging from 1.2 to 2.5, such as a nominal magnification of 1.3 to 2.4. , such as a nominal magnification of 1.4 to 2.3, such as a nominal magnification of 1.5 to 2.2, such as a nominal magnification of 1.6 to 2.1, including the passage of light transmitted through of a magnifying lens having a nominal magnification of 1.7 to 2.0, for example a nominal magnification of 1.7. For example, transmitted light is, in certain cases, collected and passed through an achromatic doublet lens with a nominal magnification of 1.7. Depending on the configuration of the light source, sample chamber and detector, objective lens properties may vary. For example, the numerical aperture of the objective lens in question can also vary, ranging from 0.01 to 1.7, such as 0.05 to 1.6, such as 0.1 to 1.5, such as 0.2 to 1.4, such as 0.3 to 1.3, such as 0.4 to 1.2, such as 0.5 to 1.1 and including a numerical aperture ranging from 0, 6 to 1.0. Likewise, the focal length of the objective lens varies, ranging from 10mm to 20mm, such as from 10.5mm to 19mm, such as from 11mm to 18mm and including from 12mm to 15mm.
[0070] In some embodiments, the projection of the slit beam transmitted through the sample chamber is also focused using an autofocus module. For example, suitable protocols for focusing the slit beam projection transmitted through the sample chamber may include, but are not limited to, those described in U.S. Patent No. 6,441,894, filed October 29, 1999 , the description of which is incorporated herein by reference.
[0071] Methods in accordance with some embodiments of the present invention also include passing transmitted light through one or more wavelength splitters. The term "wavelength separator" is used herein in its conventional sense to refer to an optical protocol for separating polychromatic light into its wavelength elements for detection. Wavelength separation, in certain embodiments, may include selectively passing or blocking wavelengths or wavelength ranges of polychromatic light. To separate wavelengths of light, transmitted light can be passed through any suitable wavelength separation protocol, including but not limited to colored glass, bandpass filters, interference filters, dichroic mirrors, diffraction gratings. , monochromators and their combinations, among other wavelength separation protocols.
[0072] In some embodiments, the methods include separating the transmitted light from the sample chamber by passing the transmitted light through one or more diffraction gratings. The diffraction gratings of interest may include, but are not limited to, transmission, scatter or reflective diffraction gratings. Appropriate diffraction grating spacings may vary depending on the configuration of the light source, slit projection module, sample chamber, objective lens, ranging from 0.01 μm to 10 μm, such as from 0.025 μm to 7.5 μm, such as from 0.5 μm to 5 μm, such as from 0.75 μm to 4 μm, such as from 1 μm to 3.5 μm and including between 1.5 μm and 3.5 μm. In other embodiments, the methods include separating the transmitted light from the sample chamber by passing the transmitted light through one or more optical filters, such as one or more bandpass filters. For example, optical filters of interest may include bandpass filters having minimum bandwidths ranging from 2 nm to 100 nm, such as 3 nm to 95 nm, such as 5 nm to 95 nm, such as 10 nm at 90 nm, such as 12 nm to 85 nm, such as 15 nm to 80 nm and including bandpass filters with minimum bands ranging from 20 nm to 50 nm. In certain cases, the methods include passing light transmitted from the sample chamber through one or more bandpass filters that selectively pass wavelengths at intervals of: 498 nm - 510 nm; 500 nm - 600 nm; 500 nm - 520 nm; 540nm - 550nm; 545 nm - 555 nm; 550 nm - 570 nm; 550 nm - 580 nm; 560 nm - 590 nm; 575 nm - 595 nm; 580 nm - 590 nm; 600 nm - 700 nm; 600 nm - 630 nm; 650 nm - 750 nm; 750 nm - 850 nm; 810 nm - 830 nm; 815 nm - 825 nm, or any combination thereof.
[0073] For example, in one case methods include passing light transmitted from the sample chamber through one or more bandpass filters that selectively pass wavelengths ranging between 500 nm - 520 nm and 650 nm - 750 nm . In another example, the methods include passing light transmitted from the sample chamber through one or more bandpass filters that selectively pass wavelengths ranging from 540 nm - 560 nm and 650 nm - 750 nm. In yet another example, the methods include passing light transmitted from the sample chamber through one or more bandpass filters that selectively pass wavelengths ranging from 560 nm - 590 nm and 650 nm - 750 nm. In yet another example, the methods include passing light transmitted from the sample chamber through one or more bandpass filters that selectively pass wavelengths ranging from 500 nm - 520 nm; 560 nm - 590 nm and 650 nm - 750 nm.
[0074] In practicing the methods according to aspects of the present description, the light transmitted through the sample chamber is measured at one or more wavelengths. In embodiments, transmitted light is measured at one or more wavelengths, such as at 5 or more different wavelengths, such as at 10 or more different wavelengths, such as at 25 or more different wavelengths, such as such as at 50 or more different wavelengths, such as 100 or more different wavelengths, such as 200 or more different wavelengths, such as 300 or more different wavelengths and including the measurement of light transmitted through sample chamber at 400 or more different wavelengths.
[0075] In some embodiments, the measurement of light transmitted through the sample chamber includes measuring light transmitted through a range of wavelengths (eg, 400 nm - 800 nm; 495 nm - 525 nm; 800 nm - 835 nm, etc.). For example, the methods may include measuring light transmitted through the sample chamber over one or more of the following wavelength ranges: 400 nm - 800 nm; 498 nm - 510 nm; 500 nm - 600 nm; 500 nm - 700 nm; 500 nm - 575 nm; 500 nm - 550 nm; 540nm - 550nm; 545 nm - 555 nm; 550 nm - 570 nm; 550 nm - 580 nm; 560 nm - 590 nm; 575 nm - 595 nm; 580 nm - 590 nm; 600 nm - 700 nm; 600 nm - 630 nm; 650 nm - 750 nm; 650 nm - 830; 750 nm - 850 nm; 810 nm - 830 nm; 815 nm - 825 nm, and any combinations thereof. In one example, the methods include measuring light transmitted over wavelengths ranging from 400 nm - 800 nm. In another example, the methods include measuring light transmitted over wavelengths ranging from 500 nm - 520 nm and 650 nm - 750 nm. In another example, the methods include measuring light transmitted through wavelengths ranging from 540 nm - 560 nm and 650 nm - 750 nm. In yet another example, the methods include measuring light transmitted over wavelengths ranging from 560 nm - 590 nm and 650 nm - 750 nm. In yet another example, the methods include measuring light transmitted over wavelengths ranging from 500 nm - 520 nm, 560 nm - 590 nm, and 650-750 nm.
[0076] The measurement of light transmitted over a range of wavelengths, in certain cases, includes collecting spectra of light transmitted over the range of wavelengths. For example, the methods may include collecting spectra of light transmitted through the sample chamber over one or more wavelength ranges: 400 nm - 800 nm; 498 nm - 510 nm; 500 nm - 600 nm; 500 nm - 700 nm; 500 nm - 520 nm; 540nm - 550nm; 545 nm - 555 nm; 550 nm - 570 nm; 550 nm - 580 nm; 560 nm - 590 nm; 575 nm - 595 nm; 580 nm - 590 nm; 600 nm - 700 nm; 600 nm - 630 nm; 650 nm - 750 nm; 750 nm - 850 nm; 810 nm - 830 nm; 815 nm - 825 nm, and any combinations thereof. In one example, the methods include collecting spectra of light transmitted over wavelengths ranging from 400 nm - 800 nm. In another example, the methods include collecting spectra of light transmitted over wavelengths ranging from 500 nm - 700 nm.
[0077] In certain embodiments, light transmitted through the sample chamber is detected at one or more specific wavelengths (eg, 548 nm or 675 nm). For example, the methods may include detecting light transmitted at 2 or more specific wavelengths, such as at 3 or more specific wavelengths, such as at 4 or more specific wavelengths, such as at 5 or more lengths. of specific wavelengths, such as at 10 or more specific wavelengths and including the detection of light transmitted at 25 or more specific wavelengths. In some cases, methods include detecting transmitted light at one or more of 504 nm, 506 nm, 514 nm, 532 nm, 543 nm, 548 nm, 550 nm, 561 nm, 568 nm, 579 nm, 580 nm, 585 nm, 586 nm, 675 nm, 710 nm, 808 nm, 815 nm, 830 nm and any combinations thereof. In certain embodiments, transmitted light is detected at 548 nm. In other embodiments, transmitted light is detected at 675 nm. In still other embodiments, transmitted light is detected at 830 nm. In still other embodiments, transmitted light is detected at 548 nm and 675 nm. In still other embodiments, transmitted light is detected at 548 nm, 675 nm and 830 nm. In yet another embodiment, transmitted light is detected at 504 nm, 506 nm, 514 nm, 532 nm, 543 nm, 548 nm, 550 nm, 561 nm, 568 nm, 579 nm, 580 nm, 585 nm, 586 nm, 650 nm, 675 nm, 710 nm, 808 nm, 815 nm and 830 nm.
[0078] Depending on the specific analysis protocol, transmitted light can be measured continuously or at discrete intervals. For example, in some modalities, the measurement of transmitted light is continuous throughout the entire time the sample is being analyzed. When the measurement of transmitted light includes measurement of two or more wavelengths or ranges of wavelengths, the wavelengths or ranges of wavelengths can all be measured simultaneously, or each wavelength or ranges of wavelengths can be measured sequentially.
[0079] In other modalities, transmitted light is measured at discrete intervals, such as measuring the light transmitted through the sample every 0.001 microseconds, every 0.01 microseconds, every 0.1 microseconds, every 1 microsecond, every 10 microseconds, every 100 microseconds and including every 1000 microseconds.
[0080] Depending on the quality (eg homogeneity) of the biological sample, the presence of interferents, light source and wavelengths to be measured, the light transmitted through the sample chamber can be measured one or more times during the methods concerned, such as 2 or more times, such as 3 or more times, such as 5 or more times and including 10 or more times. In certain embodiments, transmitted light is measured two or more times, the data being averaged to calculate absorbance by the target analyte, as described below.
[0081] In certain embodiments, methods include projecting a slit-shaped beam into the detector to provide a blank measurement. In these embodiments, the slit-shaped beam can be achieved by a blank illuminating reference window with the slit-shaped beam and focusing the slit-shaped beam projected through the blank reference window into the detector.
[0082] For example, the blank reference window can be integrated into the subject systems (as described below) where light from the light source is directed through the integrated blank reference window. In some cases, light transmitted through the blank reference window is directed through the objective lens and onto the wavelength separator and detector. In other cases, light transmitted through the blank reference window is supplied directly to the detector. In some cases, the blank reference window can be positioned on the microfluidic cartridge, such as along the same optical axis as the sample chamber.
[0083] The absorbance of the blank reference window is, in certain embodiments, set to be identical to the absorbance by the sample chamber so that transmission through the blank reference window can be used to correct for absorption, scatter, etc. ., by the microfluidic cartridge when putting into practice the methods described herein. In certain embodiments, the blank reference window has an absorbance and transmission in which one or more wavelengths of incident light is substantially the same as the capillary channel sample chamber. In other embodiments, the blank reference window scatters light at one or more wavelengths that are substantially the same as the capillary channel sample chamber. In still other embodiments, the blank reference window has an absorbance, transmission and scattering of light at one or more incident wavelengths that is substantially the same as the capillary channel sample chamber. In still other embodiments, the blank reference window has the same refractive index as the capillary channel sample chamber.
[0084] In other embodiments, the methods include projecting undifracted light from the light source to the detector to provide a blank of incident light. In certain modalities, non-diffracted light is used to calibrate the detector.
[0085] The light transmitted through the sample chamber can be measured by any suitable light detection protocol, including but not limited to photosensors or photodetectors such as active pixel sensors (APS), avalanche photodiodes, avalanche sensors. imaging, charge-coupled devices (CCD), charge-coupled devices (ICCD), light-emitting diodes, photon counters, bolometers, pyroelectric detectors, photoresistors, photovoltaic cells, photodiodes, photomultiplier tubes, phototransistors, photoconductors or point photodiodes and their combinations, among other photodetectors. In certain embodiments, transmitted light is measured with a charge-coupled device (CCD). When transmitted light is measured with a CCD, the active sensing surface area of the CCD can vary, such as 0.01 cm2 to 10 cm2, such as 0.05 cm2 to 9 cm2, such as 0.1 cm2 to 8 cm2, such as from 0.5 cm2 to 7 cm2 and including from 1 cm2 to 5 cm2.
[0086] As summarized above, aspects of the present description include methods for analyzing a sample for one or more analytes. In embodiments, for analyte analysis, the absorbance of light by the target analyte is calculated using the measured transmitted light. In some embodiments, absorbance is calculated at one or more wavelengths, such as 2 or more different wavelengths, such as 3 or more different wavelengths, such as 4 or more different wavelengths, and including calculating the target analyte absorbance at 5 or more different wavelengths. For example, target analyte absorbance can be calculated using transmitted light detected at one or more of 504 nm, 506 nm, 514 nm, 532 nm, 543 nm, 548 nm, 550 nm, 561 nm, 568 nm, 579 nm, 580 nm, 585 nm, 586 nm, 675 nm, 710 nm, 808 nm, 815 nm, 830 nm or any combinations thereof. In certain embodiments, analyte absorbance is calculated using transmitted light detected at 548 nm. In other embodiments, analyte absorbance is calculated using transmitted light detected at 675 nm. In still other embodiments, analyte absorbance is calculated using transmitted light detected at 830 nm. In still other embodiments, analyte absorbance is calculated using transmitted light detected at 548 nm and 675 nm. In still other embodiments, analyte absorbance is calculated using transmitted light detected at 548 nm, 675 nm, and 830 nm.
[0087] In some embodiments, calculating the absorbance of light by the target analyte includes calculating absorbance over a range of wavelengths (eg, 400 nm - 800 nm; 495 nm - 525 nm; 800 nm - 835 nm, etc.). For example, the methods may include calculating absorbance over one or more of the wavelength ranges: 400 nm - 800 nm; 498 nm - 510 nm; 500 nm - 600 nm; 500 nm - 700 nm; 500 nm - 520 nm; 540nm - 550nm; 545 nm - 555 nm; 550 nm - 570 nm; 550 nm - 580 nm; 560 nm - 590 nm; 575 nm - 595 nm; 580 nm - 590 nm; 600 nm - 700 nm; 600 nm - 630 nm; 650 nm - 750 nm; 750 nm - 850 nm; 810 nm - 830 nm; 815 nm - 825 nm, and any combinations thereof. For example, the methods include calculating the absorbance of light by the analyte target over wavelengths ranging from 400 nm - 800 nm. In another example, the calculation methods include the absorbance of light by the target analyte over wavelengths ranging from 500 nm - 520 nm and 650 nm - 750 nm. In another example, calculation methods include the absorbance of light by the target analyte over wavelengths ranging from 540 nm - 560 nm and 650 nm - 750 nm. In yet another example, the methods include calculating the absorbance of light by the target analyte over wavelengths ranging from 560 nm - 590 nm and 650 nm - 750 nm. In yet another example, the methods include calculating the absorbance of light by the target analyte over wavelengths ranging from 500 nm - 520 nm, 560 nm - 590 nm, and 650 - 750 nm.
[0088] For example, where the sample is whole blood and the analyte of interest is hemoglobin, the hemoglobin concentration in whole blood can be calculated by measuring the light transmitted at a first and a second wavelength, where the lengths waveforms may vary, and include, but are not limited to, isosbestic points, etc. In some cases, the first wavelength is an isosbestic point for hemoglobin with one or more of oxyhemoglobin, carboxyhemoglobin, methemoglobin, sulphahemoglobin, azidamethoglobin and cyanmethemoglobin, such as an isosbestic point for hemoglobin and oxyhemoglobin or a triple isosbestic point for hemoglobin oxyhemoglobin and carboxyhemoglobin. For example, a first wavelength is, in certain cases, 506 nm, 548 nm, 569 nm, 579 nm, 585 nm or 586 nm. The second wavelength is, in these embodiments, a low absorption wavelength (eg, near IV) and may also be an isosbestic point for hemoglobin with one or more of oxyhemoglobin, carboxyhemoglobin, methemoglobin, sulphahemoglobin, azidamethoglobin and cyanomethhemoglobin , such as an isosbestic point for hemoglobin and oxyhemoglobin or a triple isosbestic point for hemoglobin, oxyhemoglobin and carboxyhemoglobin. For example, a second wavelength is, in certain cases, 650 nm, 675 nm, 710 nm, 785 nm, 808 nm, 815 nm or 830 nm.
[0089] The absorbance of light by the target analyte can be calculated using any suitable principle, for example BeerLambert's law: Absorbance (À) = -Logio (I/Io) where I is the intensity of light transmitted through the sample and I0 is the incident light intensity used to evaluate the sample. Depending on the path length of the sample chamber (as described below), the analyte concentration can be determined using the calculated absorbance of the analyte: Absorbance (À) = [molar absorptivity] x [concentration] x [ath length]
[0090] The absorbance can be calculated in conjunction with the transmitted light measurement or it can be performed after a predetermined period after the transmitted light measurement. In some embodiments, absorbance is continuously calculated in conjunction with the measurement of transmitted light, such as where transmitted light is measured at one or more specific wavelengths. Where the subject methods include calculations of analyte absorbance at two or more wavelengths, absorbance can be calculated at both wavelengths simultaneously, or absorbance can be calculated at each wavelength sequentially.
[0091] In other embodiments, absorbance is calculated after a predetermined period after measurement of transmitted light, such as 0.001 seconds or more after measurement, such as 0.01 seconds or more after measurement, such as 0.1 seconds or more after measurement, such as 0.5 seconds or more after measurement, such as 1 second or more after measurement and including 5 seconds or more after measurement of transmitted light. For example, in modalities where a spectrum over a range of wavelengths is collected, the absorbance can be calculated at a predetermined time after the entire spectrum is collected.
[0092] In some embodiments, methods include calculating the concentration based on the absorbance determined from the transmitted light. In embodiments, analyte concentration can be calculated using absorbance at any desired wavelength, such as at two or more wavelengths, such as at three or more wavelengths and including at five or more wavelengths. In some embodiments, the concentration of analyte in the sample is calculated at one or more absorbance values of the peaks in the absorbance spectrum. In other embodiments, the concentration of analyte in the sample is calculated using one or more wavelengths where the analyte has the highest molar absorptivity. Where two or more analytes are of interest, the analyte concentration can, in certain cases, be calculated using the absorbance at a wavelength corresponding to an isosbestic point for the two or more analytes.
[0093] To calculate the analyte concentration, the light absorbance by the target analyte is first determined using BeerLambert's Law: Absorbance (À) = -Logio (l/lo) where I is the intensity of light transmitted through the chamber of sample and I0 is the intensity of incident light used to evaluate the sample. Depending on the length of the sample chamber path, the analyte concentration can be determined using the calculated absorbance of the analyte: Absorbance (À) = [molar absorptivity] x [concentration] x [ath length]
[0094] In one embodiment, the methods include calculating the analyte concentration while representing dispersion across the sample by measuring light transmitted at a first and a second wavelength. The first wavelength, in some cases, is a wavelength where the analyte has a high molar absorptivity. In other cases, the first wavelength is a wavelength to an isosbestic point with one or more derivatives of the analyte that are included in the analyte concentration. The second wavelength is, in these modalities, a wavelength where the analyte has low molar absorptivity. The second wavelength can also be a wavelength to an isosbestic point with one or more derivatives of the analyte. To calculate the analyte concentration representing dispersion: Analyte concentration = A*(Absxi) + B*(Abs A2> + C, where A, B, and C are coefficients that depend on the evaluated wavelengths and analytes to be measured. , the value of A may vary, in certain cases, ranging from 20 g/dL to 60 g/dL, such as from 25 g/dL to 57.5 g/dL, such as from 30 g/dL to 55 g/ dL, such as from 35 g/dL to 50 g/dL and including from 37.5 g/dL to 45 g/dL. The value of B can also vary, in certain cases, ranging from 0.01 g/dL to 5 g/dL, such as from 0.05 g/dL to 4.5 g/dL, such as from 0.1 g/dL to 4 g/dL, such as from 0.25 g/dL to 3.5 g/dL, such as from 0.5 g/dL to 3 g/dL and including from 0.5 g/dL to 2 g/dL. Likewise, the value of C can also vary, ranging from 0.01 g/dL to 2 g/dL, such as from 0.025 g/dL to 1.75 g/dL, such as from 0.05 g/dL to 1.5 g/dL, such as from 0.1 g/dL at 1.25 g/dL and including from 0.25 g/dL to 2 g/dL.
[0095] As discussed above, in certain modalities the sample is whole blood and the analyte of interest is hemoglobin. In some cases, the methods include calculating the concentration of whole hemoglobin in whole blood while representing sample dispersion by measuring light transmitted at a first and a second wavelength. The first wavelength can be a wavelength where hemoglobin has a high molar absorptivity. In some cases, the first wavelength may be an isosbestic point for hemoglobin with one or more of oxyhemoglobin, carboxyhemoglobin, methemoglobin, sulphahemoglobin, azidamethoglobin and cyanmethemoglobin, such as an isosbestic point for hemoglobin and oxyhemoglobin or a triple isosbestic point for hemoglobin, oxyhemoglobin and carboxyhemoglobin. For example, a first wavelength is, in certain cases, 506 nm, 548 nm, 569 nm, 579 nm, 585 nm or 586 nm. To account for scattering, a second wavelength where hemoglobin has a low absorption capacity can be chosen, such as a near infrared wavelength. In some cases, the second wavelength is an isosbestic point for hemoglobin with one or more of oxyhemoglobin, carboxyhemoglobin, methemoglobin, sulphahemoglobin, azidamethoglobin and cyanmethemoglobin, such as an isosbestic point for hemoglobin and oxyhemoglobin or a triple isosbestic point for hemoglobin, oxyhemoglobin and carboxyhemoglobin. For example, a second wavelength is, in certain cases, 650 nm, 675 nm, 710 nm, 785 nm, 808 nm, 815 nm or 830 nm.
[0096] For example, where the first wavelength is 548 nm and the second wavelength is 675 nm, to calculate the hemoglobin concentration representing dispersion: Hb Concentration = A*(Abs548 nm) + B*(Abs675 nm) + Ç,
[0097] In modalities, the value of A for a whole blood sample may vary, in certain cases, ranging from 20 g/dL to 60 g/dL, such as from 25 g/dL to 57.5 g/dL, such as from 30 g/dL to 55 g/dL, such as from 35 g/dL to 50 g/dL and including from 37.5 g/dL to 45 g/dL. The value of B for a whole blood sample may also vary, in certain cases, ranging from 0.01 g/dL to 5 g/dL, such as from 0.05 g/dL to 4.5 g/dL, such as. as from 0.1 g/dL to 4 g/dL, such as from 0.25 g/dL to 3.5 g/dL, such as from 0.5 g/dL to 3 g/dL and including from 0. 5 g/dL to 2 g/dL. Likewise, the C value of a whole blood sample can also vary, ranging from 0.01 g/dL to 2 g/dL, such as from 0.025 g/dL to 1.75 g/dL, such as from 0.05 g/dL to 1.5 g/dL, such as from 0.1 g/dL to 1.25 g/dL and including from 0.25 g/dL to 2 g/dL.
[0098] In another example, where the first wavelength is 548 nm and the second wavelength is 650 nm, to calculate the hemoglobin concentration representing dispersion: Hb Concentration = A*(Abs548 nm) + B*(Abs650 nm) ) + C,
[0099] In modalities, the value of A for a whole blood sample may vary, in certain cases, ranging from 20 g/dL to 60 g/dL, such as from 25 g/dL to 57.5 g/dL, such as from 30 g/dL to 55 g/dL, such as from 35 g/dL to 50 g/dL and including from 37.5 g/dL to 45 g/dL. The value of B for a whole blood sample may also vary, in certain cases, ranging from 0.01 g/dL to 5 g/dL, such as from 0.05 g/dL to 4.5 g/dL, such as. as from 0.1 g/dL to 4 g/dL, such as from 0.25 g/dL to 3.5 g/dL, such as from 0.5 g/dL to 3 g/dL and including from 0. 5 g/dL to 2 g/dL. Likewise, the C value of a whole blood sample can also vary, ranging from 0.01 g/dL to 2 g/dL, such as from 0.025 g/dL to 1.75 g/dL, such as from 0.05 g/dL to 1.5 g/dL, such as from 0.1 g/dL to 1.25 g/dL and including from 0.25 g/dL to 2 g/dL.
[00100] In another embodiment, the methods include calculating the analyte concentration while accounting for interferents by measuring the transmitted light and determining the absorbance at a first wavelength and a second wavelength. In this embodiment, an analyte concentration is calculated by determining the absorbance concentration at the first wavelength and determining the absorbance concentration at the second wavelength and subtracting the concentration obtained at the second wavelength from the concentration at the first wavelength.
[00101] In certain embodiments, the present methods can be coupled with methods for evaluating the sample for one or more analytes by a fluorescence assay. For example, as described in more detail below, the sample may be contacted with one or more reagents having fluorescent labels, the emission being detectable by one or more photosensors or photodetectors. As such, aspects of the present description in accordance with certain embodiments include analyzing a sample for one or more analytes by contacting the sample with one or more reagents and optically evaluating the sample through an absorption assay (as discussed above) in combination with a fluorescence assay.
[00102] In embodiments, samples analyzed for fluorescence can be illuminated with one or more light sources. Depending on the target analyte, the sample can be illuminated with one or more broadband light sources (eg halogen lamp, deuterium arc lamp, xenon arc lamp, stabilized fiber coupled broadband light source, a continuous spectrum wideband LED, superluminescent emitting diode, light emitting semiconductor diode, wide spectrum LED white light source, an integrated multi-LED white light source, combinations thereof, as described above) or can be illuminated with one or more narrowband light sources that emit a particular wavelength or narrow range of wavelengths (eg narrow wavelength LED, laser diode, or a wideband light source coupled to one or more bandpass filters, optical diffraction gratings, monochromators, or their combination, as described above).
[00103] Depending on the dimensions and positioning of the sample chamber, the incident illumination angle for analyzing fluorescence can vary, ranging from 30° to 60° with respect to the plane of the sample chamber, such as from 35° to 55°, such as such as 40° to 50° and including illuminating the sample chamber at 45° in relation to the plane of the sample chamber.
[00104] When using more than one light source, the sample can be illuminated with the light sources simultaneously or sequentially, or a combination thereof. When the sample is sequentially illuminated with two or more light sources, the time each light source illuminates it can independently be 0.001 seconds or more, such as 0.01 seconds or more, such as 0.1 seconds or more, such as 1 second or more, such as 5 seconds or more, such as 10 seconds or more, such as 30 seconds or more, and including 60 seconds or more. In modalities where the sample is sequentially illuminated by two or more light sources, the time the sample is illuminated by each light source can be the same or different. The period of time between illumination by each light source may also vary as desired, being independently separated by a delay of 1 second or more, such as 5 seconds or more, such as by 10 seconds or more, such as for 15 seconds or more, such as for 30 seconds or more and including for 60 seconds or more.
[00105] Depending on the specific analytes to be analyzed, as well as the reagents and fluorescent markers used, the illumination of the sample can be continuous or at discrete intervals. For example, in some modalities, the sample can be illuminated continuously throughout the entire time the sample is being analyzed. In other modalities, the sample can be illuminated at regular intervals, such as illuminating the sample every 0.001 microseconds, every 0.01 microseconds, every 0.1 microseconds, every 1 microsecond, every 10 microseconds, every 100 microseconds and including every 1000 microseconds. The sample may be illuminated with the light source one or more times in any given measurement period, such as 2 or more times, such as 3 or more times, including 5 or more times in each measurement period.
[00106] During fluorescence testing, the sample can be illuminated with a wideband light source with wavelengths ranging from 300 nm to 900 nm, such as from 325 nm to 875 nm, such as from 350 nm to 850 nm, such as from 375 nm to 825 nm and including from 400 nm to 800 nm, or some other range. In other embodiments, the sample is illuminated with specific wavelengths of light or a narrow range of specific wavelengths (such as with a narrowband lamp or LED). For example, the sample can be illuminated for fluorescence with a narrowband light source or one or more LEDs that emit monochromatic light in the range of 450 nm to 700 nm, such as at 480 nm, 565 nm and 650 nm.
[00107] Since the subject fluorescence assay is coupled with methods for analyzing absorption described above, the light emitted from the sample can be collected, spatially separated into component wavelengths and detected in a similar manner as described above. As described in detail below, fluorescence detection systems and absorbance detection systems use one or more common components as described herein. For example, in some cases both the fluorescence test and the absorbance test use a common objective lens module for collecting and focusing light from the sample chamber (eg, emitted light or transmitted light). In other cases, both the fluorescence assay and the absorbance assay use a common wavelength separation protocol (eg, diffraction grating, optical filters, filter wheel having one or more diffraction gratings, and optical filters) to spatially separate the collected light into its component wavelengths. In still other cases, both the fluorescence assay and the absorbance assay use the same detection protocol for measuring light (eg, emitted light or transmitted light) from the sample chamber.
[00108] In certain embodiments, the subject fluorescence assay may include methods for imaging samples in capillary channels, such as those described in US Pat. 8,248,597; 7,927,561 and 7,738,094, as well as those described in pending US Patent Application No. 13/590,114 filed August 20, 2012, the disclosures of which are incorporated herein by reference.
[00109] In certain specific embodiments, the present methods provide an analytical absorbance for hemoglobin. As discussed above, hemoglobin can be present in any type of diagnostic sample, such as supernatants, lysates, buffered solution, as well as in biological samples including whole blood. In accordance with the methods described above, a quantity of the sample is loaded into a sample chamber and illuminated by means of a slit projection module with one or more light sources, with the light transmitted through the blood sample in the chamber. sample to be collected and spatially separated into component wavelengths for detection. Depending on the size of the whole blood sample, the sample chamber may be a microfluidic capillary channel sample chamber. The absorbance of hemoglobin can be determined from light transmitted at one or more wavelengths or alternatively, a full spectrum of hemoglobin absorption can be calculated. Based on absorbance at one or more wavelengths, the hemoglobin concentration in the whole blood sample can be determined in these embodiments of the present methods.
[00110] In certain other specific embodiments, the gifts provide an absorbance analysis of reagent-free hemoglobin. By "reagent-free" it is meant that hemoglobin analysis does not use reagents that interact or are used to visualize hemoglobin in the sample. As such, hemoglobin (including derivatives such as oxyhemoglobin and carboxyhemoglobin) is analyzed in its native state without reagent modification. In these cases, an unaltered whole blood sample is loaded into a sample chamber and illuminated with one or more light sources through a slit projection module, with light transmitted through the blood sample in the sample chamber to be collected and spatially separated into component wavelengths for detection. Depending on the size of the whole blood sample, the sample chamber may be a microfluidic capillary channel sample chamber. Hemoglobin absorbance can be detected at one or more wavelengths or alternatively, a full spectrum of hemoglobin absorption can be calculated. Based on absorbance at one or more wavelengths, the hemoglobin concentration in the unaltered whole blood sample can be determined in these embodiments of the present methods.
[00111] In certain other specific embodiments, the present methods provide an analysis of the absorbance of hemoglobin in a sample also to be analyzed for one or more additional analytes, such as, for example, cell surface markers. In these modalities, one or more reagents, including specific binding members, enzymes, substrates, oxidants, as well as binding molecules coupled to one or more fluorescent markers, are contacted with whole blood and the whole blood sample mixed with the reagent is loaded into a sample chamber. The loaded sample chamber (such as a microfluidic capillary channel sample chamber) is illuminated with one or more light sources through a slit projection module, with light transmitted through the whole blood sample in the sample chamber to be collected and spatially separated into component wavelengths for detection. Hemoglobin absorbance can be detected at one or more wavelengths or alternatively, a full spectrum of hemoglobin absorption can be calculated. Based on absorbance at one or more wavelengths, the concentration of hemoglobin in the whole blood sample mixed with the reagent can be determined in these embodiments of the present methods. Along with the assay for hemoglobin in the sample mixed with the reagent, one or more additional analytes can be analyzed. In some cases, the present methods provide a fluorescence assay performed in conjunction with the analysis of hemoglobin absorbance for analysis of one or more cell surface markers that bind to one or more reagents mixed with the whole blood sample. In these cases, a fluorescence light source illuminates the sample chamber loaded with the whole blood sample mixed with the reagent and the fluorescence emission from the fluorescent markers bound to the target analytes is collected and spatially separated for detection.
[00112] In certain other specific embodiments, the present methods provide an analysis of the absorbance of hemoglobin in a sample for which fluorescence for CD4 and % CD4 is also analyzed. In these cases, the whole blood sample is applied to the sample application site of a microfluidic cartridge that has a capillary channel sample chamber. The applied sample is transported through the microfluidic capillary channel inlet to a reagent mixing chamber having a porous disc for contacting the reagent mixture with the blood sample. The reagent mix in these cases includes dehydrated stored stable reagents CD4-PECy5, CD3-APC, CD45RA-APC and CD14-PE. The whole blood sample mixed with the reagent is transported by capillary action through the sample chamber where the sample chamber is illuminated for hemoglobin analysis by two light sources, a wideband white light LED and a near-light LED. IV through a slit projection module that is moved laterally through the sample chamber. Light transmitted through the sample chamber is collected with an objective, magnifying lens and autofocused in a diffraction grating to spatially separate the light transmitted on the surface of a CCD detector. The absorbance at two wavelengths, 548 nm and 675 nm is determined and the total hemoglobin absorbance corresponding to the dispersion is calculated for analysis for hemoglobin.
[00113] The whole blood sample mixed with the reagent in the capillary channel sample chamber is also analyzed for CD4 by detecting the fluorescence through fluorescent markers in the reagent mixture. CD4 can be analyzed by illuminating the whole blood sample mixed with the reagent in the capillary channel sample chamber with a light source and the emission of the fluorescent markers in the whole blood sample mixed with the reagent is collected with a common objective, lens magnification and autofocus on the surface of the CCD detector. CD4 cell count is then performed by fluorescent imaging cytometry.
[00114] In certain embodiments, aspects of the methods include applying a sample to a microfluidic device configured to perform analysis of a liquid sample with a sample application site, an input for sample introduction from the application site of the sample, a reagent contact chamber for contacting the sample with one or more reagents, and a sample capillary chamber in fluid communication with the reagent contact chamber.
[00115] In some embodiments, the sample is applied to the application site of the microfluidic device and allowed to flow through the inlet and into the reagent contact chamber, followed by the flow through the capillary sample chamber in such a way that sufficient sample is provided to be evaluated in the capillary sample chamber as described above.
[00116] In certain cases, the methods include providing a sample application site in contact with the sample from the microfluidic device. By "sample contact sample application site" is meant a sample application site that has been contacted by the sample. In practicing the methods of the present description, a sample contact application site is provided by applying a sample to the sample application site of the microfluidic device. The amount of sample that is applied to the sample application site can vary as long as it is sufficient to provide the desired capillary flow through the sample chamber and the sample suitable for evaluation by the present methods described herein. For example, the amount of sample applied to the application site can range from 0.01 μL to 1000 μL, such as 0.05 μL to 900 μL, such as 0.1 μL to 800 μL, such as 0, 5 μL to 700 μL, such as from 1 μL to 600 μL, such as from 2.5 μL to 500 μL, such as from 5 μL to 400 μL, such as from 7.5 μL to 300 μL and including 10 μL to 200 µL of sample.
[00117] The sample can be applied to the sample application site using any suitable protocol, for example, through dropper, pipette, syringe and the like. The sample can be applied in conjunction or incorporated in an amount of an appropriate liquid, eg, buffer, to provide adequate fluidity of the fluid. Any suitable liquid can be used, including but not limited to buffers, cell culture media (e.g., DMEM), etc. Buffers include, but are not limited to: Tris, tricine, MOPS, HEPES, PIPES, MES, PBS, TBS and the like. When desired, detergents can be present in the liquid, for example, NP-40, TWEEN™ or TritonX100 detergents.
[00118] In certain embodiments, the sample-contact sample application site is provided by combining the sample with one or more analysis components (for example, a reagent, a buffer, and the like) prior to sample application which has the component (or components) of analysis of the sample application site. When the sample is combined with one or more test components prior to application of the sample having the test component (or components) from the sample application site, the combination can be achieved using any suitable protocol. The amount of a test component (or components), when combined with the sample, can be varied as desired. In some embodiments, the sample application site in contact with the sample is provided by applying one or more analysis components to the application site receiving the sample prior to application of the sample from the sample application site. In some embodiments, the sample application site in contact with the sample is provided by applying the sample to the sample application site prior to applying one or more test components to the sample application site. As mentioned above, in some embodiments, the device includes one or more analysis components (eg, reagent). In such cases, the sample application site in contact with the sample is provided by applying the sample to the sample application site, for example, without prior mixing with one or more analysis components.
[00119] After sample application, the sample is allowed to flow through the capillary test chamber, and one or more parts of the channel, for example, the detection region, including the entire channel, is then analyte evaluation analysis ( or analytes) target in the sample. Depending on the target analyte and the presence of one or more reagents, the sample can be evaluated immediately after sample application or after a predetermined period of time after sample application, such as a time period ranging from 10 seconds to 1 hour , such as 30 seconds to 30 minutes, for example, 30 seconds to 10 minutes, including 30 seconds to 1 minute.
[00120] An example of suitable methods and microfluidic devices for preparing a sample for evaluation by the present methods may include, but are not limited to those described in copending US Patent Application No. 14/152,954 filed January 10 , 2014, the description of which is incorporated herein by reference. SYSTEMS FOR ANALYSIS OF A SAMPLE FOR AN ANALYTE
[00121] Aspects of the present description additionally include systems for practicing the present methods. In embodiments, systems that include a light source, a slit projection module (for example, a slit for reducing a light beam or a slit coupled to a focusing lens that focuses the reduced light) and a detector for detection of one or more wavelengths of transmitted light are provided. In certain embodiments, the systems additionally include a microfluidic device for preparing and providing the sample for analysis using the subject systems.
[00122] As summarized above, aspects of the present invention include analyzing a sample for one or more analytes. Systems include one or more light sources to evaluate a sample chamber that contains a sample of interest. In some embodiments, the light source is a wideband light source, emitting light that has a wide range of wavelengths, such as, for example, spanning 50 nm or more, such as 100 nm or more, such as 150 nm or more, such as 200 nm or more, such as 250 nm or more, such as 300 nm or more, such as 350 nm or more, such as 400 nm or more and including from about 500 nm or more. For example, a suitable broadband light source emits light having wavelengths from 400 nm to 800 nm. Another example of a suitable broadband light source includes a light source that emits light having wavelengths from 500 nm to 700 nm. Any suitable broadband light source protocol can be used, such as a halogen lamp, deuterium arc lamp, xenon arc lamp, stabilized fiber coupled broadband light source, a continuous spectrum wideband LED , superluminescent emitting diode, semiconductor light emitting diode, wide-spectrum LED white light source, an integrated multi-LED white light source, among other broadband light sources or any combination thereof.
[00123] In other embodiments, the light source is a narrowband light source that emits a particular wavelength or a narrow range of wavelengths. In some cases, narrowband light sources emit light with a narrow range of wavelengths, such as, for example, 50 nm or less, such as 40 nm or less, such as 30 nm or less, such as 25 nm or less, such as 20 nm or less, such as 15 nm or less, such as 10 nm or less, such as 5 nm or less, such as 2 nm or less and including light sources that emit specific wavelengths of light (ie, monochromatic light). Any suitable narrowband light source protocol can be used, such as a narrow wavelength LED, laser diode or a wideband light source coupled to one or more bandpass filters, optical diffraction gratings, monochromators , or any combination thereof.
[00124] The subject systems may include one or more light sources, as desired, such as two or more light sources, such as three or more light sources, such as four or more light sources, such as five or more light sources and including ten or more light sources. The light source may include a combination of types of light sources, for example, where two light sources are used, a first light source may be a broadband white light source (e.g. broadband) and the second light source can be a wideband near infrared light source (eg, wideband near IR LED). In other examples, where two light sources are used, a first light source may be a wideband white light source (eg, wideband white light LED) and the second light source may be a light source. narrow-spectrum light (for example, a narrow-band visible light or near-IR LED). In still other cases, the light source is a plurality of narrowband light sources each emitting specific wavelengths, such as an array of two or more LEDs, such as an array of three or more LEDs, such as an array of five or more LEDs, including an array of ten or more LEDs.
[00125] In some embodiments, light sources emit light with wavelengths ranging from 400 nm to 900 nm, such as 450 nm to 850 nm, such as 500 nm to 800 nm, such as 550 nm to 750 nm and including from 600 nm to 700 nm. For example, the light source can include a wideband light source that emits light having wavelengths from 400 nm to 900 nm. In other cases, the light source includes a plurality of narrowband light sources that emit wavelengths ranging from 400 nm to 900 nm. For example, the light source can be a plurality of narrowband LEDs (1 nm - 25 nm) each independently emitting light having a wavelength range from 400 nm to 900 nm.
[00126] In certain embodiments, the systems include two broadband light sources, configured to collectively emit light wavelengths ranging from 400 nm to 900 nm. For example, light sources can be a white light LED emitting light with wavelengths ranging from 400 nm to 700 nm and a near-IR LED emitting light with wavelengths ranging from 700 nm to 900. In some embodiments, the irradiation profile of each light source can vary, having any number of emission peaks. In certain cases, the light source includes a white light LED emitting light with wavelengths ranging from 400 nm to 700 nm and having emission peaks at around 450 nm and 550 nm and a near IR LED emitting light with lengths waves ranging from 700 nm to 900 nm and having an emission peak at about 830 nm.
[00127] In other embodiments, the light source is a plurality of narrowband lamps or LEDs each independently emitting specific wavelengths of light in the range of 400 nm to 900 nm. In one example, the narrowband light source is one or more monochromatic LEDs that emit light in the range of 500 nm to 700 nm, such as at 504 nm, 506 nm, 514 nm, 532 nm, 543 nm, 548 nm, 550 nm, 561 nm, 568 nm, 579 nm, 580 nm, 585 nm, 586 nm or any combination thereof. In another example, the narrowband light source is an array of LEDs that emit light with wavelengths ranging from 400 nm to 900 nm. In another example, the narrowband light source is one or more narrowband lamps emitting light in the range of 500 nm to 700 nm, such as a narrowband cadmium lamp, cesium lamp, helium lamp, mercury lamp , mercury cadmium lamp, potassium lamp, sodium lamp, neon lamp, zinc lamp or any combination thereof.
[00128] As summarized earlier in this document, the systems include a slit projection module configured to reduce a light beam and produce a light beam in the form of a slit projected onto the sample chamber. In some embodiments, the slit projection module includes a slit. In other embodiments, the slit projection module includes a slit coupled to a focusing lens configured to focus the reduced slit-shaped light beam into the sample chamber.
[00129] In some embodiments, the systems of the present description are configured in such a way that the sample chamber, the slit projection module or both the sample chamber and the slit projection module can be moved to shift the slit beam. slit-shaped light through the sample chamber. Where movement of the slit-shaped light beam through the sample chamber is desired, in some embodiments systems are configured to move the sample chamber while the projection slit module is held in a stationary position. In other embodiments, systems are configured to move the projection slit and the sample chamber is held stationary. In still other embodiments, the system is configured to move both the slit projection module and the sample chamber. Any displacement protocol can be used in the systems concerned to move the slit-shaped light beam through the sample chamber, such as manually (ie, moving the sample chamber or slit projection module directly manually ), with the aid of a mechanical device or a motor-driven displacement device. For example, in some embodiments the sample chamber is moved in the systems concerned with a mechanically driven conversion platform, mechanical lead screw assembly, mechanical slide device, mechanical lateral movement device, mechanically operated adapted conversion device. In other embodiments, the sample chamber is moved with a motor-driven conversion platform, mechanical lead screw assembly, mechanical slide device, such as those employing a stepper motor, servo motor, brushless electric motor, motor Brushed DC, micro-step motor drive, high resolution step motor, among other types of motors. In certain cases, the sample chamber is installed in a cartridge holder that is operatively or mechanically connected to the conversion or displacement device. In these cases, the sample chamber (or microcartridge containing the sample chamber) is first loaded into the cartridge compartment and the entire compartment is moved during the present methods.
[00130] Similarly, the slit projection module, in certain cases, is moved in the systems concerned with a mechanically driven conversion platform, mechanical lead screw assembly, mechanical slide device, mechanical lateral movement device, adapted conversion device mechanically operated. In other embodiments, the slit projection module is moved with a motor driven conversion platform, mechanical lead screw assembly, mechanical slide device, such as those employing a stepper motor, servo motor, brushless electric motor , brushed DC motor, micro-step motor drive, high resolution step motor, among other types of motors.
[00131] In some embodiments, the system is configured to move the sample chamber relative to a stationary slit projection module to shift the slit beam laterally through the sample chamber in a single direction, during evaluation of the slit. sample. In other embodiments, the system is configured to move the sample chamber relative to a stationary slit projection module to move the slit beam laterally across the sample chamber in back-and-forth motion during sample evaluation. For example, the sample chamber can be moved so that the slit beam is moved along 50% or more of the sample chamber, such as 55% or more, such as 60% or more, such as 65% or more, such as 70% or more, such as 75% or more, such as 80% or more, such as 85% or more, such as 90% or more, such as 95% or more, such as 97 % or more and including over 99% or more of the length of the sample chamber. In certain cases, the sample chamber is moved such that the slit-shaped beam is moved along substantially the entire length of the sample chamber.
[00132] In other embodiments, the system is configured to move the slit projection module relative to a stationary sample chamber to shift the slit beam laterally through the sample chamber in a single direction during sample evaluation . In other embodiments, the system is configured to move the slit projection module relative to a stationary sample chamber to move the slit beam laterally across the sample chamber in back-and-forth motion during sample evaluation. For example, the slit projection module can be moved such that the slit beam is moved along 50% or more of the sample chamber, such as 55% or more, such as 60% or more, such as 65% or more, such as 70% or more, such as 75% or more, such as 80% or more, such as 85% or more, such as 90% or more, such as 95% or more, such as as 97% or more and including over 99% or more of the length of the sample chamber. In certain cases, the slit projection module is moved such that the slit-shaped beam is moved along substantially the entire length of the sample chamber.
[00133] In still other embodiments, the system is configured to move both the slit projection module and the sample chamber to move the slit beam laterally through the sample chamber in a single direction during sample evaluation. In other embodiments, the system is configured to move both the slit projection module and the sample chamber to move the slit beam laterally through the sample chamber in back-and-forth motion during sample evaluation. For example, the slit-projection module and the sample chamber can be simultaneously moved such that the slit-shaped beam is moved along 50% or more of the sample chamber, such as 55% or more, such as as 60% or more, such as 65% or more, such as 70% or more, such as 75% or more, such as 80% or more, such as 85% or more, such as 90% or more, such as 95 % or more, such as 97 % or more and including over 99 % or more of the length of the sample chamber. In certain cases, the slit projection module and sample chamber are both moved such that the slit-shaped beam is moved along substantially the entire length of the sample chamber.
[00134] The slit opening may be of any suitable shape, including but not limited to an oval, rectangle or other suitable polygon shape. In certain embodiments, the slit opening is rectangular. Depending on the size of the sample chamber and the slit beam provided by the light source, as well as the distance between the slit projection module, light source, sample chamber and detector, the dimensions of the slit opening may vary. , having a length ranging from 1 mm to 10 mm, such as 1.25 mm to 9.5 mm, such as 1.5 mm to 9 mm, such as 2 mm to 8 mm, such as 2 .5mm to 7mm, such as from 3mm to 6mm and including between 3.5mm to 5mm. The width of the slit opening can range from 1 μm to 250 μm, such as 2 μm to 225 μm, such as 5 μm to 200 μm, such as 10 μm to 150 μm, and including from 15 μm to 125 μm , for example a slit having an opening width of 100 µm. Any suitable slit device can be used as long as it is sufficient to provide the desired slit-shaped beam of light to assess the sample chamber. For example, the slit can be gold, silver, gold-plated copper, ceramic, chromium, copper, molybdenum and tungsten.
[00135] In some cases, the slit projection module also includes an optical adjustment protocol. By "optical adjustment" is meant that the slit-shaped beam of light can be altered as desired, such as increasing or decreasing the dimensions or improving the optical resolution of the slit-shaped beam. In some cases, optical adjustment is a magnification protocol configured to increase the slit width, such as by 5% or more, such as by 10% or more, such as by 25% or more, such as by 50% or more and including increasing the slit beam width by 75% or more. In other cases, optical adjustment is a reduction protocol configured to decrease the slit width, such as by 5% or more, such as by 10% or more, such as by 25% or more, such as by 50% or more and including decreasing the slit beam width by 75% or more. In certain embodiments, optical adjustment is an enhanced resolution protocol configured to improve the resolution of the slit beam, such as 5% or more, such as 10% or more, such as 25% or more, such as. as by 50% or more and including increasing the resolution of the slit beam by 75% or more. The slit beam can be adjusted with any suitable optical adjustment protocol, including but not limited to lenses, mirrors, holes, slits and combinations thereof.
[00136] In certain embodiments, the slit projection module may also include a slit-coupled focusing lens that is configured to focus the light beam in a reduced slit form. In certain embodiments, the focusing lens is a reduction lens having a magnification factor ranging from 0.1 to 0.95, such as a magnification factor of 0.2 to 0.9, such as a magnification factor from 0.3 to 0.85, such as a magnification factor of 0.35 to 0.8, such as a magnification factor of 0.5 to 0.75 and including a magnification factor of 0.55 to 0 .7, for example a magnification factor of 0.6. For example, the focusing lens is, in certain cases, a double achromatic reduction lens having a magnification factor of about 0.6. Depending on the distance between the slit projection module, light source, sample chamber and detector, as well as the sample chamber size and desired slit beam size, the focal length of the focusing lens may vary and vary. from 5mm to 20mm such as 6mm to 19mm such as 7mm to 18mm such as 8mm to 17mm such as 9mm to 16 and including a focal length in the range of 10 mm to 15 mm. In certain embodiments, the focusing lens has a focal length of about 13mm.
[00137] In some embodiments, the slit and the focusing lens are in optical communication, but not physically in contact. Depending on the size of the sample chamber, as well as the desired shape and size of the slit beam projected onto the sample chamber, the slit can be positioned at a distance from the focusing lens that varies and can be 0.1 mm or more, such as 0.2 mm or more, such as 0.5 mm or more, such as 1 mm or more, such as 5 mm or more, such as 10 mm or more, such as 25 mm or more, such as like 50mm or more, including 100mm or more. In other embodiments, the slit is physically coupled to the focusing lens, such as with an adhesive, co-molded together or integrated together in a housing having the focusing lens positioned adjacent the slit. As such, the slit and focusing lens can be integrated into a single unit.
[00138] As described above, the slit projection module is configured to provide a slit-shaped beam having a varying length and width. In some embodiments, the slit projection module is configured to provide a slit-shaped beam with a length ranging from 1 mm to 5 mm, such as 1.5 mm to 4.5 mm, such as 2 mm to 4mm, such as 2.5mm to 3.5mm and including a slit-shaped beam with a length of 3mm. In these embodiments, the slit projection module is configured to provide a slit-shaped beam with a width ranging from 10 μm to 100 μm, such as 15 μm to 95 μm, such as 20 μm to 90 μm, such as as from 25 μm to 85 μm, such as from 30 μm to 80 μm, such as from 35 μm to 75 μm, such as from 40 μm to 70 μm, such as from 45 μm to 65 μm, and including from 50 μm to 60 µm.
[00139] As described above, in some embodiments the slit projection module is configured to provide a slit-shaped beam with a length that is orthogonal to the length of the sample chamber. Depending on the size of the sample chamber, as described below, the slit projection module can be configured to provide a slit-shaped beam with a length that is 50% or more of the sample chamber width, such as 55% or more, such as 60% or more, such as 65% or more, such as 70% or more, such as 75% or more, such as 80% or more, such as 85% or more, such as 90% or more , such as 95% or more, such as 97% or more, and including a slit projection module configured to provide a slit-shaped beam with a length that is 99% or more of the width of the sample chamber. In certain cases, the slit projection module is configured to provide a slit-shaped beam that has a length that is substantially the same as the width of the sample chamber. In other embodiments, the projection slit module is configured to provide a slit-shaped projection beam that has a length that is greater than the width of the sample chamber. For example, the slit projection module is, in certain cases, configured to provide a slit-shaped beam of light that has a length that is 1% or more than the width of the sample chamber, such as 2% or more, such as 5% or more, such as 10% or more, such as 15% or more, such as 20% or more and which includes a length that is 25% more than the width of the sample chamber. In yet another case, the slit projection module is configured to provide a slit-shaped beam of light that has a length that is less than the width of the sample chamber, such as a length that is 1% or more or less than the width of the sample chamber, such as a length that is 2% or more or less than the width of the sample chamber, such as a length that is 5% or more or less than the width of the chamber of sample, such as a length that is 10% or greater or less than the width of the sample chamber, such as a length that is 15% or greater or less than the width of the sample chamber, such as a length that is 20 % or greater or less than the sample chamber width and including a length that is 25% or greater or less than the sample chamber width.
[00140] As discussed in more detail below, in certain embodiments, the subject systems are configured to receive a cartridge microfluidic device having a capillary sample chamber. In these embodiments, the systems can also include a cartridge holder for receiving the cartridge in the system. For example, the cartridge holder can include a holder for receiving the cartridge microfluidic device and one or more cartridge retainers for holding the cartridge microfluidic device in the cartridge holder. In some cases, the cartridge holder includes vibration dampeners to reduce agitation of the cartridge microfluidic device positioned in the cartridge holder, as well as one or more cartridge presence references configured to indicate that a cartridge microfluidic device is present in the holder. of the cartridge.
[00141] Where the subject systems are configured to move the sample chamber during evaluation (as discussed above), the systems may also include a transport cartridge coupled to the cartridge holder for moving the cartridge microfluidic device. In some embodiments, the transport cartridge is coupled to one or more conversion or lateral movement protocols to move the cartridge microfluidic device. For example, the transport cartridge can be coupled to a mechanically driven conversion platform, mechanical lead screw assembly, mechanical slide device, mechanical lateral movement device, mechanically operated adapted conversion device, a motor driven conversion platform , mechanical lead screw assembly, mechanical slide device, such as those employing a stepper motor, servo motor, brushless electric motor, brushed DC motor, micro-step motor drive, high-resolution stepper motor, among other types of engines. The systems may also include an assembly of cartridge positioning transport rails to facilitate lateral movement of the cartridge holder.
[00142] In some embodiments, the systems further include a blank reference window to provide a blank absorbance for use in calculating analyte concentration. The absorbance of the reference blank window is, in certain embodiments, set to be identical to the absorbance by the sample chamber so that transmission through the reference blank window can be used to correct for absorption, scatter, etc., by the microfluidic cartridge when practicing the methods described herein. In certain embodiments, the blank reference window has an absorbance and transmission at one or more wavelengths of incident light that is substantially the same as the capillary channel sample chamber. In other embodiments, the blank reference window scatters light at one or more wavelengths that are substantially the same as the capillary channel sample chamber. In still other embodiments, the blank reference window has an absorbance, transmission and scattering of light at one or more incident wavelengths that is substantially the same as the capillary channel sample chamber. In still other embodiments, the blank reference window has an index of refraction that is the same as the capillary channel sample chamber.
[00143] The blank reference window integrated in present systems can be of any appropriate size and shape. For example, the blank reference window can be in the shape of a square, circle, oval, rectangle, pentagonal, hexagonal, octagonal, or any other suitable polygon. In some embodiments, the blank reference window has a length to width ratio ranging from 1 to 50, such as 3 to 25, such as 4 to 10, such as 5 to 8, including 15 to 20. In certain embodiments, the white reference window is a square and has a length to width ratio of 1. The length of the white reference window may vary, ranging from 1 mm to 50 mm, such as from 2 mm to 25 mm and including from 5mm to 20mm. The width of the blank reference window may vary, ranging from 0.001 mm to 20 mm, such as 0.005 mm to 19 mm, such as 0.01 mm to 18 mm, such as 0.05 mm to 17 mm, such as 0.1 mm to 15 mm, such as 0.5 mm to 12.5 mm, such as 1 to 10 and including 3 to 5 mm. In some cases, the height of the channel varies from 5 μm to 500 μm, such as from 10 μm to 150 μm and including 20 μm to 70 μm. In certain embodiments, the blank reference window has a width that is substantially the same as the width of the capillary channel sample chamber. As described above, the slit-shaped beam of light that is transmitted through the sample chamber is collected and detected using one or more photodetectors. In certain embodiments, the systems include one or more objective lenses to collect light transmitted through the sample chamber. For example, the objective lens can be a magnifying glass with a nominal magnification ranging from 1.2 to 2.5, such as a nominal magnification of 1.3 to 2.4, such as a nominal magnification of 1.4 to 2.3, such as a nominal magnification of 1.5 to 2.2, such as a nominal magnification of 1.6 to 2.1, including passing light transmitted through a magnifying lens having a nominal magnification of 1.7 to 2.0, for example, a nominal magnification of 1.7. In certain cases, the objective lens is a dual magnification achromatic lens with a nominal magnification of 1.7. Depending on the configuration of the light source, sample chamber and detector, objective lens properties may vary. For example, the numerical aperture of the objective lens in question can also vary, ranging from 0.01-1.7, such as 0.05 to 1.6, such as 0.1 to 1.5, such as 0.2 to 1.4, such as 0.3 to 1.3, such as 0.4 to 1.2, such as 0.5 to 1.1 and including a numerical aperture ranging from 0.6 to 1.0. Likewise, the focal length of the objective lens varies, ranging from 10mm to 20mm, such as from 10.5mm to 19mm, such as from 11mm to 18mm and including from 12mm to 15mm.
[00144] In some embodiments, the objective lens is coupled to a focusing module to focus the projection of the slit beam transmitted through the sample chamber to the detector for detection. For example, an autofocus module suitable for focusing the slit beam projection transmitted through the sample may include, but is not limited to, that described in U.S. Patent No. 6,441,894, filed October 29, 1999 , the description of which is incorporated herein by reference.
[00145] Systems of the present description may also include one or more wavelength splitters. As discussed above, a "wavelength separator" is configured to separate polychromatic light into wavelength components such that each wavelength can be properly detected. Examples of suitable wavelength separators in such systems may include, but are not limited to, colored glass, bandpass filters, interference filters, dichroic mirrors, diffraction gratings, monochromators and their combinations, among other separation protocols. wavelengths. Depending on the light source and the sample being analyzed, systems may include one or more wavelength splitters, such as two or more, such as three or more, such as four or more, such as five or more and including 10 or more wavelength separators. In one example, systems include two or more bandpass filters. In another example, the systems include two or more bandpass filters and a diffraction grating. In yet another example, the systems include a plurality of bandpass filters and a monochromator. In certain embodiments, the systems include a plurality of bandpass filters and diffraction gratings configured in a filter wheel configuration. When systems include two or more wavelength splitters, the wavelength splitter can be used individually or in series to separate polychromatic light into component wavelengths. In some embodiments, the wavelength splitters are arranged in series. In other embodiments, the wavelength splitters are individually arranged such that one or more measurements are taken to collect the desired absorbance data using each of the wavelength splitters.
[00146] In some embodiments, the systems include one or more diffraction gratings. Diffraction gratings of interest may include, but are not limited to, broadcast, dispersive or reflective diffraction gratings. Appropriate diffraction grating spacings may vary depending on the configuration of the light source, slit projection module, sample chamber, objective lens, ranging from 0.01 μm to 10 μm, such as from 0.025 μm to 7.5 μm, such as from 0.5 μm to 5 μm, such as from 0.75 μm to 4 μm, such as from 1 μm to 3.5 μm and including 1.5 μm and 3.5 μm.
[00147] In some embodiments, the systems include one or more optical filters. In certain cases, systems include bandpass filters with minimum bandwidths ranging from 2 nm to 100 nm, such as 3 nm to 95 nm, such as 5 nm to 95 nm, such as 10 nm to 90 nm, such as 12 nm to 85 nm, such as 15 nm to 80 nm and including bandpass filters with minimum bandwidths ranging from 20 nm to 50 nm. For example, systems can include one or more bandpass filters that selectively pass wavelengths at intervals of: 498 nm - 510 nm; 500 nm - 600 nm; 500 nm - 520 nm; 540nm - 550nm; 545 nm - 555 nm; 550 nm - 570 nm; 550 nm - 580 nm; 560 nm - 590 nm; 575 nm - 595 nm; 580 nm - 590 nm; 600 nm - 700 nm; 600 nm - 630 nm; 650 nm - 750 nm; 750 nm - 850 nm; 810 nm - 830 nm; 815 nm - 825 nm, or any combination thereof.
[00148] In certain cases, systems include one or more bandpass filters that selectively pass wavelengths ranging from 500 nm - 520 nm and 650 nm - 750 nm. In other cases, systems include one or more bandpass filters that selectively pass wavelengths ranging from 540 nm - 560 nm and 650 nm - 750 nm. In still other cases, the systems include one or more bandpass filters that selectively pass wavelengths ranging from 560 nm - 590 nm and 650 nm - 750 nm. In still other cases, the systems include one or more bandpass filters that selectively pass wavelengths ranging from 500 nm - 520 nm; 560 nm - 590 nm and 650 nm - 750 nm.
[00149] The systems of the present description also include one or more detectors. Examples of suitable detectors may include, but are not limited to optical sensor or photodetectors, such as active pixel sensors (APS), avalanche photodiodes, image sensors, charge-coupled devices (CCD), charge-coupled devices (ICCD) ), light emitting diodes, photon counters, bolometers, pyroelectric detectors, photoresistors, photovoltaic cells, photodiodes, photomultiplier tubes, phototransistors, photoconductors or quantum dot photodiodes and their combinations, among other photodetectors. In certain embodiments, transmitted light is measured with a charge-coupled device (CCD). When transmitted light is measured with a CCD, the active sensing surface area of the CCD can vary, such as 0.01 cm2 to 10 cm2, such as 0.05 cm2 to 9 cm2, such as 0.1 cm2 to 8 cm2, such as from 0.5 cm2 to 7 cm2 and including from 1 cm2 to 5 cm2.
[00150] In embodiments of the present description, the detectors of interest are configured to measure light transmitted through the sample chamber at one or more wavelengths, such as at 2 or more wavelengths, such as at 5 or more wavelengths. of different wavelengths, such as at 10 or more different wavelengths, such as at 25 or more different wavelengths, such as at 50 or more different wavelengths, such as at 100 or more different wavelengths, such as at 200 or more different wavelengths, such as at 300 or more different wavelengths and including measuring the light transmitted through the sample chamber at 400 or more different wavelengths.
[00151] In some embodiments, the detectors of interest are configured to measure the light transmitted through the sample chamber over a range of wavelengths (eg 400 nm - 800 nm; 495 nm - 525 nm; 800 nm - 835 nm, etc.). For example, systems can include one or more detectors configured to measure light transmitted through the sample chamber during one or more of the following wavelength ranges: 400 nm - 800 nm; 498 nm - 510 nm; 500 nm - 600 nm; 500 nm - 700 nm; 500 nm - 520 nm; 540nm - 550nm; 545 nm - 555 nm; 550 nm - 570 nm; 550 nm - 580 nm; 560 nm - 590 nm; 575 nm - 595 nm; 580 nm - 590 nm; 600 nm - 700 nm; 600 nm - 630 nm; 650 nm - 750 nm; 750 nm - 850 nm; 810 nm - 830 nm; 815 nm - 825 nm, and any combinations thereof. In certain cases, the detector is configured to measure light transmitted over wavelengths ranging from 400 nm - 800 nm. In other cases, the detector is configured to measure transmitted light over wavelengths ranging from 500 nm - 520 nm to 650 nm - 750 nm. In other cases, the detector is configured to measure light transmitted through wavelengths ranging from 540 nm - 560 nm and 650 nm - 750 nm. In still other cases, the detector is configured to measure light transmitted through wavelengths ranging from 560 nm - 590 nm and 650 nm - 750 nm. In still other cases, the detector is configured to measure light transmitted through wavelengths ranging from 500 nm - 520 nm, 560 nm - 590 nm and 650 - 750 nm.
[00152] In certain embodiments, the detectors of interest are configured to collect light spectra over a range of wavelengths. For example, systems can include one or more detectors configured to collect light spectra over one or more of the wavelength ranges: 400 nm - 800 nm; 498 nm - 510 nm; 500 nm - 600 nm; 500 nm - 700 nm; 500 nm - 520 nm; 540nm - 550nm; 545 nm - 555 nm; 550 nm - 570 nm; 550 nm - 580 nm; 560 nm - 590 nm; 575 nm - 595 nm; 580 nm - 590 nm; 600 nm - 700 nm; 600 nm - 630 nm; 650 nm - 750 nm; 750 nm - 850 nm; 810 nm - 830 nm; 815 nm - 825 nm, and any combinations thereof. In certain cases, the detector is configured to collect light spectra with wavelengths ranging from 400 nm - 800 nm. In other cases, the detector is configured to collect light spectra with wavelengths ranging from 500 nm - 700 nm.
[00153] In still other embodiments, the detectors of interest are configured to measure light at one or more specific wavelengths. For example, systems can include one or more detectors configured to measure light at one or more of 504 nm, 506 nm, 514 nm, 532 nm, 543 nm, 548 nm, 550 nm, 561 nm, 568 nm, 579 nm , 580 nm, 585 nm, 586 nm, 675 nm, 710 nm, 808 nm, 815 nm, 830 nm and any combinations thereof. In certain cases, the detector is configured to measure light at 548 nm. In other cases, the detector is configured to measure light at 675 nm. In other cases, the detector is configured to measure light at 830 nm. In still other cases, the detector is configured to measure light at 548 nm and 675 nm. In still other embodiments, the detector is configured to measure at 548 nm, 675 nm and 830 nm.
[00154] In embodiments, the detector can be configured to measure light continuously or at discrete intervals. In some cases, the detectors of interest are configured to measure light continuously. In other cases, the detectors of interest are configured to take measurements at discrete intervals, such as measuring light every 0.001 millisecond, every 0.01 millisecond, every 0.1 millisecond, every 1 millisecond, every 10 millisecond , every 100 milliseconds and including every 1000 milliseconds, or some other interval.
[00155] Embodiments of the present systems may also include one or more optical components as desired to provide any desired configuration. For example, systems can have each of the components (ie, light source, slit projection module, sample chamber, objective lens, wavelength separator and detector) in an "in-line" configuration where the light emitted from the light source travels through each component without substantial deviation from the track shape line. When desired, one or more mirrors, beam splitters or other types of light deflection components can be used to deflect light along a different path or to separate the light into separate beams for detection.
[00156] Figure 2a represents a parallel configuration of the systems in question according to a modality. A light source (201) provides light by emitting one or more wavelengths of light through a slit projection module that includes a slit (202a) for narrowing the light beam producing a slit-shaped beam and an objective lens (202b) for focusing and reducing the slit beam. The slit-shaped beam illuminates a sample chamber (203) in which the analyte in the sample absorbs light and a remaining portion of the light is transmitted and collected by an objective lens (204) that is configured to focus light into a spacer. of wavelengths (eg, diffraction grating 205) that spatially separates light into component wavelengths. The spatially separated light is then detected by a detector (eg CCD, 206).
[00157] Figure 2b illustrates a top view of a configuration of the systems in question according to another modality. A light source (207) provides light by emitting one or more wavelengths of light through a slit projection module (208) that includes a slit and an objective lens to provide a slit-shaped beam. The slit-shaped beam illuminates a sample chamber (209) in which the analyte in the sample absorbs light and a remaining portion of the light is transmitted and collected by an objective lens (210) and supplied to a wavelength separator ( 211) that spatially separates light into component wavelengths. The spatially separated light is then detected by a detector (212).
[00158] In some embodiments, systems are configured having one or more of the light source, slit projection module, sample chamber, objective lens, wavelength separator and detector is in an offset position. By "offset" it is meant that the geometric center of the system component is positioned at a point in space not along the central optical axis connecting the light source and the detector. For example, in some modalities, the light source is in an offset position. In other embodiments, the slit projection module is in an offset position. When the slit projection module includes a focusing lens, the focusing lens is, in certain cases, in an offset position. In still other embodiments, the sample chamber is in an offset position. In still other embodiments, the objective lens for collecting and focusing the transmitted light is in an offset position. In still other embodiments, the wavelength splitter is in an offset position. In certain embodiments, the detector is in an offset position. In some cases, all of the light source, slit projection module, sample chamber, objective lens, wavelength separator and detector are all in an offset position.
[00159] The displacement distance can vary as desired ranging from 0.1 mm to 100 mm, such as from 0.2 mm to 95 mm, such as from 0.3 mm to 90 mm, such as 0. 4mm to 85mm, such as 0.5mm to 80mm, such as 0.6mm to 75mm, such as 0.7mm to 70mm, such as 0.8mm to 65mm, such as from 0.9mm to 60mm such as 1mm to 55mm such as 1.25mm to 50mm such as 1.5mm and 45mm such as 1.75mm to 40mm, such as from 2mm to 30mm, such as from 2.5mm to 25mm and including from 1mm to 20mm.
[00160] For example, where the wavelength separator is a diffraction grating, the diffraction grating may be in an offset position to facilitate diffraction of desired wavelengths (eg 548 nm, 675 nm, etc.) for a specific analysis protocol. In another example, where the detector is a CCD detector, the CCD detector may be in an offset position to facilitate light collection (eg, transmitted or emitted light) in position in the detector with calibrated pixels.
[00161] In certain embodiments, systems of interest include an integrated microfluidic sampling device that has a capillary channel sample chamber with a sample application site coupled to an inlet for introducing a fluid sample. Therefore, in these embodiments, the present systems are not configured to receive the cartridge microfluidic device described above, but rather are configured to receive the fluid sample directly, which is subsequently removed after sample analysis.
[00162] In embodiments, the integrated sampling device includes a capillary channel sample chamber and a sample application site coupled to an inlet for introducing the fluid sample. The capillary channel sample chamber of the integrated microfluidic sampling device may have an elongated structure such that it has a length that is greater than its width. Although the length to width ratio may vary, in some cases the length to width ratio ranges from 2 to 5000, such as 3 to 2500, such as 4 to 1000, such as 5 to 500, such as 6 to 100, such as 10 to 50 and including 15 to 20. In some cases, the channel length ranges from 10 mm to 500 mm, such as 20 mm to 250 mm and including 50 mm to 75 mm. In some cases, the channels have a micrometer-sized cross-sectional dimension, for example, a larger cross-sectional dimension (eg diameter in the case of the tubular channel) ranging from 0.1 mm to 20 mm, such as 1mm to 10mm and including from 3mm to 5mm. In some cases, the channel width ranges from 0.001mm to 20mm, such as 0.005mm to 19mm, such as 0.01mm to 18mm, such as 0.05mm to 17mm, such as 0.05mm to 17mm. 0.1mm to 15mm, such as 0.5mm to 12.5mm, such as 1 to 10 and including 3 to 5mm. In some cases, the height of the channel varies from 5 μm to 500 μm, such as from 10 μm to 150 μm and including 20 μm to 70 μm. Likewise, the capillary channel can have a cross-sectional shape, such as straight shapes in cross-section, eg squares, rectangles, triangles, trapezoids, hexagons, etc., curvilinear shapes in cross-section, eg circular , oval, etc., as well as irregular shapes, for example a parabolic bottom portion coupled to a flat top portion, etc.
[00163] The sample application site of the integrated microfluidic sampling device is a structure configured to receive a sample with a volume ranging from 5 μL to 100 μL, such as 10 μL to 50 μL and including 20 μL and 30 μL. The sample application site may be of any suitable shape as long as it provides for fluid access, either directly or through an intervening component (or components) that provide fluid communication, to the capillary channel.
[00164] The inlet of the integrated microfluidic sampling device is in fluid communication with the sample application site and the capillary channel sample chamber and can be of any suitable shape, where cross-sectional shapes of inlets of interest include, but are not limited to: straight shapes in cross section, eg squares, rectangles, trapezoids, triangles, hexagons, etc., curvilinear shapes in cross section, eg circular, oval, etc., as well as irregular shapes, for example, a parabolic bottom portion coupled to a flat top portion, etc. Depending on the shape of the inlet, the sample inlet can have an aperture size that varies, ranging from 0.1 mm2 to 100 mm2, such as 1 mm2 to 75 mm2 and including 5 mm2 to 50 mm2.
[00165] In some cases, the integrated microfluidic sampling device includes a mixing chamber positioned in the fluid path between the sample application site and the capillary channel sample chamber that is configured to combine sample that has been applied in the application of the sample and is flowing through the capillary channel with one or more reagents.
[00166] In some cases, the mixing chamber of the integrated microfluidic sampling device includes a contact structure that provides the high surface area (eg, porous disk) in which one or more reagents can be positioned, where in certain cases, the raised surface area structure is configured to filter or facilitate contact between one or more sample components with the reagents present in the mixing chamber. In certain cases, the raised surface area structure is configured to not filter sample components and simply to facilitate contact between the reagents and the sample flowing through. For example, where the sample is a whole blood sample, the elevated surface area structure may be one that is configured not to impede the flow of any of the whole blood components, eg, white blood cells, red blood cells, platelets , etc., through the high surface area structure. In such cases, the high surface area structure may have a porosity ranging from 20 to 80, such as 30 to 70, including 40 to 60. Suitable high surface areas, porous materials to facilitate contact between the sample and the reagents include, but are not limited to, polymeric materials, glass materials, ceramic materials, metallic materials, etc., such as, for example, polyethylene, polypropylene, polyvinylidene fluoride, and the like.
The reagents contained in the mixing chamber may, for example, include specific binding members, enzymes, substrates, oxidants, fluorescent labels, etc., such as those described below. Likewise, the amount of reagent present in the mixing chamber or contacting the structure of the integrated microfluidic sampling device may vary, for example, depending on the particular type of assay for which the device is configured. In some cases, the amount of a reagent is sufficient to provide a concentration of reagent in the sample that flows through the mixing chamber ranging from 0.002 micrograms/mL to 100 micrograms/mL, such as 0.02 micrograms/mL to 10 micrograms/ml and including 0.2 to 1 microgram/ml. While the dry weight of a reagent present in the mixing chamber may vary, in some cases the dry weight ranges from 0.01 ng to 500 ng, such as 0.3 ng to 120 ng and including 3 ng and 12 ng.
[00168] As discussed above, where the systems in question include an integrated microfluidic sampling device, the sampling device is configured to receive a fluid sample, which is subsequently removed after analyzing the sample. By "removed" it is meant that no amount of sample remains in contact with the systems concerned, including any capillary channel sample chamber, sample application site, inlet, as well as mixing chamber. In other words, when the sample is removed, all traces of the sample are cleaned from the system components. In some embodiments, the systems can additionally include one or more washing devices for cleaning the integrated microfluidic sampling device. For example, washing devices can include microconducts with or without a spray nozzle for delivering wash buffer to clean the sampling device. In certain embodiments, these systems include a reservoir for storing one or more wash buffers.
[00169] In some cases, the systems in question may include one or more components for reading or evaluating a unique identifier (for example, bar codes, serial number) of the microfluidic cartridge, where identifiers of interest can provide information about the device, for example, the particular test it is configured for, the manufacturing batch number, etc., which identifiers can be unique identifiers. Identifiers may, in certain cases, provide information or characteristics about the microfluidic cartridge, including but not limited to sample channel refractive index, blank reference window refractive index, sample channel dimensions including height sample channel width, sample channel width, sample channel length, total sample channel depth, sample channel wall thickness. Likewise, identifiers can include information about the blank reference window, such as the index of refraction of the blank reference window, dimensions of the blank reference window including the height of the blank reference window, the width of the blank reference window. blank reference, blank reference window length, blank reference window total, blank reference window wall thickness.
[00170] Any suitable identification reader or assessment protocol may be employed, including but not limited to a barcode reader, RFID assessment systems, magnetic stripe readers, tactile code identifiers, among other identification protocols .
[00171] In certain embodiments, the subject absorbance detection systems can be coupled to one or more fluorescence detection systems to evaluate the sample chamber for fluorescence. For example, fluorescence detection systems can include one or more light sources (e.g., wideband or narrowband light sources such as those described above), optical module for collecting and focusing the emission light. , wavelength splitters for spatially separating the collected light to be detected and one or more photosensors or photodetectors.
[00172] In certain embodiments, both the fluorescence detection systems and the absorbance detection systems use one or more common components as described herein. For example, in some cases, both fluorescence detection systems and absorbance detection systems use a common objective lens module for collecting and focusing light from the sample chamber (eg, emitted light or transmitted light). In other cases, both fluorescence detection systems and absorbance detection systems use a common wavelength separator apparatus (eg diffraction grating, optical filters, filter wheel having one or more diffraction gratings and filters optical). In still other cases, both fluorescence detection systems and absorbance detection systems use the same detector for measuring light from the sample chamber.
[00173] Fluorescence imaging and digital processing systems that can be coupled to the present systems, in certain cases, include systems for imaging samples in capillary channels, such as those described in US Pat. 8,248,597; 7,927,561 and 7,738,094, as well as those described in co-pending US Patent Application 13/590,114 filed August 20, 2012, the description of which is incorporated herein by reference.
[00174] Figure 3 represents a configuration of the systems in question according to another modality in which an absorbance detection system is coupled to a fluorescence detection system. As discussed above, absorbance detection systems include a light source (301) emitting one or more wavelengths of light through a slit projection module (302) that includes a slit to narrow the light beam producing a slit-shaped beam and an objective lens for focusing and reducing the slit-shaped beam. The slit-shaped beam illuminates a sample chamber in a microfluidic cartridge (303), in which the analyte in the sample absorbs light and a remaining portion of the light is transmitted and collected by an objective lens (304) that is configured to focus light on a wavelength separator 305 (e.g., the filter wheel having one or more optical filters and diffraction gratings) that spatially separates the light into component wavelengths. The spatially separated light is then detected by a detector (eg, CCD, 306). For fluorescence detection, the system includes a second light source (307), which is positioned above the sample chamber to illuminate the sample chamber and the fluorescence produced by the analytes is collected with the objective lens (304), spatially separated using filter wheel 305 and detected by detector 306. In this embodiment, the fluorescence detection system and absorbance detection system uses a common objective lens (304) for collecting light from the sample chamber (303), wavelength separator apparatus (305) and detector (306).
[00175] In some embodiments, the systems of interest also include one or more processors to process the collected analysis data, a monitor, such as a liquid crystal display (LCD) for viewing raw data collected during the analysis, or the processed results received from the processor, as well as input devices such as buttons, a keyboard, mouse, or touch screen. Furthermore, the systems can include one or more of wired or wireless communication protocols or an integrated printer to transmit the results to one or more users. For example, the systems can include one or more computer system components, such as those described in greater detail below.
[00176] Figure 4 depicts an example of an analysis of interest reader system according to an embodiment. The system includes a compartment 400 that has a front side 400a and a back side 400b. The front side 400a includes a display 401, such as a liquid crystal display (LCD) for viewing raw data collected during the assay or processed results received from the processor, an integrated printer (403) for transmitting analysis data. for the user, as well as a slot for inserting 404 the microfluidic device cartridge into the analysis reader system. The analysis reader system also includes a communication interface 405 to allow data communication (e.g., USB port) between the subject system and one or more other external devices, such as a computer terminal that is configured for communication. of similar supplementary data. The rear side 400b can include cable connections for power and data communication protocols (not shown), as well as vent openings operably connected to fans and heat sinks. The rear side 400b may also include one or more lifting handles for manually moving or transporting the analysis reader system. As shown in Figure 4, the systems in question can be configured to be an all-in-one unitary system that has the optics, electronics (described in more detail below), display, communication protocols in a single box. . In certain embodiments, the systems of interest are configured to be capable of being moved (carried or lifted at a distance of 50 meters or more) by a human being without machine assistance (eg, with a handled elevator). As such, systems of interest in these embodiments are 25 kg or less, such as 20 kg or less, such as 15 kg or less and including 10 kg or less, e.g., 5 kg or less, and may include, as desired, an integrated handle or other structure to provide ease of handling/transport. MICROFLIDIC CARTRIDGE DEVICES
[00177] Aspects of the present description also include a microfluidic cartridge device that is configured to be received by certain systems described herein. In embodiments, the microfluidic cartridge device includes a capillary channel sample chamber in fluid communication with a sample application site coupled to an inlet for introducing the fluid sample. The term "microfluidic" is used herein in its conventional sense to refer to a device that is configured to control and manipulate fluids geometrically limited to a small scale (e.g., sub-millimeters). As the devices include a capillary channel sample chamber, they include an elongated structure that is configured to provide capillary flow of liquid therethrough. In addition to the sample application site, capillary channel sample chamber and inlet, aspects of the microfluidic device include a reagent mixing chamber in communication with the sample application site and inlet for contacting and mixing the fluidic sample with an or more reagents. In certain embodiments, the mixing chamber is configured as a porous disk containing reagents to contact the sample.
[00178] In embodiments of the present description, the capillary channel sample chamber is an elongated structure such that it has a length that is greater than its width. Although the length to width ratio may vary, in some cases the length to width ratio ranges from 2 to 5000, such as 3 to 2500, such as 4 to 1000, such as 5 to 500, such as 6 to 100, such as 10 to 50 and including 15 to 20. In some cases, the length of the channel ranges from 10 mm to 500 mm, such as 20 mm to 250 mm and including 50 mm to 75 mm. In some cases, the channels have a micrometer size cross-sectional dimension size, for example, a larger cross-sectional dimension (eg diameter in the case of the tubular channel) ranging from 0.1 mm to 20 mm, such as 1mm to 10mm and including from 3mm to 5mm. In some cases, the channel width ranges from 0.001mm to 20mm, such as 0.005mm to 19mm, such as 0.01mm to 18mm, such as 0.05mm to 17mm, such as 0.05mm to 17mm. 0.1mm to 15mm, such as 0.5mm to 12.5mm, such as 1 to 10 and including 3 to 5mm. In some cases, the height of the channel varies from 5 μm to 500 μm, such as from 10 μm to 150 μm and including 20 μm to 70 μm.
[00179] The cross-sectional shape of the capillary channels may vary, in some cases, cross-sectional shapes of the channels of interest include, but are not limited to: straight shapes in cross-section, eg squares, rectangles, triangles, trapezoids , hexagons, etc., curvilinear shapes in cross section, eg circular, oval, etc., as well as irregular shapes, eg a parabolic bottom portion coupled to a flat top portion, etc., as well as irregular shapes , for example, a parabolic bottom portion coupled to a flat top portion, etc.
[00180] Positioned at one end of the capillary channel (ie, the proximal end) is a sample application site that has a fluid inlet for transporting the sample to the capillary channel sample chamber. The sample application site is a site or site configured to receive a volume of sample, for example a biological sample, to be analyzed. In some cases, the sample application site is a structure configured to receive a sample with a volume ranging from 5 μL to 100 μL, such as 10 μL to 50 μL and including 20 μL and 30 μL. The sample application site may be of any suitable shape as long as it provides for fluid access, either directly or through an intervening component (or components) that provide fluid communication, to the capillary channel.
[00181] The sample application site is in communication with an inlet to one end of the capillary channel sample chamber. The sample application site can be positioned along one side of the microfluidic device such that sample applied to the sample application site is drawn into the capillary channel sample chamber inlet. The inlet for transporting the sample to the capillary channel sample chamber can be of any suitable shape, where cross-sectional shapes of channels of interest include, but are not limited to: straight cross-sectional shapes, eg squares, rectangles, trapezoids, triangles, hexagons, etc., curvilinear shapes in cross section, for example, circular, oval, etc., as well as irregular shapes, for example, a parabolic bottom portion coupled to a flat top portion, etc. Depending on the shape of the inlet, the sample inlet can have an aperture size that varies, ranging from 0.1 mm2 to 100 mm2, such as 1 mm2 to 75 mm2 and including 5 mm2 to 50 mm2.
[00182] In some embodiments, the fluid sample is preloaded to the sample application site and the preloaded microfluidic device is stored for a predetermined period of time before the sample is analyzed. As such, the systems of the present description may also include one or more pre-filled microfluidic cartridges. For example, the fluid sample can be preloaded to the sample application site prior to sample analysis for 0.001 hours or more, such as 0.005 hours or more, such as 0.01 hours or more, such as 0, 05 hours or more, such as 0.1 hours or more, such as 0.5 hour or more, such as 1 hour or more, such as 2 hours or more, such as 4 hours or more, such as 8 hours or more , such as 16 hours or more, such as 24 hours or more, such as 48 hours or more, such as 72 hours or more, such as 96 hours or more, such as 120 hours or more, such as 144 hours or more, such such as 168 hours or more and store the pre-charged microfluidic device for 240 hours or more before analyzing the sample or the amount of storage time may vary such as 0.1 hours to 240 hours, such as 0.5 hours to 216 hours, such as from 1 hour to 192 hours and including from 5 hours to 168 hours before analyzing the sample.
[00183] In some embodiments, the microfluidic device includes a mixing chamber positioned in the fluid path between the sample application site and the capillary channel sample chamber. By mixing chamber is meant an area or location or fluid path that is configured to combine sample that has been applied to the sample application and is flowing into the capillary channel with one or more reagents.
[00184] In some cases, the mixing chamber includes a contact structure that provides high surface area (eg, porous disk) in which one or more reactants can be positioned, where in certain cases the structure of the high surface area is configured to filter or facilitate contact between one or more sample components with the reagents present in the mixing chamber. In certain cases, the raised surface area structure is configured to not filter sample components and simply facilitate contact between the reagents and the sample flowing through. For example, where the sample is a whole blood sample, the elevated surface area structure may be one that is configured not to impede the flow of any of the whole blood components, eg, white blood cells, red blood cells, platelets, etc., through the high surface area structure. In such cases, the high surface area structure may have a porosity ranging from 20 to 80, such as 30 to 70, including 40 to 60. Suitable high surface areas, porous materials to facilitate contact between the sample and the reagents include, but are not limited to, polymeric materials, glass materials, ceramic materials, metallic materials, etc., such as, for example, polyethylene, polypropylene, polyvinylidene fluoride, and the like.
[00185] Present in the mixing chamber is one or more reactants, which may be present on a surface of a high surface area structure when present. A variety of different reagents can be present in the mixing chamber or in the device domain, depending on the particular assay for which the device is configured. Reagents of interest include specific labeled binding members, enzymes, substrates, oxidants, etc., among others. In certain embodiments, the one or more reagents in the mixing chamber include a specific labeled binding member. For example, the tagged specific binding member can include a specific binding domain and a tag domain. The terms "specific binding", "specifically binds", and the like, refer to preferential binding of a domain (e.g., one binding pair member to the other binding pair member of the same binding pair) over to other molecules or fractions in a solution or reaction mixture. The specific binding domain can bind (e.g., covalently or non-covalently) to a specific epitope of an analyte of interest. In certain aspects, the specific binding domain non-covalently binds to a target. In such cases, the association of the specific binding domain with the binding target (eg cell surface marker) can be characterized by a KD (dissociation constant) of 10-5 M or less, 10-6 M or less , such as 10-7M or less, including 10-8M or less, for example 10-9M or less, 10-10M or less, 10-11M or less, 10-12M or less, 10-13 M or less, 10 -14 M or less, 10-15 M or less, including 10-16 M or less.
[00186] A variety of different types of specific binding domains can be used as well as capture ligands. Specific binding domains of interest include, but are not limited to binding agents for antibodies, proteins, peptides, haptens, nucleic acids, etc. The term "antibody binding agent" as used herein includes polyclonal or monoclonal antibodies or fragments which are sufficient to bind an analyte of interest. Antibody fragments can be, for example, monomeric Fab fragments, monomeric Fab' fragments, or dimeric F(ab')2 fragments. Also within the scope of the term "antibody binding agent" are antibody engineered molecules, such as single chain antibody (scFv) molecules or humanized or chimeric antibodies produced from monoclonal antibodies by substitution of heavy chain constant regions and light to produce chimeric antibodies or substitution of both the constant regions and the framework portions of the variable regions to produce humanized antibodies. In certain embodiments, reagents of interest include, CD4-PECy5, CD3-APC, CD45RA-APC, CD14-PE.
[00187] The marker domain may be detectable based on, for example, fluorescence emission maximum, fluorescence polarization, fluorescence lifetime, light scattering, mass, molecular weight, or combinations thereof. In certain aspects, the tag domain can be a fluorophore (e.g., a fluorescent tag, fluorescent dye, etc.). Fluorophores can be selected from any of the many dyes suitable for use in analytical applications (eg, flow cytometry, imaging, etc.). A large number of dyes are commercially available from a variety of sources, such as, for example, Molecular Probes (Eugene, OR) and Exciton (Dayton, OH). Examples of fluorophores that can be incorporated into microparticles include, but are not limited to, 4-acetamido-4'-isothiocyanatostilbene-2,2'disulfonic acid; acridine and derivatives such as acridine, acridine orange, acridine yellow, acridine red and acridine isothiocyanate; 5-(2'-aminoethyl)aminonaphthalene-1-sulfonic acid (EDANS); 4-amino-N-[3-vinylsulfonyl)phenyl]naphthalimide-3,5 disulfonate (Yellow Lucifer VS); N-(4-anilino-1-naphthyl)maleimide; anthranilamide; Bright yellow; coumarin and derivatives such as coumarin, 7-amino-4-methylcoumarin (AMC, Coumarin 120), 7-amino-4-trifluoromethylcoumarin (Coumaran 151); cyanine and its derivatives, such as cyanine, Cy3, Cy5, Cy5.5, and Cy7; 4',6-diamidino-2-phenylindole (DAPI); 5',5-dibromopyrogallol-sulfonephthalein (Bromopyrogallol Red); 7-diethylamino-3-(4'-isothiocyanatophenyl)-4-methylcoumarin; diethylaminocoumarin; diethylenetriamine pentaacetate; 4,4'-diisothioyanatodihydro-stilbene-2,2'-disulfonic acid; 4,4'-diisothiocanatostilbene-2,2'-disulfonic; 5-[dimethylamino]naphthalene-1-sulfonyl (DNS, dansyl chloride), 4-(4'-dimethylaminophenylazo)benzoic (DABCYL); 4-dimethylaminophenylazophenyl-4'-isothiocyanate (DABITC); eosin and derivatives such as eosin and eosin isothiocyanate; erythrosine and derivatives such as erythrosine B and erythrosine isothiocyanate; ethidium; fluorescein and its derivatives, such as 5-carboxyfluorescein (FAM), 5-(4,6-dichlorotriazin-2-yl) aminofluorescein (DTAF), 2'7'-dimethoxy-4'5'-dichloro-6-carboxyfluorescein ( JOE), fluorescein isothiocyanate (FITC), chlorotriazinyl fluorescein, naphthofluorescein, and QFITC (XRITC ); fluorescamine; IR144; IR1446; Green Fluorescent Protein (GFP); Reff Coral Fluorescent Protein (RCFP); Lissamine™; Rhodamine Lyssamine, Lucifer yellow; Malachite Green Isothiocyanate; 4-methylumbelliferone; ortho cresolphthalein; nitrotyrosine; pararosaniline; Nile Red; Green Oregon; Phenol Red; B-phycoerythrin; o-phthaldialdehyde; pyrene and derivatives such as pyrene, pyrene butyrate and succinimidyl 1-pyrene butyrate; Reactive Red 4 (Cibacron™ Brilliant Red 3B-A); rhodamine and derivatives such as 6-carboxy-X-rhodamine (ROX), 6-carboxyrhodamine (R6G), lyssamine 4,7-dichlororhodamine, sulfonyl chloride, rhodamine B, rhodamine (Rhod), rhodamine B, rhodamine 123, rhodamine X isothiocyanate, sulphorodamine B, sulphorodamine 101, sulfonyl chloride derivative of sulphorodamine 101 (Texas Red), N,N,N',N'-tetramethyl-6-carboxyrhodamine (TAMRA), tetramethyl rhodamine, and tetramethyl rhodamine isothiocyanate (TRITC ); riboflavin; rosolic acid derivatives and terbium chelate; xanthene; or their combinations. Other fluorophores or combinations thereof known to those skilled in the art may also be used, for example those available from Molecular Probes (Eugene, OR) and Exciton (Dayton, OH). The fluorescent label may be distinguishable based on maximum fluorescence emission values, and optionally further based on light scattering or quenching.
[00188] The amount of reagent present in the mixing chamber or the contact structure may vary, for example, depending on the particular type of assay for which the device is configured. In some cases, the amount of a reagent is sufficient to provide a concentration of reagent in the sample that flows through the mixing chamber ranging from 0.002 micrograms/mL to 100 micrograms/mL, such as 0.02 micrograms/mL to 10 micrograms/ml and including 0.2 to 1 microgram/ml. While the dry weight of a reagent present in the mixing chamber may vary, in some cases the dry weight ranges from 0.01 ng to 500 ng, such as 0.3 ng to 120 ng and including 3 ng and 12 ng.
[00189] In some cases, the device may include a specific capture domain for the analyte. An analyte-specific capture domain is a domain or region of the capillary channel from which a result can be read while using the device. The analyte-specific capture domain is positioned some distance downstream from the device sample application site. By "downstream" is meant the direction in which the sample flows by capillary action, ie the direction of fluid flow from the sample application site. The total distance that the fluid flows between the sample receiving zone and the detection zone can vary, ranging in some cases from 2 cm to 500 cm, for example 10 cm to 100 cm and including 20 cm to 50 cm.
[00190] The analyte-specific capture domain is a region that includes an amount of a capture probe, also referred to herein as a "detection capture probe." A detection capture probe is immobilized on the analyte-specific capture domain and specifically binds to the target molecule of interest, eg, an analyte, a control molecule, etc. The size of the capture probe's detection zone may vary, and in some cases, the probe's capture zone may have an area ranging from 0.01 cm2 to 0.5 cm2 as well as 0.05 cm2 to 0. 1 cm2 and including 0.1 cm2 to 0.2 cm2. An analyte-specific capture domain can have a variety of different configurations, where the configuration can be random, or the configuration can have a specific shape such as a line, circle, square, or more complex shape such as a square shape. cross if desired. A specific capture domain for a certain analyte may include a single capture probe or two or more different capture probes, where each of two or more different capture probes, where when the detection region includes two or more probes For capture purposes, the capture probes can be distinguished from one another (i.e., bind to different target molecules) if desired.
[00191] In some embodiments, an analyte-specific capture domain may be provided that includes particles exhibiting a specific binding member (or members) for a target molecule (or molecules), e.g., an analyte (or analytes) of interest , a control or reference molecule, etc. For example, in some embodiments, the device may include an analyte-specific capture domain composed of capture beads immobilized on a suitable surface, e.g., the upper surface, of a capillary channel domain, e.g., a capillary chamber. in the capillary channel, for example, as described in PCT Patent Application Serial No. PCT/US2012/065683, filed November 16, 2012 and incorporated herein by reference. Capture beads can be coated with a binding reagent that specifically binds to the analyte of interest. In some embodiments, capture beads are coated with an antigen to which the antibody of interest specifically binds. In such cases, a fluorescently labeled reagent for detection can be added that specifically binds to the analyte, allowing detection of the captured analyte by its fluorescence emissions. Capture spheres can be immobilized at a point on the upper surface of the capillary chamber by any suitable means. In some cases, the beads have remained in place by passive interactions between the beads and the capillary chamber surface, but covalent bonding can be used as desired.
[00192] Capture beads coated with different antigens can be located at different points within the capillary chamber to allow multiplexed detection of multiple analytes. Alternatively, capture beads coated with different antigens can be distinctly labeled using fluorescent dyes that are distinguishable from each other and from the dye-labeled detection reagents that are used to measure the captured analytes. In this way, the spheres can be immobilized at the same spot, but distinguished by their fluorescent emissions. In other embodiments, labeling reagents may be arranged with a specific analyte capture domain disposed at the sample application site and labeled sample may flow to a capillary channel reaction chamber for detection.
[00193] In some cases, the microfluidic cartridge may include a quality control domain in the capillary channel, for example, positioned near the far end of the channel from the sample application site. The quality control channel may vary, and may, for example, include a capture member, e.g., antibody, marker-specific reagent, etc., as described in more detail below, e.g., to provide confirmation that the sample passes through the device during each test.
[00194] In some cases, the microfluidic cartridge may include one or more identifiers, whose identifiers may provide information about the device, for example, the particular assay for which it is configured, the manufacturing batch number, etc., whose identifiers may they can be unique identifiers. Identifiers can be human readable and/or machine readable, for example, can be text (eg serial numbers) or a barcode, as desired. Identifiers may, in certain cases, provide information or characteristics about the microfluidic cartridge, including but not limited to sample channel refractive index, blank reference window refractive index, sample channel dimensions including height sample channel width, sample channel width, sample channel length, total sample channel depth, sample channel wall thickness. Likewise, identifiers can include information about the blank reference window, such as the index of refraction of the blank reference window, dimensions of the blank reference window including the height of the blank reference window, the width of the blank reference window. blank reference, blank reference window length, blank reference window total, blank reference window wall thickness.
[00195] In some embodiments, the microfluidic cartridge additionally includes a blank reference window which is also evaluated by the slit projection module to provide a blank absorbance for use in calculating analyte concentration. The absorbance of the reference blank window is, in certain embodiments, configured to be identical to the absorbance by the sample chamber so that transmission through the reference blank window can be used to correct for absorption, scatter, etc. , by the microfluidic cartridge when putting into practice the methods described herein. In certain embodiments, the blank reference window has an absorbance and transmission at one or more wavelengths of incident light that is substantially the same as the capillary channel sample chamber. In other embodiments, the blank reference window scatters light at one or more wavelengths that are substantially the same as the capillary channel sample chamber. In still other embodiments, the blank reference window has an absorbance, transmission and scattering of light at one or more incident wavelengths that is substantially the same as the capillary channel sample chamber. In still other embodiments, the blank reference window has the same refractive index as the capillary channel sample chamber.
[00196] The blank reference window can be any suitable size and shape. For example, the blank reference window can be in the form of a square, circle, oval, rectangle, pentagonal, hexagonal, octagonal, or any other suitable polygon. In some embodiments, the blank reference window has a length to width ratio ranging from 1 to 50, such as 3 to 25, such as 4 to 10, such as 5 to 8, including 15 to 20. In certain embodiments, the blank reference window is a square and has a length to width ratio of 1. The length of the blank reference window can vary, ranging from 1 mm to 50 mm, such as from 2 mm to 25 mm and including from 5 mm to 20 mm. The width of the blank reference window may vary, ranging from 0.001mm to 20mm, such as 0.005mm to 19mm, such as 0.01mm to 18mm, such as 0.05mm to 17mm, such as 0.1 mm to 15 mm, such as 0.5 mm to 12.5 mm, such as 1 to 10 and including 3 to 5 mm. In some cases, the height of the channel varies from 5 μm to 500 μm, such as from 10 μm to 150 μm and including 20 μm to 70 μm. In certain embodiments, the blank reference window has a width that is substantially the same as the width of the capillary channel sample chamber.
[00197] The blank reference window can be positioned at any suitable location on the microfluidic cartridge. In certain embodiments, the white reference window is positioned along the same axis as the capillary channel sample chamber. For example, the blank reference window can be positioned along the same axis as the capillary channel sample chamber at a position that is 1 mm or more away from the capillary channel sample chamber, such as 2 mm or more. more, such as 3 mm or more, such as 4 mm or more, such as 5 mm or more, and including 10 mm or away from the capillary channel sample chamber.
[00198] Figure 5 illustrates an example of a microfluidic cartridge with a microfluidic sample chamber for measuring absorbance 501 and a reference window for providing a blank during absorbance measurement 502.
[00199] An example of a suitable microfluidic cartridge that can be received in the systems described herein may include, but is not limited to, those described in co-pending US Patent Application No. 14/152,954, filed January 10, 2014, at description of which is incorporated herein by reference. COMPUTER CONTROLLED SYSTEMS
Aspects of the present description further include computer controlled systems for practicing the present methods, which systems further include one or more computers for automating or semi-automating a system for practicing the methods described herein. In certain embodiments, the systems include a computer having a computer readable storage medium with a computer program stored therein, where the computer program when loaded into the computer includes algorithm lighting a sample in a sample chamber with a source of light; algorithm for moving a slit projection module along a length of the sample chamber; algorithm for detecting light transmitted by the sample chamber, algorithm for calculating the absorbance of light at one or more wavelengths using the detected transmitted light, and algorithm for calculating the concentration of an analyte based on the determined absorbance of the transmitted light .
[00201] In some embodiments, the systems include a computer program that includes the algorithm to calculate the absorbance of light at one or more wavelengths based on transmitted light detected by the detector. The absorbance of light by the target analyte is determined by inputting transmittance data from the detector to a processor that applies BeerLambert's Law to calculate the absorbance at a given wavelength: Absorbance (À) = -Logio (I/Io) where I is the intensity of light transmitted through the sample chamber and I0 is the intensity of incident light used to evaluate the sample.
[00202] The systems also include a computer program that includes the algorithm to calculate the analyte concentration based on the calculated absorbance at one or more wavelengths. Analyte concentration, in certain embodiments, is calculated by inputting absorbance values calculated from transmittance data into a processor that applies the formula: Absorbance (À) = [molar absorptivity] x [concentration] x [ath length ].
[00203] In some embodiments, the systems include algorithm to calculate the analyte absorbance while representing sample dispersion. Analyte absorbance while representing sample dispersion is determined, in certain cases, by inputting calculated absorbance values based on transmittance data into a processor that applies the formula: Analyte Concentration = A*(AbsÀ1) + B*(Abs À2) + C, where A, B, and C are coefficients that depend on the evaluated wavelengths and analytes to be measured. In modalities, the value of A can vary, in certain cases, ranging from 20 g/dL to 60 g/dL, such as from 25 g/dL to 57.5 g/dL, such as from 30 g/dL to 55 g/dL, such as from 35 g/dL to 50 g/dL and including from 37.5 g/dL to 45 g/dL. The value of B can also vary, in certain cases, ranging from 0.01 g/dL to 5 g/dL, such as from 0.05 g/dL to 4.5 g/dL, such as from 0.1 g /dL to 4 g/dL, such as from 0.25 g/dL to 3.5 g/dL, such as from 0.5 g/dL to 3 g/dL and including from 0.5 g/dL to 2 g/dL. Likewise, the value of C can also vary, ranging from 0.01 g/dL to 2 g/dL, such as from 0.025 g/dL to 1.75 g/dL, such as from 0.05 g/dL to 1.5 g/dL, such as from 0.1 g/dL to 1.25 g/dL and including from 0.25 g/dL to 2 g/dL.
[00204] For example, in certain cases, systems are configured to calculate the hemoglobin concentration in whole blood while representing dispersion. In these cases, the systems include algorithm to calculate the absorbance of hemoglobin in whole blood while representing dispersion throughout the entire blood sample. The system includes a computer program with an algorithm for choosing a first wavelength and a second wavelength to evaluate the sample. In these embodiments, the computer algorithm includes choosing a first wavelength where hemoglobin has a high molar absorptivity. In some cases, the first wavelength may be an isosbestic point for hemoglobin with one or more of oxyhemoglobin, carboxyhemoglobin, methemoglobin, sulphahemoglobin, azidamethoglobin and cyanmethemoglobin, such as an isosbestic point for hemoglobin and oxyhemoglobin or a triple isosbestic point for hemoglobin, oxyhemoglobin and carboxyhemoglobin. For example, a first wavelength is, in certain cases, 506 nm, 548 nm, 569 nm, 579 nm, 585 nm or 586 nm. The computer algorithm also includes choosing a second wavelength to account for scattering. In some cases, the computer algorithm includes choosing a second wavelength that is an isosbestic point for hemoglobin with one or more of oxyhemoglobin, carboxyhemoglobin, methemoglobin, sulphahemoglobin, methemoglobin azide, and cyanmethemoglobin, such as an isosbestic point for hemoglobin and oxyhemoglobin or a triple isosbestic point for hemoglobin, oxyhemoglobin and carboxyhemoglobin. For example, a second wavelength is, in certain cases, 650 nm, 675 nm, 710 nm, 785 nm, 808 nm, 815 nm or 830 nm.
[00205] For example, in certain embodiments of the systems include a computer program that includes the algorithm for choosing a first wavelength of 548 nm and a second wavelength of 675 nm, and determining the concentration of hemoglobin in the blood total while representing dispersion in the whole blood sample by: 1, inputting transmittance data to a processor applying the Beer-Lambert law; and 2) inputting the calculated absorbance values into a processor that applies the formula: Hb Concentration = A*(Abs548 nm) + B*(Abs650 nm) + C, where the A value for a whole blood sample varies from 20 g/dL to 60 g/dL, such as from 25 g/dL to 57.5 g/dL, such as from 30 g/dL to 55 g/dL, such as from 35 g/dL to 50 g/dL and including from 37.5 g/dL to 45 g/dL; the value of B for a whole blood sample ranges from 0.01 g/dL to 5 g/dL, such as 0.05 g/dL to 4.5 g/dL, such as 0.1 g/dL to 4 g/dL, such as from 0.25 g/dL to 3.5 g/dL, such as from 0.5 g/dL to 3 g/dL and including from 0.5 g/dL to 2 g/l dL and where the C value of a whole blood sample ranges from 0.01 g/dL to 2 g/dL, such as from 0.025 g/dL to 1.75 g/dL, such as from 0.05 g/dL dL to 1.5 g/dL, such as from 0.1 g/dL to 1.25 g/dL and including from 0.25 g/dL to 2 g/dL.
[00206] In modalities, the system includes an input module, a processing module and an output module. In some embodiments, the present systems may include an input module such that the parameters or information about each fluidic sample, intensity and wavelengths (discrete or bands) of the applied light source, range of motion by the projection module slit, number of sweeps and movement by the slit projection module, duration of illumination by the light source, number of different light sources, distance from light source to the sample chamber, objective lens focal length, module parameters focus, sample chamber path length, sample refractive index, sample chamber refractive index, number of wavelength separators, wavelength separator properties including bandwidth, opacity, incidence grid, as well as properties and sensitivity of photodetectors.
[00207] The processing module includes memory having a plurality of instructions for performing the steps of the concerned methods, such as illuminating a sample in a sample chamber with a light source; moving a slit projection module along a length of the sample chamber; detecting the light transmitted through the sample chamber and calculating the absorbance of light at one or more predetermined wavelengths using the detected transmitted light.
[00208] After the processing module has performed one or more of the steps of the methods in question, an output module communicates the results (e.g., analyte absorbance at one or more wavelengths) to the user, by displaying in a monitor or by printing a report.
[00209] The systems in question may include hardware and software components, where the hardware components may take the form of one or more platforms, for example in the form of servers, such that the functional elements, i. that is, system elements that perform specific tasks (such as managing information input and output, information processing, etc.) of the system can be carried out by running software applications on and across one or more platforms representative of the system.
[00210] Systems may include a display and a user input device. User input devices can, for example, be a keyboard, mouse, or the like. The processing module includes a processor that has access to a memory having stored therein instructions for carrying out the steps of the concerned methods, such as illuminating a sample in a sample chamber with a light source; moving a slit projection module along a length of the sample chamber; detecting the light transmitted through the sample chamber and calculating the absorbance of light at one or more predetermined wavelengths using the detected transmitted light.
[00211] The processing module may include an operating system, a graphical user interface (GUI) controller, system memory, memory storage devices and input and output controllers, cache memory, a backup unit. data, and many other devices. The processor may be a commercially available processor or it may be one of other processors that are or will become available. The processor executes the operating system and operating system interfaces with firmware and hardware in a well-known manner, and facilitates the processor in coordinating and executing the functions of various computer programs that can be written in a variety of programming languages, such as Java, Perl, C ++, other high-level or low-level languages, as well as their combinations, as known in the art. The operating system, typically in cooperation with the processor, coordinates and performs the functions of the other components of the computer. The operating system also provides programming, input and output control, file and data management, memory management and communication control and related services, all in accordance with known techniques.
[00212] System memory can be any of a variety of known or future memory storage devices. Examples include any commonly available random access memory (RAM), a magnetic medium such as a resident hard disk or magnetic stripe, an optical medium such as a read-write compact disk, flash memory devices, or other memory storage device. The memory storage device can be any of a variety of known or future devices, including a compact disk drive, a magnetic tape drive, a removable hard disk drive, or a floppy disk drive. Such types of memory storage devices typically read from and/or passed to a program storage medium (not shown), such as, respectively, a compact disk, a magnetic tape, removable hard disk, or floppy disk. Any of these program storage media, or others now in use or which may be later developed, can be considered a computer program product. As will be appreciated, these program storage media typically store a computer software program and/or data. Computer software programs, also called computer control logic, typically are stored in system memory and/or the program storage device used in conjunction with the memory storage device.
[00213] In some embodiments, a computer program product is described comprising a computer-used medium having a control logic (computer software program, including program code) stored therein. Control logic, when executed by the computer's processor, causes the processor to perform the functions described here. In other modalities, some functions are performed mainly in hardware using, for example, an automaton hardware. Implementing the automaton hardware in order to perform the functions described herein will be apparent to those skilled in the relevant arts.
[00214] Memory may be any suitable device on which the processor can store and retrieve data, such as magnetic, optical or solid-state storage devices (including magnetic or optical disks or tape or RAM, or any other suitable device, whether fixed or portable). The processor may include a general purpose digital microprocessor properly programmed from a computer readable medium having the necessary program code. Programming can be provided remotely to the processor through a communication channel, or previously stored in a computer program product such as memory or other storage media that can be read by portable or fixed computer using any of these linked devices. with memory. For example, a magnetic or optical disk can perform programming, and can be read by a disk writer/reader. The systems of the invention also include programming, for example, in the form of computer program products, algorithms for use in practicing the methods as described above. Programming in accordance with the present invention may be recorded on computer readable media, for example any medium that can be read and accessed directly by a computer. Such media include, but are not limited to: magnetic storage media, such as floppy disks, hard disk storage media, and magnetic tape; optical storage media such as CD-ROM; electrical storage media such as RAM and ROM; portable flash drive; and hybrids of these categories such as optical/magnetic storage media.
[00215] The processor may also have access to a communication channel to communicate with a user at a remote location. By remote location it is meant that the user is not in direct contact with the system and transmits input data information to an input manager from an external device such as a computer connected to a Wide Area Network ("WAN") network telephone, satellite network, or any other suitable communication channel, including a mobile phone (ie, smartphones).
[00216] In some embodiments, systems in accordance with the present description may be configured to include a communication interface. In some embodiments, the communication interface includes a receiver and/or transmitter to communicate with a network and/or other device. The communication interface can be configured for wired or wireless communication, including but not limited to radio frequency (RF) communication (eg, Radio Frequency Identification (RFID), Zigbee communication protocols, WiFi, infrared, communication Wireless Universal Serial Bus (USB), Ultra Wideband (UWB), Bluetooth® communication protocols, and cellular communication such as code division multiple access (CDMA) or Global System for Mobile communications (GSM).
[00217] In one embodiment, the communication interface is configured to include one or more communication ports, for example, ports or physical interfaces, such as a USB port, an RS-232 port, or any other suitable electrical connection port to allow data communication between the systems concerned and other external devices, such as a computer terminal (eg in a doctor's office or in a hospital environment) that is configured for similar supplementary data communication.
[00218] In one embodiment, the communication interface is configured for infrared communication, Bluetooth® communication, or any other appropriate wireless communication protocol to allow the systems in question to communicate with other devices, such as computer terminals and /or networks, communication activated mobile phones, personal digital assistants, or any other communication devices that the user may use in conjunction with these in managing the treatment of a health problem such as HIV, AIDS or anemia.
[00219] In one embodiment, the communication interface is configured to provide a link for data transfer using the Internet Protocol (IP) through a mobile phone network, Short Message Service (SMS), connection without wires to a personal computer (PC) over a local area network (LAN) that is connected to the internet, or WiFi connection to the internet at a WiFi hotspot.
[00220] In one embodiment, the systems concerned are configured to communicate wirelessly with a server device through the communication interface, for example, using a common standard protocol, such as 802.11 or Bluetooth® RF, or an infrared protocol lrDA. The server device can be another portable device, such as a smart cell phone, Personal Digital Assistant (PDA) or laptop computer; or a larger device such as a personal computer, device, etc. In some embodiments, the server device has a screen, such as a liquid crystal display (LCD), as well as an input device, such as a button, keyboard, mouse, or touch screen.
[00221] In some embodiments, the communication interface is configured to automatically or semi-automatically communicate data stored on the systems concerned, for example, on an optional data storage unit, with a network device or server using one or more of the protocols and/or communication mechanisms described above.
[00222] Output controllers may include controllers of any of a variety of known devices for presenting information to a user, whether it is a human or a machine, local or remote. If one of the display devices provides visual information, this information may typically be organized logically and/or physically as an array of pixels. The graphical user interface (GUI) of the controller may include any of a variety of known or future software programs for providing graphical input and output interfaces between the system and a user, and for processing user input. The functional elements of the computer can communicate with each other via the bus system. Some of these communications can be achieved in alternative modalities using the network or other types of remote communications. The results manager can also provide information generated by the processing module to a user at a remote location, for example, via the Internet, telephone or satellite network, in accordance with known techniques. The presentation of output data by the manager can be performed according to a variety of known techniques. As some examples, data can include SQL, HTML or XML documents, email or other files, or data in other forms. Data can include Internet URL addresses so that a user can retrieve additional SQL, HTML, XML or other documents or data from remote sources. The one or more platforms present on the systems concerned may be of any known type of computer platform or a type to be developed in the future, though typically it will be of a class of computer generally referred to as servers. However, these can also be a backbone computer, a workstation or another type of computer. They can be connected via any known or future type of cable or other communications system including wireless systems, whether networked or otherwise. They can be located in the same area or they can be physically separated. Various operating systems can be used on any of the computer platforms, possibly depending on the type and/or construction of the computer platform chosen. Suitable operating systems include Windows NT®, Windows XP, Windows 7, Windows 8, iOS, Sun Solaris, Linux, OS/400, Compaq Tru64 Unix, SGI IRIX, Siemens Reliant Unix, and others. Kits
[00223] Aspects of the invention further include kits, wherein the kits include one or more microfluidic assay cartridges. In some cases, kits may include one or more analysis components (eg, labeled reagents, buffers, etc., as described above). In some cases, kits may further include a sample collection device, for example, a lance or needle configured to pierce the skin to obtain a whole blood sample, a pipette, etc., as desired.
[00224] Figure 6 shows an example of a kit with a microfluidic cartridge packaged together with a lancet for obtaining whole blood. Figure 7 shows an example of a set of different types of kits, which in certain embodiments can be packed together and supplied in a box.
[00225] The kits' various assay components may be present in separate containers, or some or all of them may be pre-combined into a reagent mix. For example, in some cases one or more kit components, eg the device, are present in a sealed pouch, eg a foil pouch or sterile wrap.
[00226] In addition to the above components, the kits in question may additionally include (in certain embodiments) instructions for practicing the present methods. These instructions may be present in the subject kits in a variety of forms, one or more of which may be present in the kit. One form in which instructions can be presented is as information printed on a suitable medium or substrate, for example, a piece or pieces of paper on which the information is printed, on kit packaging, on an information sheet, and the like. Yet another form of these instructions is a computer medium, eg floppy disk, compact disk (CD), portable flash drive, and the like, on which the information has been recorded. Yet another form of these instructions that may be present is a website address that can be used over the Internet to access information in a secluded location. UTILITY
[00227] Methods, systems, microfluidic cartridges and kits of the present description find utility in a variety of different applications and can be used to determine the presence and amount of an analyte in a large number of different sample types from a multitude of possible sources . Depending on the application and desired result of the methods described herein, an analyte can be detected qualitatively ("present" versus "absent"; "yes, above a predetermined limit" versus "no, not above a predetermined limit" ; etc.) or a quantitative form, for example, as an amount in a sample (such as the concentration in the sample).
[00228] The present methods and systems can be employed to characterize many types of analytes, in particular analytes relevant to medical diagnosis or protocols for caring for a patient, including, but not limited to: proteins (including both free proteins and proteins attached to the surface of a structure, such as a cell), nucleic acids, viral particles, and the like. In addition, the samples can be of in vitro or in vivo origin, and the samples can be diagnostic samples.
[00229] When putting into practice the methods of the invention, samples can be obtained from in vitro origin (eg extract from a cell culture grown in the laboratory) or from in vivo origin (eg a mammalian subject, a being human, a research animal, etc.). In some embodiments, the sample is obtained from an in vitro source. In vitro origins include, but are not limited to, prokaryotic (eg bacterial) cell cultures, eukaryotic (eg mammalian, fungal) cell cultures (eg established cell line cultures, eukaryotic cell line cultures). known or acquired cells, immortalized cell cultures, primary cell cultures, laboratory yeast cultures, etc.), tissue cultures, column chromatography eluents, cell lysates/extracts (eg protein-containing lysates/extracts, lysates/extracts containing nucleic acids, etc.), viral packaging supernatants, and the like. In some embodiments, the sample is obtained from an in vivo source. In vivo origins include living multicellular organisms and can give rise to diagnostic samples.
[00230] In some embodiments, the analyte is a diagnostic analyte. A "diagnostic analyte" is an analyte from a sample that has been obtained from or derived from a living multicellular organism, eg mammal, in order to make a diagnosis. In other words, the sample was taken to determine the presence of one or more disease analytes in order to diagnose a disease or condition. Thus, methods are diagnostic methods. Since methods are "diagnostic methods," they are methods that diagnose (ie, determine the presence or absence of) a disease (eg, disease condition, diabetes, etc.) or condition (eg, pregnancy) in a living organism, such as a mammal (eg, a human being). As such, certain embodiments of the present invention are methods that are used to determine whether a living subject has a particular disease or condition (e.g., diabetes). "Diagnostic methods" also include methods that determine the severity or status of a particular disease or condition.
[00231] In certain embodiments, methods are methods of determining whether an analyte is present in a diagnostic sample. As such, methods are methods of evaluating a sample where the analyte of interest may or may not be present. In some cases, it is not known whether the analyte is present in the sample prior to performing the analysis. In other cases, prior to performing the assay, it is unknown whether the analyte is present in the sample in an amount that is greater than (exceeds) a predetermined threshold amount. In such cases, methods are methods of evaluating a sample in which the analyte of interest may or may not be present in an amount that is greater than (exceeds) the predetermined limit.
[00232] Diagnostic samples include those obtained from in vivo sources (eg, a mammalian subject, a human subject, and the like) and may include samples obtained from tissues or cells from a subject (eg, biopsies, tissue samples, whole blood, fractionated blood, hair, skin and the like). In some cases, cells, fluids or tissues derived from a subject are cultured, stored or manipulated prior to evaluation and such a sample may be considered a diagnostic sample if the results are used to determine the presence, absence, status, or severity of a disease (eg disease condition, diabetes, etc.) or condition (eg pregnancy) in a living organism.
[00233] In some cases, a diagnostic sample is a tissue sample (eg whole blood, fractionated blood, plasma, serum, saliva and the like) or is obtained from a tissue sample (eg whole blood, blood fractionated, plasma, serum, saliva, skin, hair and the like). An example of a diagnostic sample includes, but is not limited to, cell and tissue cultures derived from a subject (and their derivatives, such as supernatants, lysates, and the like); tissue and body fluid samples; non-cellular samples (eg, column eluents; acellular biomolecules such as proteins, lipids, carbohydrates, nucleic acids; synthesis reaction mixtures; nucleic acid amplification reaction mixtures; in vitro enzymatic or biochemical reactions or solutions analysis; or products of other in vitro and in vivo reactions, etc.); etc.
In some embodiments, the present methods provide an assay for hemoglobin. As discussed above, hemoglobin can be present in any type of diagnostic sample, such as supernatants, lysates, buffered solution, as well as in biological samples, including whole blood. A quantity of whole blood is loaded into a sample chamber and illuminated by means of a slit projection module with one or more light sources, with light transmitted through the blood sample in the sample chamber to be collected and spatially separated in wavelengths for component detection. Depending on the size of the whole blood sample, the sample chamber may be a microfluidic capillary channel sample chamber. The absorbance of hemoglobin can be determined from light transmitted at one or more wavelengths or alternatively a full spectrum of hemoglobin absorption can be calculated. Based on absorbance at one or more wavelengths, the hemoglobin concentration in the whole blood sample can be determined in these embodiments of the present methods.
[00235] In certain other examples, the methods in question provide a reagent-free hemoglobin analysis. As discussed above, a reagent-free assay is a hemoglobin assay that does not use reagents to interact or visualize hemoglobin in the sample. As such, hemoglobin (including derivatives such as oxyhemoglobin and carboxyhemoglobin) is analyzed in its native state, without reagent modification. In these cases, an unaltered whole blood sample is loaded into a sample chamber and illuminated with one or more light sources through a slit projection module, with light transmitted through the blood sample in the sample chamber to be collected and spatially separated into component wavelengths for detection. Depending on the size of the whole blood sample, the sample chamber may be a microfluidic capillary channel sample chamber. Hemoglobin absorbance can be detected at one or more wavelengths or alternatively, a full spectrum of hemoglobin absorption can be calculated. Based on absorbance at one or more wavelengths, the hemoglobin concentration in the unaltered whole blood sample can be determined in these embodiments of the present methods.
[00236] In certain other cases, the present methods provide an assay of hemoglobin in a sample also to be analyzed for one or more analytes, such as, for example, cell surface markers. In these modalities, one or more reagents, including specific binding members, enzymes, substrates, oxidants, as well as binding molecules coupled to one or more fluorescent markers, are contacted with whole blood and the whole blood sample mixed with the reagent is loaded into a sample chamber. The loaded sample chamber (such as a microfluidic capillary channel sample chamber) is illuminated with one or more light sources through a slit projection module, with light transmitted through the whole blood sample in the sample chamber to be collected and spatially separated into component wavelengths for detection. Hemoglobin absorbance can be detected at one or more wavelengths or alternatively, a full spectrum of hemoglobin absorption can be calculated. Based on absorbance at one or more wavelengths, the concentration of hemoglobin in the whole blood sample mixed with the reagent can be determined in these embodiments of the present methods. Along with the assay for hemoglobin in the sample mixed with the reagent, one or more additional analytes can be analyzed. In some cases, the present methods provide a fluorescence assay performed in conjunction with the analysis of hemoglobin absorbance for analysis of one or more cell surface markers that bind to one or more reagents mixed with the whole blood sample. In these cases, a fluorescence light source illuminates the sample chamber loaded with the whole blood sample mixed with the reagent and the fluorescence emission from the fluorescent markers bound to the target analytes is collected and spatially separated for detection.
[00237] In certain specific examples, the present methods provide an analysis of the absorbance of hemoglobin in a sample for which fluorescence for CD4 and % CD4 is also analyzed. In these cases, the whole blood sample is applied to the sample application site of a microfluidic cartridge that has a capillary channel sample chamber. The applied sample is transported through the microfluidic capillary channel inlet to a reagent mixing chamber having a porous disc for contacting the reagent mixture with the blood sample. The reagent mix in these cases includes dehydrated stored stable reagents CD4-PECy5, CD3-APC, CD45RA-APC and CD14-PE. The whole blood sample mixed with the reagent is transported by capillary action through the sample chamber where the sample chamber is illuminated for hemoglobin analysis by two light sources, a wideband white light LED and a near-light LED. IV through a slit projection module that is moved laterally through the sample chamber. Light transmitted through the sample chamber is collected with an objective, magnifying lens and autofocused in a diffraction grating to spatially separate the light transmitted on the surface of a CCD detector. The absorbance at two wavelengths, 548 nm and 675 nm is determined and the total hemoglobin absorbance corresponding to the dispersion is calculated for analysis for hemoglobin.
[00238] The whole blood sample mixed with the reagent in the capillary channel sample chamber is also analyzed for CD4 by detecting the fluorescence through fluorescent markers in the reagent mixture. CD4 can be analyzed by illuminating the whole blood sample mixed with the reagent in the capillary channel sample chamber with a light source and the emission of the fluorescent markers in the whole blood sample mixed with the reagent is collected with a common objective, lens magnification and autofocus on the surface of the CCD detector. CD4 cell count is then performed by fluorescent imaging cytometry.
[00239] The present methods can be used with samples from a variety of different types of subjects. In some embodiments, a sample is from a subject within the Mammalia class, including, for example, the order carnivore (eg, dogs and cats), Rodentia (eg, mice, guinea pigs, and rats), Lagomorpha (eg. rabbits) and primates (eg, humans, chimpanzees and monkeys), and the like. In certain embodiments, the animals or hosts, that is, the subjects are human beings. EXAMPLES
[00240] As can be appreciated from the description given above, the present description has a wide variety of applications. Accordingly, the following examples are presented in order to provide those skilled in the art with a full description and description of how to make and use the present invention, and are not intended to limit the scope of what the inventors consider their invention to be, nor are they intended to represent that the experiments below are all or the only experiments performed. Those skilled in the art will readily recognize a variety of non-critical parameters that could be altered or modified to produce essentially similar results. Thus, the following examples are presented in order to provide those skilled in the art with a complete description and description of how to make and use the present invention, and are not intended to limit the scope of what the inventors consider their invention to be, nor are they intended. to represent that the experiments below are all or the only experiments performed. Efforts have been made to ensure accuracy with respect to numbers used (eg quantities, temperature, etc.) but some experimental errors and deviations must be considered. Example 1
[00241] One drop (~25 μL) of whole blood sample is applied to the sample application site of a cartridge microfluidic device having a mixing chamber containing dehydrated stored, stable CD4 reagents (eg, CD4-PECy5, CD3- APC, CD45RA-APC and CD14-PE) which are hydrated when mixed with the whole blood sample. The cartridge microfluidic device is allowed to be left until capillary action transports the sample-reagent mixture into the capillary channel sample chamber. The sample chamber is illuminated by a wide-spectrum LED light source (one white light LED and one near-IR LED, sequentially illuminated) with a wavelength from 500 nm to 850 nm through a slit projection module , having a slit and a reduction lens for concentrating the slit-shaped beam on the surface of the sample chamber. The sample chamber is moved in a back-and-forth motion to pass light through the sample chamber which is diffracted using a diffraction grating having 300 µm spacings in a CCD detector. Figure 8 illustrates light detected by the CCD detector in a column plot of pixel versus wavelength (801), where white pixels indicate detected light. The graph at 801 is compressed into a 1-D spectrum at (802) by plotting each pixel column with respect to wavelength to detect a spectrum of transmitted light with respect to wavelength (803). Using the Beer-Lambert law, the absorbance is calculated at (804) to provide the sample's absorbance spectrum at (805). The hemoglobin concentration can be calculated based on the determined absorbance and the blank reference obtained when measuring light through the blank reference window in the microfluidic cartridge. Example 2
[00242] A drop (~25 μL) of whole blood samples having 25 g/L or 7 g/L of hemoglobin is applied to the sample application site of a cartridge microfluidic device having a mixing chamber containing stored stable reagents dehydrated. After the sample and reagent mixture reaches the sample chamber it is illuminated by a broad-spectrum LED light source (one white light LED and one near-IR LED, sequentially illuminated) with a wavelength from 500 nm to 850 nm through a slit projection module, having a slit and a reduction lens for concentrating the slit-shaped beam on the surface of the sample chamber. The sample chamber is moved in a back-and-forth motion to pass light through the sample chamber which is diffracted using a diffraction grating having 300 µm spacings in a CCD detector. CCD detector pixel graphics are compressed to a one-dimensional spectrum of transmitted light with respect to wavelength. Using the Beer-Lambert law, absorbance spectra were calculated from the transmitted light spectra. Figure 9a shows the absorbance spectra of hemoglobin in whole blood at a concentration of 25 g/dL. Figure 9b shows the absorbance spectra of hemoglobin in whole blood at a concentration of 7 g/dL. The absorbance at 569 nm was determined for each hemoglobin concentration from the spectra obtained. The protocol was repeated with whole blood samples with hemoglobin concentrations of 3 g/dL, 13 g/dL, 19 g/dL and the absorbance at 569 nm for each of the whole blood samples was plotted against the concentration . Figure 9c illustrates a linear relationship between hemoglobin concentration and absorbance at 569 nm indicating that measurements using the slit projection module can be used over a wide range of hemoglobin concentrations. Example 3
[00243] Fresh whole blood samples from 120 HIV+ patients (both venipuncture and blood drop samples) were analyzed using a Sysmex XS-1000i automated hematology system to determine the hemoglobin concentration in the whole blood samples. Together, each sample was applied to the sample application site of a separate cartridge microfluidic device having a mixing chamber containing dehydrated stored, stable CD4 reagents. The sample chamber of each of the 120 microfluidic cartridge devices was illuminated by a broad-spectrum LED light source (one white light LED and one near-IR LED, sequentially illuminated) with a wavelength from 500 nm to 850 nm through a slit projection module having a slit and a reduction lens to focus the slit beam on the surface of the sample chamber. The sample chamber is moved through the slit beam to pass light through the sample chamber which is diffracted using a diffraction grating in a CCD detector. CCD detector pixel graphics are compressed to a one-dimensional spectrum of transmitted light with respect to wavelength. Using the Beer-Lambert law, absorbance spectra were calculated from the transmitted light spectra. The hemoglobin concentration for each sample was calculated using the absorbance at 548 nm and scatter corrected by measuring the absorbance at 650 nm or 675 nm. Figure 10 shows a graph of hemoglobin concentration as determined using the absorbance assay described herein and hemoglobin concentration determined using the Sysmex XS-1000i automated hematology system. As shown in Figure 10, there is a strong linear relationship between hemoglobin concentrations determined using the present methods compared to the hematology analyzer. This shows that the present methods are suitable for providing clinically accurate concentrations of hemoglobin in whole blood (venipuncture or blood drop).
[00244] Notwithstanding the annexed clauses, the description set forth herein is also defined by the following clauses:
[00245] 1. A method of analyzing a sample for an analyte, the method comprising: illuminating a sample in a sample chamber with a light source through a slit projection module to provide a slit-shaped beam in the sample chamber; detect the light transmitted by the sample; and calculating the absorbance of the detected light at one or more wavelengths to analyze the sample for the analyte in the sample.
[00246] 2. The method according to clause 1, wherein the method further comprises calculating the absorbance of light detected at one or more wavelengths to compensate for scattering by the sample.
[00247] 3. The method according to any one of clauses 12, wherein the method comprises calculating the absorbance of light detected at a wavelength of 700 nm or less to compensate for scattering through the sample.
[00248] 4. The method according to clause 3, wherein the method comprises calculating the absorbance of light detected at 650 nm to compensate for scattering by the sample.
[00249] 5. The method according to any one of clauses 1-4, wherein the sample is illuminated with one or more broad spectrum light sources.
[00250] 6. The method according to clause 5, wherein the sample is illuminated with two broad spectrum light sources.
[00251] 7. The method according to clause 6, wherein the sample is illuminated with light having wavelengths in the range of 500 nm to 700 nm with a first broad-spectrum light source and illuminated with light having lengths of wave in the 700 nm to 830 nm range with a second broad-spectrum light source.
[00252] 8. The method according to any one of clauses 17, wherein the broad spectrum light source comprises a visible light source and a near infrared light source.
[00253] 9. The method according to any one of clauses 18, in which illuminating through the slit projection module produces a beam of light which is in the form of a slit.
[00254] 10. The method according to clause 9, wherein the slit-shaped beam has a length that is greater than the width of the microfluidic chamber.
[00255] 11. The method according to clause 9, wherein the slit-shaped beam has a length that is less than the width of the microfluidic chamber.
[00256] 12. The method according to clause 9, wherein the slit-shaped beam has a length that is substantially the same as the width of the microfluidic chamber.
[00257] 13. The method according to any one of clauses 9 to 12, wherein illuminating the sample chamber through the slit projection module produces a slit-shaped beam with a length of about 2.5 mm to about 3.5 mm.
[00258] 14. The method according to clause 13, wherein illuminating the sample chamber through the slit projection module produces a slit-shaped beam with a length of about 3 mm.
[00259] 15. The method according to any one of clauses 9-13, wherein illuminating the sample chamber through the slit projection module produces a slit-shaped beam with a width of about 25 µm to about 75 µM
[00260] 16. The method according to clause 15, wherein illuminating the sample chamber through the slit projection module produces a slit-shaped beam with a width of about 50 µm.
[00261] 17. The method according to any one of clauses 16, wherein the method comprises moving the sample chamber or slit projection module in a manner sufficient to move the slit beam along a length of the sample chamber.
[00262] 18. The method according to any one of clauses 9 to 17, wherein the sample chamber is moved in a way sufficient to displace the slit beam in a back-and-forth motion.
[00263] 19. The method according to any one of clauses 9 to 18, wherein the sample chamber is moved sufficiently to displace the slit beam over 75% or more of the length of the sample chamber .
[00264] 20. The method according to any one of clauses 9 to 19, wherein the sample chamber is moved in a manner sufficient to displace the slit beam along the entire length of the sample chamber.
[00265] 21. The method according to any one of clauses 120, wherein the sample chamber is moved in a manner sufficient to move the slit beam along the length of the sample chamber in discrete increments.
[00266] 22. The method according to clause 21, wherein the sample chamber is moved sufficiently to move the slit beam along the length of the sample chamber in 3mm increments.
[00267] 23. The method according to any one of clauses 21-22, wherein light is detected at each discrete increment.
[00268] 24. The method according to clause 23, wherein the absorbance of light by the analyte is calculated from the detected light.
[00269] 25. The method according to any one of clauses 121, wherein the sample chamber is moved in a manner sufficient to continuously displace the slit beam along the length of the sample chamber.
[00270] 26. The method according to clause 25, wherein light is detected continuously during movement of the sample chamber.
[00271] 27. The method according to clause 26, wherein the absorbance of light by the analyte is calculated from the detected light.
[00272] 28. The method according to any one of clauses 127, wherein detecting the light transmitted by the sample comprises the spatial separation of wavelengths of light collected from the sample chamber.
[00273] 29. The method according to any one of clauses 128, wherein spatially separating the wavelengths of light comprises light diffraction with diffraction grating.
[00274] 30. The method according to any one of clauses 129, wherein the method further comprises illuminating a blank reference window.
[00275] 31. The method according to any one of clauses 130, wherein the method further comprises projecting an undifracted image of the slit into a detector.
[00276] 32. The method according to clause 31, wherein the method comprises using the non-diffracted image of the slit for calibration.
[00277] 33. The method according to clause 32, wherein the absorbance is calculated at a wavelength between 500 nm and 600 nm.
[00278] 34. The method according to clause 33, wherein the absorbance is calculated at one or more wavelengths selected from the group consisting of: 504 nm, 506 nm, 514 nm, 532 nm, 543 nm, 548 nm, 550 nm, 561 nm, 568 nm, 579 nm, 580 nm, 585 nm and 586 nm.
[00279] 35. The method according to any one of clauses 33-34, wherein the absorbance is calculated at about 548 nm.
[00280] 36. The method according to any one of clauses 33-34, wherein the absorbance is calculated at a wavelength between 600 nm and 700 nm.
[00281] 37. The method according to any one of clauses 33-34, in which the absorbance is calculated at one or more wavelengths selected from the group consisting of: 650 nm, 675 nm, 710 nm, 808 nm, 815 nm, 830 nm.
[00282] 38. The method according to any one of clauses 36-37, wherein the absorbance is calculated at 675 nm.
[00283] 39. The method according to any one of clauses 33-38, wherein the absorbance is calculated at the first wavelength which lies between 500 nm and 600 nm and at a second wavelength which lies between 600 nm and 700 nm.
[00284] 40. The method according to clause 39, wherein the absorbance is calculated at 548 nm and 675 nm.
[00285] 41. The method according to clause 39, wherein the absorbance is calculated at 548 nm and 650 nm.
[00286] 42. The method according to any one of clauses 1-41, wherein the analyte is hemoglobin.
[00287] 43. A method of analyzing a sample for an analyte, the method comprising: illuminating a sample in a sample chamber with a light source at a first wavelength between 500 nm and 600 nm and a second wavelength wave between 600 nm and 700 nm; detect the light transmitted by the sample; and calculating the absorbance of the detected light at the first and second wavelengths to analyze the sample for the analyte in the sample.
[00288] 44. The method according to clause 43, wherein the first wavelength is 548 nm.
[00289] 45. The method according to clause 43, wherein the second wavelength is 675 nm.
[00290] 46. The method according to clause 43, wherein the second wavelength is 650 nm.
[00291] 47. The method according to clause 43, wherein the first wavelength is 548 nm and the second wavelength is 675 nm.
[00292] 48. The method according to clause 43, wherein the first wavelength is 548 nm and the second wavelength is 650 nm.
49. A method of analyzing a sample for an analyte, the method comprising: positioning a microfluidic device having a capillary channel sample chamber on a stationary support for the microfluidic device; illuminating a sample in a sample chamber with a light source through a slit projection module to provide a slit-shaped beam in the sample chamber; illuminate a blank reference window with the light source through the slit projection module; detect the light transmitted by the sample; and calculating the absorbance of the detected light at one or more wavelengths to analyze the sample for the analyte in the sample.
[00294] 50. A system for testing a sample for an analyte, the system comprising: a broad-spectrum light source; a slit-projection module coupled to the broad-spectrum light source, wherein the slit-projection module comprises: a slit that reduces a beam of light from the broad-spectrum light source with a width equal to the width of the slit; and a focusing lens that focuses light from the slit; an objective lens that focuses the transmitted light from a sample; a diffraction grating; and a detector for detecting one or more predetermined wavelengths of transmitted light.
[00295] 51. The system according to clause 50, wherein the broad spectrum light source comprises a visible light source and a near infrared light source.
52. The system of clause 51, wherein the broad spectrum light source comprises an irradiation profile having emission peaks at about 450 nm, about 550 nm and about 830 nm.
[00297] 53. The system according to any one of clauses 50-53, wherein the slit projection module comprises: a slit configured to narrow a beam of light from the broad spectrum light source; and a focusing lens coupled to the slit for focusing light passing through the slit.
[00298] 54. The system according to clause 53, wherein the slit has a width of about 75 µm to 125 µm.
[00299] 55. The system according to clause 53, wherein the slit has a width of about 100 µm.
[00300] 56. The system according to clause 53, wherein the slit projection module is configured to project a light beam in the form of a slit that has a length that is greater than the width of the microfluidic chamber.
[00301] 57. The system according to clause 53, wherein the slit projection module is configured to project a light beam in the form of a slit having a length that is substantially the same as the width of the microfluidic chamber .
[00302] 58. The system according to clause 53, wherein the slit projection module is configured to project a light beam in the form of a slit that has a length that is less than the width of the microfluidic chamber.
[00303] 59. The system according to any one of clauses 50-58, wherein the slit projection module is configured to project a light beam in the form of a slit having a length of about 2.5 mm to about 3.5 mm.
[00304] 60. The system according to any one of clauses 50-58, wherein the slit projection module is configured to project a beam of light in the form of a slit having a length of about 3 mm.
[00305] 61. The system according to any one of clauses 50-58, wherein the slit-projection module is configured to project a beam of light in the form of a slit with a width from about 25 µm to about 75 µm.
[00306] 62. The system according to clause 61, wherein the slit projection module is configured to project a light beam in the form of a slit with a width of about 50 µm.
63. The system according to any one of clauses 50-62, wherein the slit comprises a material selected from the group consisting of gold-plated copper, ceramic, chromium, copper, molybdenum and tungsten.
[00308] 64. The system according to any one of clauses 50-62, wherein the slit-coupled focusing lens comprises a reducing lens.
[00309] 65. The system according to clause 64, wherein the focusing lens is a dual achromatic lens.
[00310] 66. The system according to any one of clauses 64-65, wherein the slit-coupled focusing lens has a magnification factor of about 0.5 to about 0.75.
[00311] 67. The system according to any one of clauses 64-65, wherein the slit-coupled focusing lens has a magnification factor of about 0.6.
[00312] 68. The system according to any one of clauses 50-67, wherein the slit projection module is configured to move along the length of a microfluidic chamber.
[00313] 69. The system according to clause 68, wherein the slit projection module is configured to move along the length of the microfluidic chamber in discrete increments.
[00314] 70. The system according to clause 68, wherein the slit projection module is configured to move continuously along the length of the microfluidic chamber.
[00315] 71. The system according to any one of clauses 50-67, wherein the system is configured to move a microfluidic chamber relative to the slit projection module.
[00316] 72. The system according to clause 71, wherein the microfluidic chamber is configured to move in discrete increments.
[00317] 73. The system according to clause 71, wherein the microfluidic chamber is configured to move continuously.
[00318] 74. The system according to any one of clauses 50-67, wherein the objective lens has a magnification factor of 1.5 to 2.5.
[00319] 75. The system according to clause 74, in which the objective lens has a magnification factor of about 1.7.
[00320] 76. The system according to any one of clauses 50-67, wherein the objective lens is a dual achromatic lens.
[00321] 77. The system according to any one of clauses 50-67, wherein the system further comprises a diffraction grating configured to spatially separate light into separate wavelengths.
[00322] 78. The system according to clause 77, wherein the diffraction grating is positioned on a filter wheel.
[00323] 79. The system according to clause 77, wherein the slit projection module, objective lens and diffraction grating provide a spatial separation resolution of 5 nm or less.
[00324] 80. The system according to clause 79, wherein the slit projection module, objective lens and diffraction grating provide a spatial separation resolution of 2 nm or less.
[00325] 81. The system according to any one of clauses 50-80, wherein the detector is a load coupling device.
[00326] 82. The system according to any one of clauses 50-80, wherein the detector is configured to detect light transmitted by the sample at a wavelength between 500 nm and 600 nm.
[00327] 83. The system according to clause 82, wherein the detector is configured to detect light transmitted by the sample at about 548 nm.
[00328] 84. The system according to any one of clauses 50-83, wherein the detector is configured to detect light transmitted by the sample at a wavelength between 600 nm and 700 nm.
[00329] 85. The system according to clause 84, wherein the detector is configured to detect light transmitted by the sample at about 675 nm.
[00330] 86. The system according to any one of clauses 50-85, wherein the detector is configured to detect the light transmitted by the sample at a first wavelength which is between 500 nm and 600 nm and at a second wavelength that is between 600 nm and 700 nm.
[00331] 87. The system according to clause 86, wherein the first wavelength is about 548 nm and the second wavelength is about 675 nm.
88. A system comprising: a broad spectrum light source; a slit-projection module coupled to the broad-spectrum light source, wherein the slit-projection module comprises: a slit that narrows a beam of light from the broad-spectrum light source to a width equal to the width of the slit; and a focusing lens that focuses light from the slit; a cartridge holder configured to receive a microfluidic device having a capillary channel sample chamber; and a detector for detecting one or more predetermined wavelengths of transmitted light; and a microfluidic device configured to perform an analysis of a liquid sample positioned in the cartridge holder, the device comprising: a sample application site in fluid communication with an inlet to a capillary channel sample chamber; a capillary channel sample chamber; and a reagent mixing chamber positioned between the sample application site and the capillary channel sample chamber.
[00333] 89. The system according to clause 88, wherein the broad spectrum light source comprises a visible light source and a near infrared light source.
[00334] 90. The system according to any one of clauses 88-89, wherein the broad spectrum light source comprises an irradiation profile having emission peaks at about 450 nm, at about 550 nm and at about 830 nm.
[00335] 91. The system according to any one of clauses 88-90, wherein the slit projection module comprises: a slit configured to narrow a light beam from the broad spectrum light source; and a focusing lens coupled to the slit for focusing light passing through the slit.
[00336] 92. The system according to clause 91, wherein the slit has a width of about 75 µm to 125 µm.
[00337] 93. The system according to clause 91, wherein the slit has a width of about 100 µm.
[00338] 94. The system according to clause 91, wherein the slit projection module is configured to project a light beam in the form of a slit that has a length that is greater than the width of the microfluidic chamber.
[00339] 95. The system according to clause 91, wherein the slit projection module is configured to project a light beam in the form of a slit that has a length that is substantially the same as the width of the microfluidic chamber .
[00340] 96. The system according to clause 91, wherein the slit projection module is configured to project a light beam in the form of a slit that has a length that is less than the width of the microfluidic chamber.
[00341] 97. The system according to clause 91, wherein the slit projection module is configured to project a beam of light in the form of a slit having a length from about 2.5 mm to about 3 .5 mm.
[00342] 98. The system according to clause 97, wherein the slit projection module is configured to project a beam of light in the form of a slit having a length of about 3 mm.
[00343] 99. The system according to clause 91, wherein the slit projection module is configured to project a light beam in the form of a slit with a width of about 25 µm to about 75 µm.
[00344] 100. The system according to clause 99, wherein the slit projection module is configured to project a light beam in the form of a slit with a width of about 50 µm.
101. The system according to any one of clauses 88-100, wherein the slit comprises a material selected from the group consisting of gold-plated copper, ceramic, chromium, copper, molybdenum and tungsten.
102. The system according to any one of clauses 88-100, wherein the slit-coupled focusing lens comprises a reducing lens.
103. The system according to clause 102, wherein the focusing lens is a dual achromatic lens.
[00348] 104. The system according to clause 102, wherein the slit-coupled focusing lens has a magnification factor of from about 0.5 to about 0.75.
105. The system according to clause 102, wherein the slit-coupled focusing lens has a magnification factor of about 0.6.
[00350] 106. The system according to any one of clauses 88-105, wherein the slit projection module is configured to move along the length of the microfluidic chamber.
[00351] 107. The system according to clause 106, wherein the slit projection module is configured to move along the length of the microfluidic chamber in discrete increments.
[00352] 108. The system according to clause 106, wherein the slit projection module is configured to move continuously along the length of the microfluidic chamber.
[00353] 109. The system according to any one of clauses 88-108, wherein the system is configured to move a microfluidic chamber relative to the slit projection module.
[00354] 110. The system according to clause 109, wherein the microfluidic chamber is configured to move in discrete increments.
[00355] 111. The system according to clause 109, wherein the microfluidic chamber is configured to move continuously.
[00356] 112. The system according to any one of clauses 88-111, wherein the objective lens has a magnification factor of 1.5 to 2.5.
[00357] 113. The system according to clause 112, in which the objective lens has a magnification factor of about 1.7.
[00358] 114. The system according to any one of clauses 88-113, wherein the objective lens is a dual achromatic lens.
[00359] 115. The system according to any one of clauses 88-114, wherein the system further comprises a diffraction grating configured to spatially separate light into separate wavelengths.
[00360] 116. The system according to clause 115, wherein the diffraction grating is positioned on a filter wheel.
[00361] 117. The system according to clause 115, wherein the slit projection module, objective lens and diffraction grating provide a spatial separation resolution of 5 nm or less.
[00362] 118. The system according to clause 115, wherein the slit projection module, objective lens and diffraction grating provide a spatial separation resolution of 2 nm or less.
[00363] 119. The system according to any one of clauses 88-118, wherein the detector is a load coupling device.
[00364] 120. The system according to any one of clauses 88-119, wherein the detector is configured to detect light transmitted by the sample at a wavelength between 500 nm and 600 nm.
[00365] 121. The system according to clause 120, wherein the absorbance is calculated at one or more wavelengths selected from the group consisting of: 504 nm, 506 nm, 514 nm, 532 nm, 543 nm, 548 nm, 550 nm, 561 nm, 568 nm, 579 nm, 580 nm, 585 nm and 586 nm.
[00366] 122. The system according to clause 120, wherein the detector is configured to detect light transmitted by the sample at about 548 nm.
[00367] 123. The system according to any one of clauses 88-119, wherein the detector is configured to detect light transmitted by the sample at a wavelength between 600 nm and 700 nm.
[00368] 124. The system according to clause 123, wherein the absorbance is calculated at one or more wavelengths selected from the group consisting of: 650 nm, 675 nm, 710 nm, 808 nm, 815 nm, 830 nm.
[00369] 125. The system according to clause 123, wherein the detector is configured to detect light transmitted by the sample at about 675 nm.
[00370] 126. The system according to clause 123, wherein the detector is configured to detect light transmitted by the sample at about 650 nm.
[00371] 127. The system according to any one of clauses 88-119, wherein the detector is configured to detect the light transmitted by the sample at a first wavelength which is between 500 nm and 600 nm and at a second wavelength that is between 600 nm and 700 nm.
128. The system according to clause 127, wherein the first wavelength is about 548 nm and the second wavelength is about 675 nm.
[00373] 129. The system according to clause 127, wherein the first wavelength is about 548 nm and the second wavelength is about 650 nm.
130. The system according to any one of clauses 88-119, wherein the capillary channel sample chamber has a depth between 20 µm to 70 µm.
131. The system according to any one of clauses 88-119, wherein the reagent mixing chamber comprises a porous disk for contacting the sample with one or more reagents.
132. The system according to clause 131, wherein the one or more reagents comprise CD4-PECy5, CD3-APC, CD45RA-APC, CD14-PE.
[00377] 133. The system according to any one of clauses 88-132, wherein the microfluidic device further comprises a reference window which is not in fluid communication with the capillary channel sample chamber.
[00378] 134. The system according to clause 133, wherein the reference window is configured as a blank reference when it is illuminated by one or more light sources.
[00379] 135. The system according to clause 133, wherein the reference window has the same refractive index as the capillary channel sample chamber.
136. A method comprising: providing a system for analyzing a sample for an analyte, the system comprising: a broad spectrum light source; a slit-projection module coupled to the broad-spectrum light source, wherein the slit-projection module comprises: a slit reduces a beam of light from the broad-spectrum light source with a width equal to the width of the slit; and a focusing lens that focuses light from the slit; a cartridge holder configured to receive a microfluidic device having a capillary channel sample chamber; and a detector for detecting one or more predetermined wavelengths of transmitted light; position the microfluidic device in the cartridge holder; illuminating a sample in a sample chamber with a light source through a slit projection module to provide a slit-shaped beam in the sample chamber; detect the light transmitted by the sample; and calculating the absorbance of the detected light at one or more wavelengths to analyze the sample for the analyte in the sample.
[00381] 137. The method according to clause 136, wherein the sample has a volume between 1 μL and 100 μL.
[00382] 138. The method according to clause 137, wherein the sample has a volume of 25 µL.
[00383] 139. The process according to any one of clauses 136-138, wherein positioning the microfluidic device in the cartridge holder comprises sliding the microfluidic device into the system.
140. The method according to any one of clauses 136-138, wherein the cartridge holder is configured to slide out of the system to receive the microfluidic device.
[00385] 141. The method according to any one of clauses 136-140, wherein the method further comprises calculating the absorbance of light detected at one or more wavelengths to compensate for scattering by the sample.
[00386] 142. The method according to any one of clauses 136-140, wherein the method comprises calculating the absorbance of light detected at a wavelength of 700 nm or less to compensate for scattering by the sample.
[00387] 143. The method according to clause 142, wherein the method comprises calculating the absorbance of light detected at 650 nm to compensate for scattering by the sample.
[00388] 144. The method according to any one of clauses 136-143, wherein the sample is illuminated with one or more broad spectrum light sources.
[00389] 145. The method according to any one of clauses 136-143, wherein the sample is illuminated with two broad-spectrum light sources.
[00390] 146. The method according to any one of clauses 136-143, wherein the broad spectrum light source comprises a visible light source and a near infrared light source.
[00391] 147. The method according to any one of clauses 136-143, in which illuminating through the slit projection module produces a beam of light which is in the form of a slit.
[00392] 148. The method according to clause 147, wherein the slit-shaped beam has a length that is greater than the width of the microfluidic chamber.
[00393] 149. The method according to clause 147, wherein the slit-shaped beam has a length that is less than the width of the microfluidic chamber.
[00394] 150. The method according to clause 147, wherein the slit-shaped beam has a length that is substantially the same as the width of the microfluidic chamber.
[00395] 151. The method according to clause 147, wherein illuminating the sample chamber through the slit projection module produces a slit-shaped beam with a length of about 2.5 mm to about 3 .5 mm.
[00396] 152. The method according to clause 151, wherein illuminating the sample chamber through the slit projection module produces a slit-shaped beam with a length of about 3 mm.
[00397] 153. The method according to clause 147, wherein illuminating the sample chamber through the slit projection module produces a slit-shaped beam with a width of about 25 µm to about 75 µM.
[00398] 154. The method according to clause 153, wherein illuminating the sample chamber through the slit projection module produces a slit-shaped beam with a width of about 50 µm.
[00399] 155. The method according to clause 147, wherein the method comprises moving the sample chamber or the slit projection module in a manner sufficient to displace the slit beam along a length of the chamber of sample.
[00400] 156. The method according to clause 147, wherein the sample chamber is moved in a way sufficient to shift the slit beam in a back-and-forth motion.
[00401] 157. The method of clause 147, wherein the sample chamber is moved sufficiently to displace the slit beam over 75% or more of the length of the sample chamber.
[00402] 158. The method according to clause 147, wherein the method comprises moving the slit beam along a length of the sample chamber.
[00403] 159. The method according to clause 147, wherein the method comprises moving the slit beam in a back-and-forth motion along a length of the sample chamber.
[00404] 160. The method according to any one of clauses 136-159, wherein the absorbance of light by the analyte is calculated from the detected light.
[00405] 161. The method according to any one of clauses 136-160, wherein light is detected continuously.
[00406] 162. The method according to clause 161, wherein the absorbance of light by the analyte is calculated from the detected light.
[00407] 163. The method according to clause 136, wherein the absorbance of light by the analyte is calculated at two or more different wavelengths.
[00408] 164. The method according to clause 163, wherein the absorbance is calculated at a wavelength between 500 nm and 600 nm.
[00409] 165. The method according to clause 164, wherein the absorbance is calculated at one or more wavelengths selected from the group consisting of: 504 nm, 506 nm, 514 nm, 532 nm, 543 nm, 548 nm, 550 nm, 561 nm, 568 nm, 579 nm, 580 nm, 585 nm and 586 nm.
[00410] 166. The method according to clause 164, wherein the absorbance is calculated at about 548 nm.
[00411] 167. The method according to clause 166, wherein the absorbance is calculated at a wavelength between 600 nm and 700 nm.
[00412] 168. The method according to clause 167, in which the absorbance is calculated at one or more wavelengths selected from the group consisting of: 650 nm, 675 nm, 710 nm, 808 nm, 815 nm, 830 nm.
[00413] 169. The method according to clause 167, wherein the absorbance is calculated at 675 nm.
[00414] 170. The method according to clause 167, wherein the absorbance is calculated at 650 nm.
171. The method according to any one of clauses 136-170, wherein the analyte is hemoglobin.
172. A kit comprising: (a) a microfluidic device comprising: a sample application site in fluid communication with an inlet to a capillary channel sample chamber; a capillary channel sample chamber; and a reagent mixing chamber positioned between the sample application site and the capillary channel sample chamber; and (b) a container that houses the device.
[00417] 173. The kit according to clause 172, wherein the container comprises a pouch.
[00418] Although the aforementioned invention has been described in some detail by way of illustration and examples for purposes of clarity of understanding, it is readily apparent to those of ordinary skill in the art in light of the teachings of the present description that certain changes and modifications can be made. without departing from the spirit or scope of the appended claims.
[00419] Accordingly, the foregoing merely illustrates the principles of the invention. It will be appreciated that those skilled in the art are able to devise different arrangements which, although not explicitly described or shown herein, embody the principles of the invention and are included within its spirit and scope. Furthermore, all examples and conditional language cited herein are intended primarily to assist the reader in understanding the principles of the invention, this being without limitation to these specifically enumerated examples and conditions. Furthermore, all statements herein enumerating principles, aspects and embodiments of the invention, as well as specific examples thereof, are intended to encompass both structural and functional equivalents thereof. Furthermore, such equivalents are intended to include both currently known equivalents and equivalents developed in the future, that is, any elements developed that perform the same function, regardless of structure. The scope of the present invention, therefore, is not intended to be limited to the exemplary embodiments shown and described herein. Rather, the scope and spirit of the present invention is realized by the appended claims.

权利要求:
Claims (15)
[0001]
1. Method of analyzing a sample for an analyte, the method characterized in that it comprises: illuminating a sample in a sample chamber (102, 203, 209, 303) with a light source (201, 207, 301) through a slit projection module (208, 302) to provide a slit-shaped beam (101) in the sample chamber (102, 203, 209, 303), wherein the slit projection module (208, 302 ) comprises: a slit (202a) which extracts a beam of light from the light source (201, 207, 301) to a width equal to the width of the slit (202a); and a focusing lens that focuses light from the slit; detect, with a detector (206, 212, 306), light transmitted through the sample, in which the light from the sample is propagated through an objective lens (202b, 204, 210, 304), diffraction grating (205) and directly for the detector (206, 212, 306), wherein the light source (201, 207, 301), slit projection module (208, 302), objective lens (202b, 204, 210, 304), diffraction (205) and detector (206, 212, 306) are positioned in line with each other such that light from the light source (201, 207, 301) is propagated along an optical axis through the slit (202a) and the focusing lens and is transmitted through the sample, the objective lens (202b, 204, 210, 304) and the diffraction grating (205) without optical axis deviation; and calculating the absorbance of the detected light at one or more wavelengths to analyze the sample for the analyte in the sample.
[0002]
2. Method according to claim 1, characterized in that the sample is illuminated with a light source (201, 207, 301) at a first wavelength between 500 nm and 600 nm and at a second wavelength between 600 nm and 700 nm.
[0003]
A method according to claim 1, characterized in that it further comprises moving the sample chamber (102, 203, 209, 303) in a manner sufficient to move the slit beam (101) along 75 % or more of the length of the sample chamber (102, 203, 209, 303).
[0004]
4. Method according to claim 1, characterized in that the detection of light transmitted by the sample comprises spatially separating wavelengths of light collected from the sample chamber (102, 203, 209, 303).
[0005]
5. Method according to claim 1, characterized in that the method further comprises calculating the absorbance of light detected at one or more wavelengths to compensate for scattering by the sample.
[0006]
6. Method according to claim 5, characterized in that the method comprises calculating the absorbance of light detected at a wavelength of 700 nm or less to compensate for dispersion by the sample.
[0007]
7. Method according to claim 1, characterized in that the absorbance is calculated at 548 nm and 675 nm.
[0008]
8. Method according to claim 1, characterized in that the method further comprises illuminating a blank reference window.
[0009]
9. A method according to claim 1, characterized in that the method further comprises projecting an undifracted image of the slit into a detector (206, 212, 306).
[0010]
10. System for analyzing a sample for an analyte, characterized in that it comprises: a broad-spectrum light source (201, 207, 301); a slit projection module (208, 302) coupled to the broad spectrum light source (201, 207, 301), wherein the slit projection module (208, 302) comprises: a slit (202a) that narrows a light beam from the broad-spectrum light source (201, 207, 301) having a width equal to the width of the slit (202a); and a focusing lens that focuses light from the slit (202a); an objective lens (202b, 204, 210, 304) that focuses transmitted light from a sample; a diffraction grating (205); and a detector (206, 212, 306) for detecting one or more predetermined wavelengths of transmitted light, wherein the light source (201, 207, 301), slit projection module (208, 302), objective lens (202b, 204, 210, 304), diffraction grating (205) and detector (206, 212, 306) are positioned in line with each other so that the light from the light source (201, 207, 301) spectrum is propagated along an optical axis through the slit (202a) and the focusing lens and is transmitted through the sample, objective lens (202b, 204, 210, 304) and the diffraction grating directly to the detector (206, 212, 306) without optical axis shift.
[0011]
11. System according to claim 10, characterized in that the focusing lens is coupled to the slit (202a) and comprises a reduction lens.
[0012]
12. System according to claim 10, characterized in that the broad spectrum light source (201, 207, 301) comprises a visible light source and a near infrared light source.
[0013]
13. System according to claim 10, characterized in that it further comprises: a cartridge holder configured to receive a microfluidic device having a capillary channel sample chamber (102, 203, 209, 303); and a microfluidic device configured to perform an analysis of a liquid sample placed in the cartridge holder, the device comprising: a sample application site in fluid communication with an inlet to a sample chamber (102, 203, 209, 303) of capillary channel; a capillary channel sample chamber (102, 203, 209, 303); and a reagent mixing chamber positioned between the sample application site and the capillary channel sample chamber (102, 203, 209, 303).
[0014]
14. System according to claim 13, characterized in that the microfluidic device comprises a reference window that is free from fluid communication with the sample chamber (102, 203, 209, 303) of capillary channel.
[0015]
15. System according to claim 14, characterized in that the reference window has the same refractive index as the sample chamber (102, 203, 209, 303) of capillary channel.

类似技术:

---

公开号 | 公开日 | 专利标题

---

BR112016010721B1|2021-06-01|METHOD AND SYSTEM OF ANALYSIS OF A SAMPLE FOR AN ANALYTE

---

ES2856191T3|2021-09-27|Microfluidic devices and methods of using them

---

CN104661594B|2017-10-13|The device infrared measurement apparatus of intelligent movable, π methods and the system for analyzing material

---

CN104081210B|2018-11-30|Optical detecting device with the actuating of pneumatic type sample

---

CN102859365B|2016-01-20|For determining equipment, the system and method for medical conditions fast

---

JP6296457B2|2018-03-20|Low-cost clinical on-site assay device

---

US10032270B2|2018-07-24|System and methods for the in vitro detection of particles and soluble chemical entities in body fluids

---

US20100110439A1|2010-05-06|Optical measuring instrument

---

BRPI0710105A2|2011-08-02|DEVICE AND METHOD FOR DETECTION OF BIOLOGICAL COMPONENTS MARKED BY FLUORESCENCE

---

KR102074153B1|2020-02-06|Automated Device for Analyzing Immunoassay in Liquid

---

US10324020B2|2019-06-18|Fluidic optical cartridge

---

EP2726852B1|2020-11-25|Multiple examinations of a sample

---

CN108106994A|2018-06-01|A kind of scan-type local enhances biochemical sensitive device

---

JP2021514051A|2021-06-03|Analysis equipment

---

US10677709B2|2020-06-09|Particle detection cartridges, systems thereof and methods for using the same

---

CN210803281U|2020-06-19|Special detection equipment for lateral flow immunochromatography based on near-infrared two-zone fluorescence imaging

---

CN210071844U|2020-02-14|Cancer detection device based on PD-L1 receptor

---

US20200324282A1|2020-10-15|Pipette Tip with Integrated Light Guides in the Body and Method of Spectroscopic Analysis Using Same

---

CN214252308U|2021-09-21|Multi-channel fluorescence immunochromatography quantitative detector

---

CN112748245A|2021-05-04|Multi-channel fluorescence immunochromatography quantitative detector and detection method thereof

---

Keahey2018|Point-Of-Care Imaging and Lateral Flow Diagnostics for Improving Medical Care in Low-Resource Settings

---

WO2018093896A1|2018-05-24|Pipette tip with integrated light guides in the body and method of spectroscopic analysis using same

同族专利:

---

公开号 | 公开日

---

US20190004067A1|2019-01-03|

---

JP6518245B2|2019-05-22|

---

CN105899936B|2019-12-24|

---

EP3074754A4|2017-07-26|

---

AU2014348910B2|2017-04-20|

---

AU2014348910A1|2016-05-19|

---

EP3074754A1|2016-10-05|

---

US10663476B2|2020-05-26|

---

US10018640B2|2018-07-10|

---

US20150132789A1|2015-05-14|

---

JP2016540974A|2016-12-28|

---

WO2015073384A1|2015-05-21|

---

CN105899936A|2016-08-24|

引用文献:

---

公开号 | 申请日 | 公开日 | 申请人 | 专利标题

---

---

US816135A|1901-03-25|1906-03-27|Stromberg Carlson Telephone|Telephone-exchange system.|

---

US4125828A|1972-08-04|1978-11-14|Med-El Inc.|Method and apparatus for automated classification and analysis of cells|

---

US3819913A|1973-05-21|1974-06-25|Corning Glass Works|Detection of eosinophil cells on a blood smeared slide|

---

US3916205A|1973-05-31|1975-10-28|Block Engineering|Differential counting of leukocytes and other cells|

---

JPS5424680B2|1973-11-13|1979-08-22|

---

DE2523209A1|1975-05-26|1976-12-16|Noeller Hans Guenter Dr Med|ELECTRO-OPTIC, SUBSTANCE-CARE DETECTION OF NON-CELL-BONDED IMMUNE SUBSTANCES|

---

SE399768B|1975-09-29|1978-02-27|Lilja Jan E|CYVETT FOR SAMPLING, MIXING OF, THE SAMPLE WITH A REAGENTS AND DIRECT PERFORMANCE OF, SPECIAL OPTICAL, ANALYSIS OF THE SAMPLE MIXED WITH THE REAGENTS|

---

JPH0133782B2|1980-01-07|1989-07-14|Fuji Photo Film Co Ltd|

---

US4501496A|1982-05-07|1985-02-26|Griffin Gladys B|Specimen slide for analysis of liquid specimens|

---

DE3238353A1|1982-10-15|1984-04-19|Max Planck Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen|METHOD FOR SIMULTANEOUSLY QUANTITATIVE DETERMINATION OF BLOOD CELLS AND REAGENT THEREFOR|

---

JPS5994037A|1982-11-19|1984-05-30|Shimadzu Corp|Apparatus for counting corpuscle|

---

JPS6073343A|1983-09-30|1985-04-25|Shimadzu Corp|Spectrophotometer|

---

US4727020A|1985-02-25|1988-02-23|Becton, Dickinson And Company|Method for analysis of subpopulations of blood cells|

---

US5134662A|1985-11-04|1992-07-28|Cell Analysis Systems, Inc.|Dual color camera microscope and methodology for cell staining and analysis|

---

US4959305A|1986-06-18|1990-09-25|Miles Inc.|Reversible immobilization of assay reagents in a multizone test device|

---

US6159740A|1987-03-13|2000-12-12|Coulter Corporation|Method and apparatus for screening obscured or partially obscured cells|

---

US4857735A|1987-10-23|1989-08-15|Noller Hans G|Light emitting diode spectrophotometer|

---

US5200152A|1988-03-28|1993-04-06|Cytonix Corporation|Miniaturized biological assembly|

---

US5073857A|1989-06-01|1991-12-17|Accuron Corporation|Method and apparatus for cell analysis|

---

US5053626A|1989-09-29|1991-10-01|Boston University|Dual wavelength spectrofluorometer|

---

US5102625A|1990-02-16|1992-04-07|Boc Health Care, Inc.|Apparatus for monitoring a chemical concentration|

---

JPH03291567A|1990-04-10|1991-12-20|Olympus Optical Co Ltd|Virus infection inspecting device and virus infection inspecting method|

---

US5159642A|1990-07-13|1992-10-27|Toa Medical Electronics Co., Ltd.|Particle image analyzing apparatus|

---

IE76732B1|1990-08-07|1997-11-05|Becton Dickinson Co|One step test for absolute counts|

---

US5348859A|1990-11-23|1994-09-20|Coulter Corporation|Method and apparatus for obtaining an absolute white blood cell subset count and white blood cell multipart differential|

---

US5196709A|1991-05-03|1993-03-23|University Of Maryland Systems|Fluorometry method and apparatus using a semiconductor laser diode as a light source|

---

US5385539A|1992-06-30|1995-01-31|Advanced Haemotechnologies|Apparatus for monitoring hematocrit levels of blood|

---

US5332905A|1992-08-26|1994-07-26|Atto Instruments, Inc.|Apparatus and method for multiple emission ratio photometry and multiple emission ratio imaging|

---

US6262798B1|1992-09-29|2001-07-17|Board Of Regents, The University Of Texas System|Method and apparatus for direct spectrophotometric measurements in unaltered whole blood|

---

WO1994009366A1|1992-10-08|1994-04-28|Abbott Laboratories|Assay devices using subsurface flow|

---

US5733721A|1992-11-20|1998-03-31|The Board Of Regents Of The University Of Oklahoma|Cell analysis method using quantitative fluorescence image analysis|

---

US5294799A|1993-02-01|1994-03-15|Aslund Nils R D|Apparatus for quantitative imaging of multiple fluorophores|

---

US5556764A|1993-02-17|1996-09-17|Biometric Imaging, Inc.|Method and apparatus for cell counting and cell classification|

---

US5547849A|1993-02-17|1996-08-20|Biometric Imaging, Inc.|Apparatus and method for volumetric capillary cytometry|

---

US5489771A|1993-10-15|1996-02-06|University Of Virginia Patent Foundation|LED light standard for photo- and videomicroscopy|

---

US5491343A|1994-03-25|1996-02-13|Brooker; Gary|High-speed multiple wavelength illumination source, apparatus containing the same, and applications thereof to methods of irradiating luminescent samples and of quantitative luminescence ratio microscopy|

---

FR2719903B1|1994-05-11|1996-07-19|Secomam Sa|Method and device for analyzing the composition of a liquid using a spectrophotometer with multiple detection ranges.|

---

JP3146858B2|1994-06-30|2001-03-19|株式会社日立製作所|Optical detector for flow samples|

---

JP3529786B2|1994-07-14|2004-05-24|アボット・ラボラトリーズ|Cyanide-free assay method and reagents for hemoglobin and leukocytes in whole blood|

---

CA2156226C|1994-08-25|1999-02-23|Takayuki Taguchi|Biological fluid analyzing device and method|

---

US5599668A|1994-09-22|1997-02-04|Abbott Laboratories|Light scattering optical waveguide method for detecting specific binding events|

---

DE4438391C2|1994-10-27|1997-07-03|Evotec Biosystems Gmbh|Device for determining substance-specific parameters of one or fewer molecules by means of correlation spectroscopy|

---

US5554536A|1995-01-05|1996-09-10|Millipore Investment Holdings Limited|Biological analysis device having improved contamination prevention|

---

US5658745A|1995-02-17|1997-08-19|E. I. Du Pont De Nemours And Company|Cell enumeration immunoassay|

---

US5692503A|1995-03-10|1997-12-02|Kuenstner; J. Todd|Method for noninvasive total hemoglobin, oxyhemogolobin, deoxyhemoglobin, carboxyhemoglobin and methemoglobin concentration determination|

---

US5528045A|1995-04-06|1996-06-18|Becton Dickinson And Company|Particle analyzer with spatially split wavelength filter|

---

US5682038A|1995-04-06|1997-10-28|Becton Dickinson And Company|Fluorescent-particle analyzer with timing alignment for analog pulse subtraction of fluorescent pulses arising from different excitation locations|

---

SE504193C2|1995-04-21|1996-12-02|Hemocue Ab|Capillary microcuvette|

---

US5675155A|1995-04-26|1997-10-07|Beckman Instruments, Inc.|Multicapillary fluorescent detection system|

---

JP3304692B2|1995-05-23|2002-07-22|株式会社島津製作所|Spectrometer|

---

US5732150A|1995-09-19|1998-03-24|Ihc Health Services, Inc.|Method and system for multiple wavelength microscopy image analysis|

---

AR003846A1|1995-10-18|1998-09-09|Shell Int Research|A TRANSMISSION CELL SUITABLE FOR USE IN A DEVICE TO MEASURE INFRARED SPECTRUMS OF A HYDROCARBONACEOUS MATERIAL, A SPECTROMETER THAT UNDERSTANDS IT, USE OF THE SAME, A PHYSICAL PROPERTY OF SUCH MATERIAL PROCEDURE TO PREPARE A BETUM COMPOSITION USING SUCH METHOD WITH SUCH SPECTOMETER|

---

US6215892B1|1995-11-30|2001-04-10|Chromavision Medical Systems, Inc.|Method and apparatus for automated image analysis of biological specimens|

---

AU1288497A|1995-12-18|1997-07-14|Center For Laboratory Technology, Inc.|Multi-parameter hematology apparatus and method|

---

AT403412B|1996-04-02|1998-02-25|Avl Verbrennungskraft Messtech|DEVICE AND METHOD FOR DETERMINING THE CONCENTRATION OF HEMOGLOBIN DERIVATIVES IN AN UNDILINED, UNHEMOLYZED WHOLE BLOOD SAMPLE|

---

JP3788519B2|1996-06-28|2006-06-21|カリパー・ライフ・サイエンシズ・インコーポレーテッド|High-throughput screening assay system for microscale fluid devices|

---

AT404513B|1996-07-12|1998-12-28|Avl Verbrennungskraft Messtech|METHOD AND MEASURING ARRANGEMENT FOR THE OPTICAL DETERMINATION OF TOTAL HEMOGLOBIN CONCENTRATION|

---

US6396941B1|1996-08-23|2002-05-28|Bacus Research Laboratories, Inc.|Method and apparatus for internet, intranet, and local viewing of virtual microscope slides|

---

US6272235B1|1997-03-03|2001-08-07|Bacus Research Laboratories, Inc.|Method and apparatus for creating a virtual microscope slide|

---

AT555375T|1997-05-05|2012-05-15|Chemometec As|METHOD AND DEVICE FOR DETERMINING PARTICLES IN A LIQUID SAMPLE|

---

US6043880A|1997-09-15|2000-03-28|Becton Dickinson And Company|Automated optical reader for nucleic acid assays|

---

US6041246A|1997-10-14|2000-03-21|Transonic Systems, Inc.|Single light sensor optical probe for monitoring blood parameters and cardiovascular measurements|

---

SE9703780D0|1997-10-17|1997-10-17|Tms Chem Ab|Capillary based immunoassay|

---

GB9800263D0|1998-01-08|1998-03-04|Bio Diagnostics Ltd|A device for testing liquids|

---

US6064474A|1998-02-06|2000-05-16|Optical Sensors, Inc.|Optical measurement of blood hematocrit incorporating a self-calibration algorithm|

---

US6929953B1|1998-03-07|2005-08-16|Robert A. Levine|Apparatus for analyzing biologic fluids|

---

US6350613B1|1998-03-07|2002-02-26|Belton Dickinson & Co.|Determination of white blood cell differential and reticulocyte counts|

---

US6235536B1|1998-03-07|2001-05-22|Robert A. Levine|Analysis of quiescent anticoagulated whole blood samples|

---

US6723290B1|1998-03-07|2004-04-20|Levine Robert A|Container for holding biologic fluid for analysis|

---

JP4350897B2|1998-03-11|2009-10-21|ボーリンガーインゲルハイムミクロパルツゲーエムベーハー|Sample carrier|

---

US6181418B1|1998-03-12|2001-01-30|Gretag Macbeth Llc|Concentric spectrometer|

---

DE19820861B4|1998-05-09|2004-09-16|Bruker Axs Gmbh|Simultaneous X-ray fluorescence spectrometer|

---

US6094592A|1998-05-26|2000-07-25|Nellcor Puritan Bennett, Inc.|Methods and apparatus for estimating a physiological parameter using transforms|

---

US6064897A|1998-06-01|2000-05-16|Abbott Laboratories|Sensor utilizing Raman spectroscopy for non-invasive monitoring of analytes in biological fluid and method of use|

---

JP3437094B2|1998-07-03|2003-08-18|松下電器産業株式会社|Multi-wavelength fluorescence polarization method|

---

US6214629B1|1998-08-06|2001-04-10|Spectral Diagnostics, Inc.|Analytical test device and method for use in medical diagnoses|

---

US6410341B1|1998-08-06|2002-06-25|Spectral Diagnostics, Inc.|Analytical test device and method for use in medical diagnoses|

---

US6087182A|1998-08-27|2000-07-11|Abbott Laboratories|Reagentless analysis of biological samples|

---

DE19840731A1|1998-09-07|2000-03-09|Hoechst Marion Roussel De Gmbh|Two-color differential display as a method for the detection of regulated genes|

---

US6154282A|1998-10-26|2000-11-28|Cytotelesis Inc.|Semiconductor based excitation illuminator for fluorescence and phosphorescence microscopy|

---

WO2000028297A2|1998-11-05|2000-05-18|Chemometec A/S|A method for the assessment of particles and a system and a device for use in the method|

---

WO2000029847A2|1998-11-16|2000-05-25|Umedik, Inc.|Device and method for analyzing a biologic sample|

---

US6187592B1|1998-12-23|2001-02-13|Sandia Corporation|Method for determining properties of red blood cells|

---

DE60044490D1|1999-02-23|2010-07-15|Caliper Life Sciences Inc|MANIPULATION OF MICROTEILS IN MICROFLUID SYSTEMS|

---

US6305804B1|1999-03-25|2001-10-23|Fovioptics, Inc.|Non-invasive measurement of blood component using retinal imaging|

---

EP1040788B1|1999-03-29|2001-12-19|F.Hoffmann-La Roche Ag|Apparatus for quantitative determination of the local distribution of a measurement value|

---

US6453060B1|1999-06-29|2002-09-17|Tri Path Imaging, Inc.|Method and apparatus for deriving separate images from multiple chromogens in a branched image analysis system|

---

US6294094B1|1999-09-03|2001-09-25|Baxter International Inc.|Systems and methods for sensing red blood cell hematocrit|

---

US6284142B1|1999-09-03|2001-09-04|Baxter International Inc.|Sensing systems and methods for differentiating between different cellular blood species during extracorporeal blood separation or processing|

---

US6611320B1|1999-09-08|2003-08-26|Optoq Ab|Method and apparatus|

---

JP2001088098A|1999-09-14|2001-04-03|Kawamura Inst Of Chem Res|Micro chemical device with depressurized liquid feeding mechanism|

---

US6696240B1|1999-10-26|2004-02-24|Micronix, Inc.|Capillary test strip to separate particulates|

---

US6665060B1|1999-10-29|2003-12-16|Cytyc Corporation|Cytological imaging system and method|

---

US6825921B1|1999-11-10|2004-11-30|Molecular Devices Corporation|Multi-mode light detection system|

---

US6563585B1|1999-11-24|2003-05-13|University Of Maryland Biotechnology Institute|Ratiometric fluorometer|

---

JP2001221951A|1999-11-29|2001-08-17|Olympus Optical Co Ltd|Microscope|

---

US6716588B2|1999-12-09|2004-04-06|Cellomics, Inc.|System for cell-based screening|

---

US20030175947A1|2001-11-05|2003-09-18|Liu Robin Hui|Enhanced mixing in microfluidic devices|

---

US6612111B1|2000-03-27|2003-09-02|Lifescan, Inc.|Method and device for sampling and analyzing interstitial fluid and whole blood samples|

---

US20060263888A1|2000-06-02|2006-11-23|Honeywell International Inc.|Differential white blood count on a disposable card|

---

WO2002001194A1|2000-06-25|2002-01-03|Affymetrix, Inc.|Optically active substrates|

---

SE518539C2|2000-06-28|2002-10-22|Migrata U K Ltd|Method and cuvette for quantitative hemoglobin determination in undiluted whole blood|

---

US6858400B2|2000-07-05|2005-02-22|Cynthia L Bristow|Detection of surface-associated human leukocyte elastase|

---

DE10033268C2|2000-07-10|2002-08-08|Innovatis Gmbh|Method for examining cells in a culture fluid|

---

US7630063B2|2000-08-02|2009-12-08|Honeywell International Inc.|Miniaturized cytometer for detecting multiple species in a sample|

---

US7139073B1|2000-09-04|2006-11-21|Hamamatsu Photonics K.K.|Imaging apparatus|

---

US20020187485A1|2000-10-25|2002-12-12|Jakobsen Mogens Hausteen|Open substrate platforms suitable for analysis of biomolecules|

---

GB0029154D0|2000-11-30|2001-01-17|Lee Helen|Signal enhancement with multiple labelled-antibodies|

---

US6826424B1|2000-12-19|2004-11-30|Haishan Zeng|Methods and apparatus for fluorescence and reflectance imaging and spectroscopy and for contemporaneous measurements of electromagnetic radiation with multiple measuring devices|

---

AT364174T|2001-01-26|2007-06-15|Biocal Technology Inc|OPTICAL DETECTION IN A MULTI-CHANNEL BIOSEPARATION SYSTEM|

---

US7476533B2|2002-04-19|2009-01-13|Adhesives Research, Inc.|Diagnostic devices for use in the assaying of biological fluids|

---

US6960165B2|2001-05-16|2005-11-01|Olympus Corporation|Endoscope with a single image pick-up element for fluorescent and normal-light images|

---

EP1405073B1|2001-07-11|2010-03-03|National Health Laboratory Service|Cell enumeration|

---

WO2003014678A1|2001-08-10|2003-02-20|Gbc Scientific Equipment Pty Ltd|Atomic absorption spectrometer|

---

ES2430854T3|2001-09-06|2013-11-22|Rapid Micro Biosystems, Inc.|Rapid detection of cells in replication|

---

US6862534B2|2001-12-14|2005-03-01|Optiscan Biomedical Corporation|Method of determining an analyte concentration in a sample from an absorption spectrum|

---

SE0104443D0|2001-12-28|2001-12-28|Hemocue Ab|Analysis method and cuvette for that|

---

EP1474772A4|2002-02-14|2005-11-09|Immunivest Corp|Methods and algorithms for cell enumeration in a low-cost cytometer|

---

WO2004100887A2|2003-05-08|2004-11-25|Phynexus, Inc.|Three-dimensional solid phase extraction surfaces|

---

US20040224329A1|2003-05-08|2004-11-11|Gjerde Douglas T.|Three-dimensional solid phase extraction surfaces|

---

JP2004017374A|2002-06-13|2004-01-22|Matsushita Electric Ind Co Ltd|Squeegee for filling electroconductive paste, filling method and device for electroconductive paste|

---

US20030230728A1|2002-06-13|2003-12-18|Zhengshan Dai|Multiwavelength transilluminator for absorbance and fluorescence detection using light emitting diodes|

---

JP3869324B2|2002-06-26|2007-01-17|オリンパス株式会社|Image processing device for fluorescence observation|

---

WO2004017374A2|2002-08-16|2004-02-26|Clinical Microarrays, Inc.|Reading of fluorescent arrays|

---

US7279134B2|2002-09-17|2007-10-09|Intel Corporation|Microfluidic devices with porous membranes for molecular sieving, metering, and separations|

---

US20040142484A1|2002-09-30|2004-07-22|Intel Corporation|Spectroscopic analysis system and method|

---

AU2003275940A1|2002-10-31|2004-05-25|Chemometec A/S|A method for assessment of particles|

---

EP2711415B1|2002-12-26|2022-02-16|Meso Scale Technologies, LLC.|Assay cartridges and methods of using the same|

---

DE10305050A1|2003-02-07|2004-08-19|Roche Diagnostics Gmbh|Analytical test element and method for blood tests|

---

US6985224B2|2003-03-14|2006-01-10|The United States Of America As Represented By The Secretary Of The Navy|Light emitting diode array for excitation emission matrix fluorescence spectroscopy|

---

US7271912B2|2003-04-15|2007-09-18|Optiscan Biomedical Corporation|Method of determining analyte concentration in a sample using infrared transmission data|

---

DE10326152A1|2003-06-06|2005-01-05|Aventis Pharma Deutschland Gmbh|Method and device for the quantitative analysis of solutions and dispersions by means of near-infrared spectroscopy|

---

US6999173B2|2003-09-25|2006-02-14|Ffa Sciences Llc|Method and apparatus for ratio fluorometry|

---

US20050142565A1|2003-12-30|2005-06-30|Agency For Science, Technology And Research|Nucleic acid purification chip|

---

WO2005071372A1|2004-01-23|2005-08-04|Olympus Corporation|Image processing system and camera|

---

US7781226B2|2004-02-27|2010-08-24|The Board Of Regents Of The University Of Texas System|Particle on membrane assay system|

---

US7265669B2|2004-03-01|2007-09-04|Mesosystems Technology, Inc.|Networks with sensors for air safety and security|

---

WO2005090969A1|2004-03-18|2005-09-29|Fuji Photo Film Co., Ltd.|Analysis element for use in method of testing specimen|

---

ES2548567T3|2004-04-07|2015-10-19|Levine, Robert Aaron|Disposable chamber to analyze biological fluids|

---

US7674598B2|2004-05-21|2010-03-09|Beckman Coulter, Inc.|Method for a fully automated monoclonal antibody-based extended differential|

---

US7625712B2|2004-05-21|2009-12-01|Beckman Coulter, Inc.|Method for a fully automated monoclonal antibody-based extended differential|

---

JP2006006834A|2004-06-29|2006-01-12|Pentax Corp|Electronic endoscope system|

---

WO2006047831A1|2004-11-03|2006-05-11|Agen Biomedical Limited|Detection device and method|

---

JP4623716B2|2004-11-25|2011-02-02|旭化成株式会社|Nucleic acid detection cartridge and nucleic acid detection method|

---

CA2589996C|2004-12-13|2012-02-21|Bayer Healthcare Llc|Transmission spectroscopy system for use in the determination of analytes in body fluid|

---

DE102004063438A1|2004-12-23|2006-07-06|Oktavia Backes|Novel microfluidic sample carriers|

---

JP4566754B2|2005-01-12|2010-10-20|Ｈｏｙａ株式会社|Image processing device|

---

EP1851545B1|2005-02-25|2014-12-31|Dako Denmark A/S|Cell counting|

---

SE528697C2|2005-03-11|2007-01-30|Hemocue Ab|Volumetric determination of the number of white blood cells in a blood sample|

---

US20060241495A1|2005-03-23|2006-10-26|Eastman Kodak Company|Wound healing monitoring and treatment|

---

WO2007012975A1|2005-03-29|2007-02-01|Inverness Medical Switzerland Gmbh|Hybrid device|

---

EP2605020B1|2005-03-29|2017-05-17|Sysmex Corporation|Method of specimen analysis and specimen analyzer|

---

EP2453223B1|2005-04-12|2019-07-03|Caliper Life Sciences Inc.|Optical detection system for a microfluidic device and method for aligning and focusing an optical detection system|

---

US20070014695A1|2005-04-26|2007-01-18|Applera Corporation|Systems and Methods for Multiple Analyte Detection|

---

EP2312317A3|2005-05-03|2011-06-08|Life Technologies Corporation|Fluorescent detection system and dye set for use therewith|

---

EP1910824A4|2005-05-31|2012-11-21|Labnow Inc|Methods and compositions related to determination and use of white blood cell counts|

---

CA2610753C|2005-09-13|2014-04-29|Edwards Lifesciences Corporation|Continuous spectroscopic measurement of total hemoglobin|

---

DE102005052752A1|2005-11-04|2007-05-10|Clondiag Chip Technologies Gmbh|Apparatus and method for detecting molecular interactions|

---

US8353848B2|2005-11-21|2013-01-15|Alere Switzerland Gmbh|Test device|

---

JP4887989B2|2005-12-02|2012-02-29|ナノフォトン株式会社|Optical microscope and spectrum measuring method|

---

US7515268B1|2006-02-02|2009-04-07|E.I. Spectra, Llc|Fluorescence-activated cell detector|

---

JP4758793B2|2006-03-16|2011-08-31|シスメックス株式会社|Sample analysis method and sample analyzer|

---

SE531233C2|2006-03-28|2009-01-27|Hemocue Ab|Apparatus and method for detecting fluorescently labeled biological components|

---

US7790464B2|2006-05-04|2010-09-07|Blaze Medical Devices, LLC|Blood hemolysis analyzer|

---

SE530244C2|2006-05-05|2008-04-08|Hemocue Ab|Method and system for quantitative hemoglobin determination|

---

EP2041573B1|2006-06-23|2019-09-04|PerkinElmer Health Sciences, Inc.|Methods and devices for microfluidic point-of-care immunoassays|

---

SE530750C2|2006-07-19|2008-09-02|Hemocue Ab|A measuring device, a method and a computer program|

---

WO2008037068A1|2006-09-29|2008-04-03|Ottawa Health Research Institute|Correlation technique for analysis of clinical condition|

---

US7952692B2|2006-12-12|2011-05-31|Orsense Ltd.|Method and apparatus for determination of analyte concentration|

---

US8244021B2|2006-12-20|2012-08-14|Ventana Medical Systems, Inc.|Quantitative, multispectral image analysis of tissue specimens stained with quantum dots|

---

US7738094B2|2007-01-26|2010-06-15|Becton, Dickinson And Company|Method, system, and compositions for cell counting and analysis|

---

US20080213823A1|2007-02-23|2008-09-04|Christensen Kenneth A|Capillary-channeled polymer film flow cytometry|

---

US7518727B2|2007-02-28|2009-04-14|Beckman Coulter, Inc.|Multicapillary multilaser detection system|

---

EP2153208A1|2007-04-12|2010-02-17|Regents of the University of Minnesota|Systems and methods for analyzing a particulate|

---

US8361782B2|2007-05-02|2013-01-29|Siemens Healthcare Diagnostics, Inc.|Piezo dispensing of a diagnostic liquid into microfluidic devices|

---

EP1990638A1|2007-05-11|2008-11-12|Koninklijke Philips Electronics N.V.|Flow-through biosensor|

---

JP2009002933A|2007-05-24|2009-01-08|Taiyo Yuden Co Ltd|Analytical medium|

---

US7816135B2|2007-07-05|2010-10-19|Becton, Dickinson And Company|Method of analyzing lymphocytes|

---

US7993608B2|2007-08-07|2011-08-09|Massachusetts Institute Of Technology|Fluid injection port|

---

SE532499C2|2008-01-18|2010-02-09|Hemocue Ab|Method and apparatus for analyzing particles in a liquid sample|

---

AU2009217355A1|2008-02-21|2009-08-27|Avantra Biosciences Corporation|Assays based on liquid flow over arrays|

---

US7903241B2|2008-03-21|2011-03-08|Abbott Point Of Care, Inc.|Method and apparatus for determining red blood cell indices of a blood sample utilizing the intrinsic pigmentation of hemoglobin contained within the red blood cells|

---

KR100968524B1|2008-04-11|2010-07-08|인싸이토 주식회사|Micoro-nano fluidic biochip for assaying biomass|

---

US8306594B2|2008-06-12|2012-11-06|Paseman Sabrina K|Transmission fluorometer|

---

US9017946B2|2008-06-23|2015-04-28|Canon U.S. Life Sciences, Inc.|Systems and methods for monitoring the amplification of DNA|

---

WO2010019515A2|2008-08-10|2010-02-18|Board Of Regents, The University Of Texas System|Digital light processing hyperspectral imaging apparatus|

---

JP4762303B2|2008-12-25|2011-08-31|シャープ株式会社|Micro analysis chip|

---

AU2010206657A1|2009-01-23|2011-08-11|Drexel University|Apparatus and methods for detecting inflammation using quantum dots|

---

DE102009016712A1|2009-04-09|2010-10-14|Bayer Technology Services Gmbh|Disposable microfluidic test cassette for bioassay of analytes|

---

US20100291599A1|2009-05-18|2010-11-18|Bruker Optics, Inc.|Large area scanning apparatus for analyte quantification by surface enhanced raman spectroscopy and method of use|

---

EP2550351A4|2010-03-25|2014-07-09|Quantalife Inc|Detection system for droplet-based assays|

---

WO2011133540A2|2010-04-19|2011-10-27|Research Foundation Of State University Of New York|Capillary biosensor system and its method of use|

---

EP2563901A4|2010-04-28|2018-03-21|Siemens Healthcare Diagnostics Inc.|Sample analysis system and method of use|

---

JP5336425B2|2010-05-24|2013-11-06|日本電信電話株式会社|Gas measuring method and apparatus|

---

JP5462084B2|2010-06-21|2014-04-02|オリンパス株式会社|Image processing apparatus and program|

---

JP5092104B2|2010-08-30|2012-12-05|ナノフォトン株式会社|Spectrometer and spectroscopic method|

---

JP5743558B2|2011-01-12|2015-07-01|株式会社東芝|Analysis equipment|

---

EP2780705B1|2011-11-16|2018-09-19|Becton, Dickinson and Company|Methods and systems for detecting an analyte in a sample|

---

CN104755925B|2013-01-11|2017-06-23|贝克顿·迪金森公司|The point-of-care of low cost determines device|

---

BR112016009958B1|2013-11-06|2021-08-03|Becton, Dickinson And Company|MICROFLUIDIC DEVICE, METHOD, SYSTEM AND KIT|EP2780705B1|2011-11-16|2018-09-19|Becton, Dickinson and Company|Methods and systems for detecting an analyte in a sample|

---

CN104755925B|2013-01-11|2017-06-23|贝克顿·迪金森公司|The point-of-care of low cost determines device|

---

BR112016009958B1|2013-11-06|2021-08-03|Becton, Dickinson And Company|MICROFLUIDIC DEVICE, METHOD, SYSTEM AND KIT|

---

EP3692914A1|2014-10-14|2020-08-12|Becton, Dickinson and Company|Blood sample management using open cell foam|

---

CA2966701A1|2014-11-07|2016-05-12|National Research Council Canada|Compact apparatus for laser induced breakdown spectroscopy and method therefor|

---

US9759651B2|2014-12-23|2017-09-12|Magellan Diagnostics, Inc.|Combination optical hemoglobin and electrochemical lead assay|

---

CN106604780B|2015-03-10|2019-06-25|贝克顿·迪金森公司|The micro- sample management device of biofluid|

---

JP6817284B2|2015-03-25|2021-01-20|ヴィータビーム リミテッド|Methods and devices for stimulating plant growth and growth with near-infrared and visible light|

---

WO2017033809A1|2015-08-26|2017-03-02|倉敷紡績株式会社|Cell measurement method|

---

US10613096B2|2015-08-28|2020-04-07|Captl Llc|Multi-spectral microparticle-fluorescence photon cytometry|

---

CA2996863C|2015-09-01|2021-04-13|Becton, Dickinson And Company|Depth filtration device for separating specimen phases|

---

US9933411B2|2016-02-04|2018-04-03|Nova Biomedical Corporation|Analyte system and method for determining hemoglobin parameters in whole blood|

---

US10151630B2|2016-02-04|2018-12-11|Nova Biomedical Corporation|Analyte system and method for determining hemoglobin parameters in whole blood|

---

US10088468B2|2016-02-04|2018-10-02|Nova Biomedical Corporation|Analyte system and method for determining hemoglobin parameters in whole blood|

---

US10088360B2|2016-02-04|2018-10-02|Nova Biomedical Corporation|Spectroscopic analyte system and method for determining hemoglobin parameters in whole blood|

---

US10753862B2|2016-02-16|2020-08-25|Stichting Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis|Method, apparatus and software for detection and localization of hidden defects in optically diffuse media|

---

JP1568300S|2016-06-07|2017-05-29|

---

CN110192097A|2016-11-18|2019-08-30|美国西门子医学诊断股份有限公司|The sequence multi-wavelength of liquid assay object measures|

---

CA3047272A1|2016-12-16|2018-06-21|Siemens Healthcare Diagnostics Inc.|Simultaneous measurement of multiple analytes of a liquid assay|

---

WO2018144633A1|2017-01-31|2018-08-09|Theranos Ip Company, Llc|Methods and devices for improved signal detection from biological samples|

---

US20200023360A1|2017-03-22|2020-01-23|The Board Trustees Of The University Of Illinois|System for Rapid, Portable, and Multiplexed Detection and Identification of Pathogen Specific Nucleic Acid Sequences|

---

WO2018191497A2|2017-04-13|2018-10-18|Captl Llc|Photon counting and spectroscopy|

---

CN107220625B|2017-06-01|2020-05-01|中国海洋大学|LIBS spectrum automatic identification and classification method for sample|

---

JP2021097599A|2018-03-30|2021-07-01|住友ベークライト株式会社|Plastic product|

---

CN110057788B|2019-05-23|2021-11-05|上海景瑞阳实业有限公司|Nano material absorbance test device, and stabilization phase test method, system and device|

---

US11161109B2|2019-09-19|2021-11-02|Invidx Corp.|Point-of-care testing cartridge with sliding cap|

法律状态:
2020-03-10| B06U| Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]|

---

2020-08-04| B06A| Notification to applicant to reply to the report for non-patentability or inadequacy of the application [chapter 6.1 patent gazette]|

---

2021-03-30| B09A| Decision: intention to grant [chapter 9.1 patent gazette]|

---

2021-06-01| B16A| Patent or certificate of addition of invention granted|Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 10/11/2014, OBSERVADAS AS CONDICOES LEGAIS. |

优先权:

---

申请号 | 申请日 | 专利标题

---

US201361903804P| true| 2013-11-13|2013-11-13|

---

US61/903,804|2013-11-13|

---

US201461949833P| true| 2014-03-07|2014-03-07|

---

US61/949,833|2014-03-07|

---

PCT/US2014/064873|WO2015073384A1|2013-11-13|2014-11-10|Microimager analysis system comprising optics and methods of use thereof|

---